Element Solutions (ESI) 10-K30 Mar 152014 FY Annual reportFinancial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
Document And Entity Information (USD $)	Dec. 31, 2014	Mar. 23, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	Platform Specialty Products Corp
Document Type	10-K
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		192,220,472
Entity Public Float			$1,900,000,000
Amendment Flag	FALSE
Entity Central Index Key	1590714
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	9 Months Ended		10 Months Ended		12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013		Oct. 31, 2013		Dec. 31, 2014		Dec. 31, 2012
Net sales	$118.20	[1]	$627.70	[1]	$843.20	[1]	$731.20	[1]
Restructuring					3
Operating profit (loss)	27.4		152.7		212.2		162.2
Other (expense) income, net					-2.5
Income tax benefit (provision)	5.8		-13		6.7		-24.7
Net (loss) income			13.5				46.3
Weighted average shares outstanding (In millions)
Basic (in Shares)					135,300
Diluted (in Shares)					135,300
Successor [Member]
Net sales	118.2				843.2
Cost of sales	82.5				446.6
Gross profit	35.7				396.6
Selling, technical, general and administrative	54.5				357.9
Non-cash charge related to preferred stock dividend rights	172
Research and development	4				26.2
Restructuring	0.8				3
Total operating expenses	231.3				387.1
Operating profit (loss)	-195.6				9.5
Interest, net	-5.4				-37.9
Other (expense) income, net	-0.4				-2.5
Other expense	-5.8				-40.4
(Loss) income before income taxes, non-controlling interests and dividends on preferred shares	-201.4				-30.9
Income tax benefit (provision)	5.8				6.7
Net (loss) income	-195.6				-24.2
Net loss (income) attributable to the non-controlling interests	1.4				-5.7
Net (loss) income attributable to shareholders	-194.2				-29.9
Accrued stock dividend on Founder's preferred shares					-232.7
Accrued payment-in-kind dividend on cumulative preferred shares					-232.7
Net (loss) income attributable to common shares	-194.2				-262.6
Earnings (loss) per share
Basic (in Dollars per share)	($2.10)				($1.94)
Diluted (in Dollars per share)	($2.10)				($1.94)
Weighted average shares outstanding (In millions)
Basic (in Shares)	92.6				135
Diluted (in Shares)	92.6				135
Predecessor [Member]
Net sales			627.7				731.2
Cost of sales			304.9				376.1
Gross profit			322.8				355.1
Selling, technical, general and administrative			207.6				214.6
Research and development			19.9				25.1
Restructuring			3.6				0.3
Total operating expenses			231.1				240
Operating profit (loss)			91.7				115.1
Interest, net			-45.9				-49.1
Loss on extinguishment of debt			-18.8
Other (expense) income, net	-0.5		-0.5				5
Other expense			-65.2				-44.1
(Loss) income before income taxes, non-controlling interests and dividends on preferred shares			26.5				71
Income tax benefit (provision)			-13				-24.7
Net (loss) income			13.5				46.3
Net loss (income) attributable to the non-controlling interests			-0.3				-0.3
Net (loss) income attributable to shareholders			13.2				46
Accrued payment-in-kind dividend on cumulative preferred shares			-22.4				-44.6
Net (loss) income attributable to common shares			($9.20)				$1.40
Earnings (loss) per share
Basic (in Dollars per share)
Diluted (in Dollars per share)
Weighted average shares outstanding (In millions)
Basic (in Shares)
Diluted (in Shares)

[1]	Net sales are attributed to countries based on the country which generates the sale.

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive (Loss) Income (USD $)	10 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2014
Net (loss) income	$13.50	$46.30
Derivative financial instrument revaluation
Other comprehensive (loss) income, net of tax	14.4	-15.3
Accrued payment-in-kind dividend on cumulative preferred shares		0.1
Successor [Member]
Net (loss) income			-195.6	-24.2
Foreign currency translation adjustments
Foreign currency translation adjustments arising during the period			-0.6	-121.4
Pension and postretirement plans
Net actuarial (loss) gain arising during the period			3.8	-25.3
Net (gain) loss recognized during the year			-0.2
Translation adjustment				0.6
			3.6	-24.7
Tax benefit (expense)			-1.8	8
			1.8	-16.7
Unrealized gain on available for sale securities
			1.3	-138.3
Derivative financial instrument revaluation
Unrealized hedging (loss) gain arising during the period			0.2	-0.2
			0.2	-0.2
Tax benefit (expense)			-0.1	0.1
			0.1	-0.1
Other comprehensive (loss) income, net of tax			1.3	-138.2
Comprehensive (loss) income			-194.3	-162.4
Comprehensive (loss) income attributable to the non-controlling interests			1.4	0.7
Comprehensive (loss) income attributable to shareholders			-195.7	-163.1
Accrued stock dividend on Founder's preferred shares				-232.7
Comprehensive (loss) income attributable to Common Shareholders			-195.7	-395.8
Predecessor [Member]
Net (loss) income	13.5	46.3
Foreign currency translation adjustments
Foreign currency translation adjustments arising during the period	-6.1	-5.5
Pension and postretirement plans
Net actuarial (loss) gain arising during the period	28.4	-17.4
Prior service costrecognized during the year		-0.4
Net (gain) loss recognized during the year	2	1.2
Translation adjustment	0.3	-0.7
	30.7	-17.3
Tax benefit (expense)	-10.1	5.4
	20.6	-11.9
Unrealized gain on available for sale securities
Unrealized holding gain on available for sale securities	0.2	0.3
	0.2	0.3
Tax benefit (expense)	-0.1	-0.1
	0.1	0.2
Derivative financial instrument revaluation
Unrealized hedging (loss) gain arising during the period	-0.3	3
	-0.3	3
Tax benefit (expense)	0.1	-1.1
	-0.2	1.9
Other comprehensive (loss) income, net of tax	14.4	-15.3
Comprehensive (loss) income	27.9	31
Comprehensive (loss) income attributable to the non-controlling interests	-0.3	-0.3
Comprehensive (loss) income attributable to shareholders	28.2	31.3
Accrued stock dividend on Founder's preferred shares	-22.4	-44.6
Accrued payment-in-kind dividend on cumulative preferred shares	-22.4	-44.6
Comprehensive (loss) income attributable to Common Shareholders	$5.80	($13.30)

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Assets
Cash & cash equivalents	$397.30		$123
Restricted cash	600
Accounts receivable, net of allowance for doubtful accounts of $9.6 and $10.1 at December 31, 2014 and 2013, respectively	327.3		140.5
Inventories	205.8		89.6
Prepaid expenses & other current assets	48		30.4
Total current assets	1,578.40		383.5
Property, plant & equipment, net	175	[1]	136.2	[1]
Goodwill	1,405.30		989.8
Intangible assets, net	1,341.50		720.3
Other assets	57.4		30.4
Total assets	4,557.60		2,260.20
Liabilities & Stockholders' Equity
Accounts payable	106.7		56.2
Accrued salaries, wages and employee benefits	31.3		22.7
Current installments of long-term debt	15.1		8
Accrued income taxes payable	16.7		6.7
Accrued acquisition payable	14.3
Accrued expenses and other current liabilities	58.5		26.1
Total current liabilities	242.6		119.7
Long-term debt	1,400.80		744.3
Long-term retirement benefits, less current portion	38.8		25.1
Long-term deferred income taxes	202.3		169.8
Long-term contingent consideration	63.9		34.8
Other long-term liabilities	56.6		30.4
Total liabilities	2,005		1,124.10
Redeemable 401(k) plan interest			21
Stockholders' Equity
Common shares, 400,000,000 and 200,000,000 shares authorized, 182,066,980 and 103,571,941 shares issued and outstanding at December 31, 2014 and 2013, respectively. 10,050,290 shares declared for stock dividend at December 31, 2014	1.9
Additional paid-in capital	2,812.40		1,212
Accumulated deficit	-224.1		-194.2
Accumulated other comprehensive (loss) income	-130.6		1.3
Total stockholders equity	2,459.60		1,019.10
Non-controlling interests	93		96
Total equity	2,552.60		1,115.10
Total liabilities, redeemable 401(k) plan interest and stockholders equity	$4,557.60		$2,260.20

[1]	Long-lived assets represent property, plant and equipment, net.

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Accounts receivable, allowance for doubtful accounts (in Dollars)	$9.60	$10.10
Common shares authorized	400,000,000	400,000,000
Common shares issued	182,066,980	103,571,941
Common shares outstanding	182,066,980	103,571,941
Series A Preferred Stock [Member]
Preferred shares authorized	5,000,000	5,000,000
Preferred shares issued	2,000,000	2,000,000
Preferred shares issued	2,000,000	2,000,000

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2014	Dec. 31, 2012
Cash flows from operating activities:
Net (loss) income		$13.50		$46.30
Adjustments to reconcile net (loss) income from operations to net cash flows provided by operating activities:
Depreciation and amortization	12.8	32.8	88	42.2
Deferred income taxes	-7.5	-4.8	-43.2	-8.3
Cash flows from financing activities:
Cash and cash equivalents at beginning of period			123
Cash and cash equivalents at end of period	123		397.3
Successor [Member]
Cash flows from operating activities:
Net (loss) income	-195.6		-24.2
Adjustments to reconcile net (loss) income from operations to net cash flows provided by operating activities:
Non-cash charge related to preferred stock dividend rights	172
Depreciation and amortization	12.8		88
Deferred income taxes	-7.5		-43.2
Manufacturer's profit in inventory adjustment	23.9		35.5
Non-cash fair value adjustment to contingent consideration	-0.7		29.1
Restructuring charges	0.8		1.5
Provision for bad debt	0.3		1.2
Equity compensation expense	0.5		1.3
Other, net	-0.9		3.2
Changes in assets & liabilities, net of acquisitions:
Accounts receivable	6.2		4.9
Inventory	2.1		11.4
Accounts payable	-0.2		10.9
Accrued expenses	-8.7		-15.7
Other assets and liabilities	2.5		-5.7
Net cash flows provided by operating activities	7.5		98.2
Cash flows from investing activities:
Capital expenditures	-2.3		-18.5
Proceeds from sale of non-financial assets	4.4		0.6
Acquisition of business, net of cash acquired	-922.4		-1,361.80
Cash restricted to fund acquisition			-600
Purchases of marketable securities	-359.9
Redemption of marketable securities	359.9
Other, net			-3
Net cash flows used in investing activities	-920.3		-1,982.70
Cash flows from financing activities:
Proceeds from issuance of debt, net of discount and fees	0.2		678.8
Repayments of borrowings	-2.2		-9.1
Proceeds from issuance of preferred stock, net	20
Proceeds from issuance of common stock, net	1,019.50		1,512.60
Payment of financing fees	-1.8		-13.2
Other, net			-0.2
Net cash flows provided by (used in) financing activities	1,035.70		2,168.90
Effect of exchange rate changes on cash and cash equivalents	0.1		-10.1
Net increase (decrease) in cash and cash equivalents	123		274.3
Cash and cash equivalents at beginning of period			123
Cash and cash equivalents at end of period	123		397.3
Supplemental disclosure information:
Cash paid for interest	5.1		36.3
Cash paid for income taxes	2.9		27.5
Non-cash investing activities:
Unpaid capital expenditures included in accounts payable and accrued expenses			2.4
Predecessor [Member]
Cash flows from operating activities:
Net (loss) income		13.5		46.3
Adjustments to reconcile net (loss) income from operations to net cash flows provided by operating activities:
Depreciation and amortization		32.8		42.2
Deferred income taxes		-4.8		-8.4
Loss on extinguishment of debt		18.8
Restructuring charges		3.6		0.3
Provision for bad debt		2.1		1.7
Equity compensation expense		9.3		0.2
Other, net		1.4		-1.7
Changes in assets & liabilities, net of acquisitions:
Accounts receivable		-11.3		-4.9
Inventory		-4.6		0.8
Accounts payable		2.4		3.3
Accrued expenses		3.9		-3.6
Other assets and liabilities		-11.1		-1
Net cash flows provided by operating activities		56		75.2
Cash flows from investing activities:
Capital expenditures		-8.9		-13.4
Proceeds from sale of non-financial assets		2.1		0.1
Acquisition of business, net of cash acquired				-5.1
Other, net		-1		0.1
Net cash flows used in investing activities		-7.8		-18.3
Cash flows from financing activities:
Proceeds from issuance of debt, net of discount and fees		1,109.50
Repayments of borrowings		-732.9		-26.1
Repurchase of Series A preferred stock		-270.2
Advance from Platform Acquisition Holdings Limited		33.3
Payment of accumulated dividends on Series A preferred stock		-229.8
Payment of financing fees		-13.6		-0.3
Other, net		-0.6		-0.8
Net cash flows provided by (used in) financing activities		-104.3		-27.2
Effect of exchange rate changes on cash and cash equivalents		-0.2		0.2
Net increase (decrease) in cash and cash equivalents		-56.3		29.9
Cash and cash equivalents at beginning of period		143.4		113.5
Cash and cash equivalents at end of period		87.1		143.4
Supplemental disclosure information:
Cash paid for interest		50		45.2
Cash paid for income taxes		21.8		27.1
Non-cash financing activities:
Cash paid by Platform Acquisition Holdings, Ltd for interest		$5

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Equity (USD $)	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Treasury Stock [Member]	Parent [Member]	Noncontrolling Interest [Member]	Predecessor [Member]	Total
In Millions	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Predecessor [Member]	Total
Balance at Dec. 31, 2011	$480.50		$50	$2.20	($274.50)	($15)	($1)	$242.20	($0.40)		$241.80
Net income					46			46	0.3	46.3	46.3
Other comprehensive income (loss) net of taxes						-15.3		-15.3		-15.3	-15.3
Equity compensation				0.2				0.2			0.2
Accrual of paid in kind dividend on cumulative preferred shares	44.5				-44.6			-0.1		44.6	-0.1
Shares repurchased							-0.2	-0.2			-0.2
Dividend paid to non-controlling interest partner									-0.6		-0.6
Assignment of value for non controlling interest in business acquisition									0.4		0.4
Balance at Dec. 31, 2012	525		50	2.4	-273.1	-30.3	-1.2	272.8	-0.3		272.5
Net income					13.2			13.2	0.3	13.5	13.5
Other comprehensive income (loss) net of taxes						14.4		14.4		14.4	14.4
Equity compensation				0.2				0.2			0.2
Accrual of paid in kind dividend on cumulative preferred shares	20.8	1.6			-22.4					22.4
Shares repurchased	-500							-500			-500
Shares exchanged	-45	45
Shares canceled	-0.8		-0.4				1.2
Dividend paid to non-controlling interest partner									-0.6		-0.6
Balance at Oct. 31, 2013	$0	$46.60	$49.60	$2.60	($282.30)	($15.90)		($199.40)	($0.60)		($200)

Consolidated_Statement_of_Chan1

Consolidated Statement of Changes in Stockholders' Equity

Issued on April 25, 2013 [Member]

Preferred Shares Issued On May 22, 2013 [Member]

Issued on May 22, 2013 [Member]

Issued on October 30, 2013 [Member]

Issued on November 13, 2013 [Member]

Issued on November 20, 2013 [Member]

Additional Shares Issued December 23, 2013 [Member]

Issued on January 5, 2014 [Member]

Issued on May 20, 2014 [Member]

Shares Issued In Connection With 401(k) Exchange Agreement [Member]

Issued On October 8Th, 2014 [Member]

Issued On November 6, 2014 [Member]

Issued On November 17, 2014 [Member]

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Parent [Member]

Noncontrolling Interest [Member]

Successor [Member]

Total

Preferred Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Parent [Member]

Successor [Member]

Agriphar [Member]

Chemtura [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Successor [Member]

USD ($)

Agriphar [Member]

Chemtura [Member]

USD ($)

Agriphar [Member]

Chemtura [Member]

USD ($)

Agriphar [Member]

Chemtura [Member]

USD ($)

EUR (€)

USD ($)

Balance at Apr. 22, 2013

Net loss

($194,200,000)

($1,400,000)

($195,600,000)

Other comprehensive income loss net of taxes

1,300,000

Issuance of stock

20,000,000

885,000,000

8,000,000

3,900,000

Issuance of stock (in Shares)

1,999,998

88,529,500

761,904

351,591

Assignment of value for non controlling interest in business acquisition

97,400,000

Issuance costs

-24,100,000

Equity compensation expense

500,000

Exercise of warrants

137,200,000

4,100,000

5,400,000

Exercise of warrants (in Shares)

13,071,199

391,081

466,666

Preferred stock dividend rights

172,000,000

Balance at Dec. 31, 2013

1,212,000,000

-194,200,000

1,300,000

1,019,100,000

96,000,000

1,115,100,000

Balance (in Shares) at Dec. 31, 2013

2,000,000

103,571,941

Net loss

-29,900,000

5,700,000

-24,200,000

Other comprehensive income loss net of taxes

-131,900,000

-6,400,000

-138,300,000

Impact of Domestication

1,000,000

-1,000,000

Issuance of stock

200,000

300,000,000

300,200,000

18,400,000

200,000

410,800,000

411,000,000

240,600,000

200,000

402,700,000

402,900,000

Issuance of stock (in Shares)

3,959

15,800,000

1,670,386

16,060,960

9,404,064

16,445,000

Issuance of common shares to Directors on July 31, 2014 (in Shares)

9,242

Issuance of common shares from Employee Stock Purchase Plan

200,000

11,139,000

Issuance of common shares from Employee Stock Purchase Plan (in Shares)

11,139

Issuance costs

-13,800,000

-300,000

-15,100,000

Declaration of stock dividend on Founders' preferred shares

100,000

-100,000

232,700,000

Recovery of short swing profits, net

500,000

Issuance of common shares in connection with Acquisition

16,600,000

52,000,000

16,600,000

52,000,000

16,600,000

15,000,000

52,000,000

Issuance of common shares in connection with Acquisition (in Shares)

711,551

2,000,000

Equity compensation expense

700,000

Conversion of PDH non-controlling interest to common shares

1,500,000

-1,500,000

Conversion of PDH non-controlling interest to common shares (in Shares)

134,044

Distribution to non-controlling interest

-800,000

Exercise of warrants

200,000

186,700,000

186,900,000

Exercise of warrants (in Shares)

16,244,694

Balance at Dec. 31, 2014

1,900,000

2,812,400,000

-224,100,000

-130,600,000

2,459,600,000

93,000,000

2,552,600,000

Balance (in Shares) at Dec. 31, 2014

2,000,000

182,066,980

Balance at Dec. 30, 2014

Issuance of common shares in connection with Acquisition

$18,200,000

Balance (in Shares) at Dec. 31, 2014

2,000,000

Consolidated_Statement_of_Chan2

Consolidated Statement of Changes in Stockholders' Equity (Parentheticals) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2014
Issued on April 25, 2013 [Member] \| Preferred Stock [Member] \| Successor [Member]
Issuance of common shares, share price	10
Preferred Shares Issued On May 22, 2013 [Member] \| Preferred Stock [Member] \| Successor [Member]
Issuance of common shares, share price	10
Issued on May 22, 2013 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price	10
Issued on October 30, 2013 [Member] \| Common Stock [Member] \| Successor [Member]
Exercise of warrants, exercise price	10.5
Issued on November 13, 2013 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price	10.5
Exercise of warrants, exercise price	10.5
Issued on November 20, 2013 [Member] \| Common Stock [Member] \| Successor [Member]
Exchange of warrants, share price	11.5
Additional Shares Issued December 23, 2013 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price	11
Issued on January 5, 2014 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price		$11
Issued on May 20, 2014 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, Private Placement Offering, per share		$19
Shares Issued In Connection With 401(k) Exchange Agreement [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price		$11
Issued On October 8Th, 2014 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, Private Placement Offering, per share		$25.59
Issued On November 6, 2014 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price		$25.59
Issued On November 17, 2014 [Member] \| Common Stock [Member] \| Successor [Member]
Issuance of common shares, share price		$24.50
Preferred Stock [Member] \| Successor [Member]
Matching warrants (in Shares)	2
Common Stock [Member] \| Successor [Member]
Exercise of warrants, exercise price		$11.50

Note_1_Basis_of_Presentation_a

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Description of the Company – Platform Specialty Products Corporation (formerly named “Platform Acquisition Holdings Limited”) is a global, diversified producer of high-technology specialty chemical products and provider of technical services. Platform was originally incorporated with limited liability under the laws of the British Virgin Islands under the BVI Companies Act on April 23, 2013. Until the MacDermid Acquisition on October 31, 2013, Platform had neither engaged in any operations nor generated any income. As such, the Company was considered to be in the development stage as defined in FASB Accounting Standards Codification 915, or FASB ASC 915, “Development Stage Entities,” and was subject to the risks associated with activities of development stage companies. The Company selected December 31 as its fiscal year end. All activity through October 31, 2013 was related to the Company’s formation, Initial Public Offering and identification and investigation of prospective target businesses with which to consummate an initial business combination.

	On October 31, 2013, we completed the MacDermid Acquisition pursuant to which we indirectly acquired substantially all of the equity of MacDermid Holdings, which, at the time, owned approximately 97% of MacDermid. As a result, we became a holding company for the MacDermid business. We acquired the remaining 3% of MacDermid on March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between us and the fiduciaries of the 401K Plan. Concurrently with the closing of the MacDermid Acquisition, we changed our name to “Platform Specialty Products Corporation.” On January 22, 2014, we completed our Domestication and on January 23, 2014, our common stock, par value $0.01 per share, began trading on the NYSE under the ticker symbol “PAH.”

	Business Description – Our business involves the formulation of a broad range of specialty chemicals, created by blending raw materials, through multi-step technological processes or formulating AIs into final agricultural products, which can be easily and safely used by growers in the fields. These specialty chemicals are sold into multiple industries including agrochemical, electronics, graphic arts, metal and plastic plating, and offshore oil production and drilling industries. We refer to our products as “dynamic chemistries” due to their intricate chemical compositions. We deliver our products to our customers through our sales and service workforce, regional distributors, as well as manufacturing representatives. The financial statements and information included herein represent Platform as of December 31, 2014 and 2013 and for the year ended December 31, 2014 and the period from April 23, 2013 (inception) through December 31, 2013, and MacDermid for the ten month period ended October 31, 2013 and the year ended December 31, 2012, which was prior to the consummation of the MacDermid Acquisition.

	Principles of Consolidation – The accompanying consolidated financial statements include the accounts of the Successor or the Predecessor, as applicable, and all of its majority-owned domestic and foreign subsidiaries. All intercompany accounts and transactions were eliminated in consolidation.

	Use of Estimates – In preparing the consolidated financial statements in conformity with U.S. GAAP, company management must undertake decisions that impact the reported amounts and related disclosures. Such decisions include the selection of the appropriate accounting principles to be applied and assumptions upon which accounting estimates are based. The Company applies judgment based on its understanding and analysis of the relevant circumstances to reach these decisions. By their nature, these judgments are subject to an inherent degree of uncertainty. Accordingly, actual results could differ significantly from the estimates applied. Significant items subject to such estimates and assumptions include: the useful lives of fixed assets, allowances for doubtful accounts and sales returns, deferred tax asset valuation allowances, inventory valuation, stock-based compensation, liabilities for employee benefit obligations, environmental liabilities, income tax uncertainties, valuation of goodwill, acquisition-related contingent consideration, as discussed in Note 2 below, and other contingencies.

	Cash and Cash Equivalents – The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents.

	The Company is required to maintain cash deposits with certain banks with respect to contractual obligations related to our acquisition activity. As of December 31, 2014, $600 million of cash was restricted related to the Arysta Acquisition. As of December 31, 2013, the Company was not required to maintain any restricted cash deposits.

	Credit Risk Management – The Company’s products are sold primarily to customers in the agricultural, automotive, oil, electronic and printing industries. We are exposed to certain collection risks which are subject to a variety of factors, including economic and technological change within these industries. As is common industry practice, the Company generally does not require collateral or other security as a condition of sale, rather relying on credit approval, balance limitation and monitoring procedures to control credit risk on trade accounts receivable. The Company establishes reserves against estimated uncollectible amounts based on historical experience and specific knowledge regarding customers’ ability to pay.

	Derivatives – The Company operates internationally, with manufacturing and sales facilities in various locations around the world, and uses certain financial instruments to manage its foreign currency exposures. To qualify a derivative as a hedge at inception and throughout the hedge period, the Company formally documents the nature and relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategies for undertaking various hedge transactions, and the method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of a forecasted transaction are specifically identified, and the likelihood of each forecasted transactions of occurring is deemed probable. If it is determined that the forecasted transaction will not occur, the gain or loss is recognized in current earnings. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. The Company does not engage in trading or other speculative use of financial instruments.

	The Company has used and may use forward contracts and options to mitigate its exposure to changes in foreign currency exchange rates on third party and intercompany forecasted transactions. If hedge accounting is applied, the effective portion of unrealized gains and losses associated with forward contracts and the intrinsic value of option contracts are deferred as a component of other comprehensive income until the underlying hedged transactions are reported in the Company’s Consolidated Statements of Operations.

	The Company has also used and may use contracts and options to mitigate its exposure in the precious metals markets. Such contracts are designated as Normal Purchases, the effects of which are not deferred as components of other comprehensive income.

	Inventories – Inventories are stated at the lower of cost or market with cost being determined principally by the first-in/first-out method. The Company regularly reviews inventories for obsolescence and excess quantities and calculates a reserve based on historical write-offs, customer demand, product evolution, usage rates and quantities of stock on hand. Inventory in excess of estimated usage requirements is written down to its estimated net realizable value.

	Property, Plant and Equipment – Property, plant and equipment are stated at cost less accumulated depreciation. Equipment under capital lease arrangements is stated at the net present value of minimum lease payments. The Company records depreciation on a straight-line basis over the estimated useful life of each asset. Estimated useful lives by asset class are as follows:

	Buildings and building improvements (years) -	5	to	20
	Machinery, equipment and fixtures (years) -	3	to	15
	Computer hardware and software (years) -	3	to	5
	Leasehold improvements -	Lesser of useful life
		or lease life

	Maintenance and repair costs are charged directly to expense; renewals and betterments which significantly extend the useful life of the asset are capitalized. Costs and accumulated depreciation on assets retired or disposed of are removed from the accounts and any resulting gains or losses are recorded to earnings in the period of disposal.

	Goodwill and Indefinite-Lived Purchased Intangible Assets – Goodwill represents the excess of the acquisition cost over the fair value of the identifiable net assets of an acquired business. The Company does not amortize goodwill and other intangible assets that have indefinite useful lives; rather, goodwill and other intangible assets with indefinite lives are tested for impairment. Goodwill is tested for impairment at the reporting unit level annually, or when events or changes in circumstances indicate that goodwill might be impaired in accordance with ASC 350-20 “Intangibles—Goodwill and Other”. MacDermid’s annual test for goodwill impairment was historically performed as of April 1. Our annual impairment testing date for goodwill is October 1.

	A two-step impairment test is performed at the reporting unit level. In the first step of impairment testing, the fair value of each reporting unit is compared to its carrying value. The fair value of each reporting unit is determined using the income approach based on the present value of discounted future cash flows of those units using the twelve months ended preceding the date of impairment testing. The cash flows utilized in goodwill impairment testing differ from actual consolidated cash flows due to exclusion of non-recurring charges. The cash flow model utilized in the goodwill impairment test involves significant judgments related to future growth rates, working capital needs, discount rates and tax rates, among other considerations. The Company relies on data developed by business unit management as well as macroeconomic data in making these calculations. The discounted cash flow model utilizes a risk adjusted weighted average cost of capital to discount estimated future cash flows. Changes in these estimates can impact the present value of the expected cash flow that is used in determining the fair value of a given reporting unit. If the fair value of a reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and no further testing is required. If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the second step of the impairment test is performed to determine the implied fair value of the reporting unit’s goodwill. The implied fair value of goodwill is determined by measuring the excess of the estimated fair value of the reporting unit over the estimated fair values of the individual assets, liabilities and identifiable intangibles as if the reporting unit was being acquired in a business combination. If the carrying value of the reporting unit’s goodwill exceeds its implied fair value, an impairment charge is recorded equal to the difference. Platform performed its annual goodwill assessment on October 1, and no goodwill impairment charges were recorded for the year ended December 31, 2014.

	However, in performing the first step of the goodwill impairment test for the year ended December 31, 2014, the excess of the fair value of the Offshore and ASF Americas reporting units over their carrying values were 7.6% and 11.1% respectively. Goodwill assigned to the Offshore and ASF Americas reporting units totaled $364 million and $78.3 million, respectively. We determine the fair value of these reporting units as follows:

		·	Valuation Techniques - we use discounted cash flow analyses, which require assumptions about short and long-term net cash flows, growth rates, as well as discount rates. Additionally, we consider guideline company and guideline transaction information, where available, to aid in the valuation of the reporting units.

		·	Growth Assumptions - Multi-year financial forecasts are developed for each reporting unit by considering several key business drivers such as new business initiatives, client service and retention standards, market share changes, historical performance, and industry and economic trends, among other considerations. The annual revenue growth rates used in the initial seven year period range from (0.7%) to 9% for Offshore and 2.3% to 5.9% for ASF Americas. The long-term growth rates used in determining the terminal value of the Offshore and ASF Americas reporting units were estimated at 3.5% and 3.0%, respectively based on management's assessment of the minimum expected terminal growth rate of each reporting unit, as well as broader economic considerations such as gross domestic product and inflation.

		·	Discount Rate Assumptions - Discount rates are estimated based on a Weighted Average Cost of Capital, or WACC. The WACC combines the required return on equity, based on a Modified Capital Asset Pricing Model, which considers the risk-free interest rate, market risk premium, beta, small stock risk premium and a company specific risk premium, with the cost of debt, based on BBB rated corporate bonds, adjusted using an income tax factor. The calculation resulted in a WACC rate of 10.5% for both offshore and ASF Americas.

		·	Estimated Fair Value and Sensitivities - The estimated fair value of each reporting unit is derived from the valuation techniques described above. The estimated fair value of each reporting unit is analyzed in relation to numerous market and historical factors, including current economic and market conditions, company-specific growth opportunities, and guideline company information.

	The estimated fair value of the reporting unit is highly sensitive to changes in these estimates and assumptions; therefore, in some instances, changes in these assumptions could impact whether the fair value of a reporting unit is greater than its carrying value. We perform sensitivity analyses around these assumptions in order to assess the reasonableness of the assumptions and the resulting estimated fair values. Based on the sensitivity analysis performed for the Offshore reporting unit, a 1% decrease it the terminal growth rate or a 1% increase in the WACC rate would have resulted in the carrying value of the net assets to exceed their fair value, making it necessary to proceed to the second step of the impairment test. For ASF Americas, a 1% decrease it the terminal growth rate does not result in the carrying value exceeding their fair value, however, a 1% increase in the WACC rate would have resulted in the carrying value of the net assets to exceed their fair value, making it necessary to proceed to the second step of the impairment test. Ultimately, if any of these assumptions do not materialize in a manner consistent with the Company’s expectations, including discounts rates, annual revenue growth rates and terminal growth rates, there is risk of impairment to recorded goodwill.

	Indefinite-lived intangible assets consist of certain tradenames which are reviewed for potential impairment on an annual basis, or when events or changes in circumstances indicate that indefinite-lived intangible assets might be impaired. MacDermid’s annual test for indefinite-lived intangible assets impairment was historically performed as of April 1. Our annual impairment testing date for indefinite-lived intangible assets is October 1. Indefinite-lived intangible assets are reviewed for impairment by comparing the estimated fair value of the indefinite-lived intangible assets to the carrying value. The estimated fair value of these intangible assets is determined using the “relief from royalty” approach. An impairment loss is recognized when the estimated fair value of an indefinite-lived intangible asset is less than the carrying value.

	Finite-Lived Intangible Assets – Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives, which currently range from eight to 30 years for customer lists, five to 14 years for developed technology, five to 20 years for tradenames and one to five years for non-compete agreements. The Company evaluates long-lived assets, such as property, plant and equipment and intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. If circumstances require a long-lived asset group to be tested for possible impairment, the Company first determines if the estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. When an impairment is identified, the carrying amount of the asset is reduced to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values.

	Asset Retirement Obligations – The Company records the fair value of legal obligations associated with the retirement of tangible long-lived assets in the period in which they are incurred, if a reasonable estimate of fair value can be made. Upon initial recognition of a liability, the Company capitalizes the cost of the asset retirement obligation by increasing the carrying amount of the related long-lived asset. Over time, the liability is increased for changes in its present value as accretion through interest expense and the capitalized cost is depreciated over the useful life of the related asset.

	Employee Benefits – The Company sponsors a variety of employee benefit programs, some of which are non-contributory. The accounting policies used to account for these plans are as follows:

	Retirement – The Company provides non-contributory defined benefit plans to domestic and certain foreign employees. The projected unit credit actuarial method is used for financial reporting purposes. The Company recognizes the funded status; the difference between the fair value of the plan assets and the projected benefit obligation (pension plans) or the accumulated postretirement benefit obligation (other postretirement plan) in its Consolidated Balance Sheets. The Company’s funding policy for qualified plans is consistent with federal or other local regulations and customarily equals the amount deductible for federal and local income tax purposes. Foreign subsidiaries contribute to other plans, which may be administered privately or by government agencies in accordance with local regulations.

	Effective January 1, 2014, the Company also provides benefits under the Platform Specialty Products Employee Savings & 401(k) Plan, or PSP 401(k) Plan, for substantially all domestic employees, which consists of two components: a profit-sharing/ non-elective component funded by the Company as well as a defined contribution 401(k) component. Under the discretionary profit sharing and/or non-elective component, the Company made a non-elective contribution to the MacDermid, Incorporated Employee Savings and 401(k) Plan of $1.4 million during the first quarter of 2015 for the year ended December 31, 2014. Under the 401(k) component, on a yearly basis, the Company may determine to make contributions that match some or all of the participants’ contributions and contributed $0.7 million to the plan in 2014.

The Predecessor also provided a defined contribution 401K Plan (401(a), (k) and 501(a)) for substantially all domestic employees, with the ability to make discretionary contributions to the 401K Plan. Effective with the MacDermid Acquisition on October 31, 2013, this 401K Plan was terminated. There were no such discretionary contributions made for the Predecessor 2013 and 2012 Periods.

Post-retirement – The Company currently accrues for post-retirement health care benefits for U.S. employees hired prior to April 1, 1997. The post-retirement health care plan is unfunded.

Financial Instruments – The Company’s financial instruments consist primarily of cash and cash equivalents, restricted cash, accounts receivable, investments, accounts payable, contingent consideration and current and long-term debt. The Company believes that the carrying value of the cash and cash equivalents, restricted cash, accounts receivable and accounts payable are representative of their respective fair values because of the short maturities of these instruments. Available for sale equity investments are carried at fair value with net unrealized gains or losses reported as a component of accumulated other comprehensive (loss) income. See Note 11 for the fair value of the Company’s financial instruments.

Foreign Currency Translation – Primarily all of the Company’s foreign subsidiaries use their local currency as their functional currency. The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. Dollars using foreign currency exchange rates prevailing as of the balance sheet dates. Revenue and expense accounts are translated at weighted-average foreign currency exchange rates for the periods presented. Cumulative currency translation adjustments are included in other comprehensive income (loss) in the stockholders’ equity section of the Consolidated Balance Sheets. Net gains and losses from transactions denominated in a currency other than the functional currency of the entity are included in Other (expense) income in the Consolidated Statements of Operations.

Revenue Recognition – The Company recognizes revenue, including freight charged to customers, net of applicable rebates, estimates for sales returns and allowances and discounts, when the earnings process is complete. This occurs when products are shipped to or received by the customer in accordance with the terms of the agreement, title and risk of loss have been transferred, collectability is probable and pricing is fixed or determinable. Shipping terms are customarily “FOB shipping point” and do not include right of inspection or acceptance provisions. Equipment sales arrangements may include right of inspection or acceptance provisions, in which case revenue is deferred until these provisions are satisfied.

Cost of Sales – Cost of sales consists primarily of raw material costs and related purchasing and receiving costs used in the manufacturing process, direct salary and wages and related fringe benefits, packaging costs, shipping and handling costs, plant overhead and other costs associated with the manufacture and distribution of the Company’s products. For the year ended December 31, 2014, cost of sales included a manufacturer’s profit in inventory adjustment of $35.5 million associated with inventory revaluations related to the MacDermid, Agriphar and CAS Acquisitions, and for the Successor 2013 Period, cost of sales included a manufacturer’s profit in inventory adjustment of $23.9 million related to the MacDermid Acquisition.

Shipping and Handling Costs – Costs related to shipping and handling are recognized as incurred and included in cost of sales in the Consolidated Statements of Operations.

Selling, technical, general and administrative expenses – Selling, technical, general and administrative expenses consist primarily of personnel and travel costs, advertising and marketing expenses, administrative expenses associated with accounting, finance, legal, human resource, amortization of intangible assets, risk management and overhead associated with these functions.

Research and development – Research and development costs, primarily relating to internal salaries, are expensed as incurred.

Income Taxes – The provision for income taxes includes federal, foreign, state and local income taxes currently payable as well as the net change in deferred tax assets and liabilities during the period. Deferred income taxes are recorded at currently enacted tax rates for temporary differences between the financial reporting and income tax basis of assets and liabilities. A valuation allowance is assessed and recorded when it is estimated that it becomes more likely that not than the full value of a deferred tax asset may not be realized. Deferred federal and state income taxes are not provided on the undistributed earnings of certain foreign subsidiaries where management has determined that such earnings have been permanently reinvested.

Stock-based Compensation Plans – The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation - Stock Compensation”. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based awards that are ultimately expected to vest. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. The fair value of restricted stock is determined based on the number of share granted and the closing price of the Company's common stock on the date of grant. Compensation expense for all share-based payment awards is recognized using the straight-line amortization method over the vesting period.

Earnings (Loss) Per Common Share – Basic earnings (loss) per common share excludes dilution and is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net (loss) income per common share assumes the issuance of all potentially dilutive share equivalents using the if converted or treasury stock method, if the effect is not anti-dilutive. For stock options, it is assumed that the proceeds will be used to buy back shares. Such proceeds equal the average unrecognized compensation plus the assumed exercise of weighted average number of options outstanding and windfall tax benefits. For unvested restricted shares, the assumed proceeds equal the average unrecognized compensation expense plus windfall tax benefits.

New Accounting Standards

Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-01, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015, but entities may apply the guidance retrospectively to all prior periods presented in the financial statements. The Company does not expect this ASU to have a material impact on its financial statements.

Derivatives and Hedging (Topic 815) - In November 2014, the FASB issued ASU No. 2014-16, “Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity (a consensus of the FASB Emerging Issues Task Force).” Under current practice, there were predominantly two methods used to evaluate whether the nature of the host contract in a hybrid financial instrument is more akin to debt or equity: one considered all the features including the embedded and the other excluded the embedded derivative in the consideration. This update eliminates the difference in practice by clarify that the evaluation should be based on all the instrument’s features, including the embedded derivative, and that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. The guidance is effective for fiscal years and interim periods beginning after December 15, 2015 and is applied in a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of our fiscal year 2016. The Company is in the process of evaluating the impact of this new ASU.

Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company does not expect this ASU to have a material impact on its financial statements.

Revenue from Contracts with Customers (Topic 606) - In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” which (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016. The Company is continuing to evaluate the impact of this new ASU.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year’s presentation.

Note_2_Acquisitions_of_Busines

Note 2 - Acquisitions of Businesses	12 Months Ended
Note 2 - Acquisitions of Businesses	Dec. 31, 2014
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	2. ACQUISITIONS OF BUSINESSES

	CAS Acquisition

	On November 3, 2014, we completed the CAS Acquisition for $1.04 billion, consisting of $983 million in cash, after certain post-closing working capital and other adjustments, 2,000,000 shares of our common stock and the assumption of certain liabilities by Platform. The CAS Acquisition was financed with the proceeds from additional borrowings made under our Amended and Restated Credit Agreement and available cash on hand. As of December 31, 2014, the Company recognized, in accrued expenses and other current liabilities, a final working capital adjustment of $15.0 million. Due to regulatory constraints, title to certain CAS businesses located in Russia was not transferred to Platform until the first quarter of 2015. In connection with the CAS Acquisition, the Company entered into six supply agreements with Chemtura to supply the Company certain products, on an exclusive basis. These arrangements include capital leases for certain equipment. We have agreed to fund the asset retirement obligations associated with the related equipment. Accordingly, we have recognized an asset retirement obligation of $13.2 million. The agreements will continue until either party provides advance termination notice, with a minimum term of four years.

	In line with our business strategy of growing into niche markets and applications, we acquired CAS to enter the agrochemical industry. CAS is a niche provider of seed treatments and crop protection applications in numerous geographies across seven major product lines – adjuvants, fungicides, herbicides, insecticide, miticides, plant growth regulators and seed treatments.

	In connection with the CAS Acquisition, the Company incurred $33.9 million in related expenses that are included in “Selling, technical, general and administrative expenses” in the Consolidated Statement of Operations. CAS contributed revenues of $61.9 million and net losses of $20.5 million to the Company for the period of November 3, 2014 through December 31, 2014.

	Agriphar Acquisition

	On October 1, 2014, we completed the acquisition of Percival, including Percival’s agrochemical business conducted under the Agriphar trade name. Pursuant to the terms of the acquisition agreement, MAS Holdings, a newly-formed subsidiary of Platform, acquired 100% of the equity interests of Percival for a purchase price of approximately €300 million ($370 million), consisting of $350 million in cash, after certain post-closing working capital and other adjustments, and 711,551 restricted shares of our common stock, which will become unrestricted beginning January 2, 2018 unless agreed otherwise in accordance with the terms of the acquisition agreement. The agreement also stipulates that prior to January 2, 2018, the seller may transfer (i) a maximum of 1/3 of its shares as of January 2, 2016, (ii) 1/3 of its shares as of January 2, 2017 and (iii) 1/3 of its shares as of January 2, 2018, in each case subject to the terms and provisions of a solvency letter described in the Agreement. Additionally, MAS Holdings granted the seller a put option to sell and transfer all (but not part) of the shares, on (but not prior to) the date that is six months from the closing of the Agriphar Acquisition. The consideration payable by Platform for the transfer of such shares under the put option is expected to be an amount equal to €15.0 million ($18.2 million based on the December 31, 2014 exchange rate of $1.21 per €1.00). The put option is recorded in the December 31, 2014, Consolidated Balance Sheet within accrued expense and other current liabilities in the amount of $3.4 million.

	We acquired Agriphar in our crop protection vertical as we believe Agriphar’s and CAS’ businesses are very complementary in terms of product range and distribution capabilities. Agriphar is a European crop protection group supported by a team of researchers and regulatory experts which provides a wide range of fungicides, herbicides and insecticides with end markets primarily across Europe.

	In connection with the Agriphar Acquisition, the Company incurred $4.2 million in related expenses that are included in “Selling, technical, general and administrative expenses” in the Consolidated Statement of Operations. Agriphar contributed revenues of $26.1 million and net losses of $8.3 million to the Company for the period of October 1, 2014 to December 31, 2014.

	MacDermid Acquisition

	On October 31, 2013, the Company completed the MacDermid Acquisition. The total consideration paid in connection with the MacDermid Acquisition and the acquisition of the 3% of MacDermid equity interests not already held by MacDermid Holdings was approximately $1.80 billion (including the assumption of $754 million of indebtedness, consisting primarily of MacDermid’s then existing first lien credit facility), plus (i) up to $100 million of contingent consideration tied to achieving certain EBITDA and stock trading price performance metrics over a seven-year period following the closing of the MacDermid Acquisition and (ii) an interest in certain MacDermid pending litigation. As a result of a favorable adjustment to the preliminary estimated working capital factored into the purchase price, the Company received a payment of $8.5 million in January 2014 which was recorded in prepaid expenses and other current assets on the Consolidated Balance Sheets at December 31, 2013 and in “Acquisition of business, net” in the accompanying Consolidated Statements of Cash Flows as of December 31, 2014.

	The fair value of contingent consideration was measured based on significant inputs not observable in the market, which are considered to be Level 3 inputs under the FASB ASC Topic 820 fair value hierarchy (see Note 11 – Fair Value Measurements). Key assumptions included in the fair value calculation of the EBITDA related earnout include a discount rate of approximately 2% and expected future value of payments of $60.0 million calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. Key assumptions included in the fair value calculation of the stock price related earnout include the fair value of common stock and an assumption of volatility. The stock price related earnout was calculated using a Monte Carlo simulation. At the inception of the acquisition, the fair value of the contingent payments was $35.5 million. As of December 31, 2014 and 2013, the fair value of the contingent consideration was $63.9 million and $34.8 million, respectively. The $29.1 million increase in fair value, which is recorded in “Selling, technical, general and administrative expenses” in the accompanying Consolidated Statements of Operations, is comprised of $18.8 million primarily related to achieving each of the three stock trading price performance metric targets of the contingent consideration arrangement and $10.3 million in compensation expense associated with the contingent consideration allocated to Tartan.

	Immediately prior to the closing of the MacDermid Acquisition, the Retaining Holders, including certain current officers of the Company, executed a RHSA with the Company pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for equity in our subsidiary, PDH, at an exchange rate of $11.00 per share plus (i) a proportionate share of the $100 million contingent consideration and (ii) an interest in certain MacDermid pending litigation. This 6.76% ownership has been accounted for as a non-controlling interest in the Company’s financial statements. Since October 31, 2014, each Retaining Holders is entitled to exchange up to 25% of shares of PDH Common Stock for shares of our common stock, on a one-for-one basis, with the remaining shares of PDH becoming eligible for exchange on November 2015, 2016 and 2017 in 25% increments. The total number of shares of common stock originally issuable upon the exchange of PDH Common Stock pursuant to the RHSA was approximately 8.8 million. As of December 31, 2014, 134,044 shares of our common stock were issued in connection with the exchange of PDH Common Stock, reducing the non-controlling interest to 6.66%.

	Upon the closing of the MacDermid Acquisition, the 401K Plan retained a 3% interest in MacDermid. The fair value of the obligation to purchase these shares of $21.0 million was recorded as a redeemable 401(k) interest in the mezzanine section of the Consolidated Balance Sheets at December 31, 2013 since it could be settled in either cash or stock. On March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between the Company and the fiduciaries of the 401K Plan, the Company acquired the remaining 3% for $2.6 million in cash (which is reflected in “Acquisition of businesses, net” in the accompanying Consolidated Statements of Cash Flows) and 1,670,386 shares of the Company’s common stock.

	Purchase Price Allocation

	The following table summarizes the consideration transferred and transaction related costs incurred to acquire MacDermid, Agriphar and CAS and the amounts of identified assets acquired and liabilities assumed at the acquisition date:

			MacDermid				Agriphar			CAS
	Consideration
	Cash, net		$	916.5			$	350.2		$	983.1
	Equity Instruments			115.4				16.6			52
	Long-term debt			754.2				-			-
	Derivative liability			-				3.5			-
	Contingent Consideration			35.5				-			-
	Total Consideration			1,821.60				370.3			1,035.10

	Transaction related costs			15.2				4.2			33.9

	Identifiable Assets acquired and Liabilities Assumed
	Accounts receivable			147.4				57.6			150.7
	Inventories			115.3				41.5			129.3
	Other current assets			26.2				1.6			15.5
	Property, plant and equipment			140.9				31.7			11.6
	Identifiable intangible assets			729				183			534
	Other assets			28.3				5.4			21.5
	Current Liabilities			(117.9	)			(48.3	)		(69.9	)
	Non-current deferred tax liability			(171.2	)			(64.9	)		(25.3	)
	Other long term liabilities			(66.6	)			(15.9	)		(13.3	)
	Total identifiable net assets			831.4				191.7			754.1

	Goodwill			990.2				178.6			281

	Total purchase price		$	1,821.60			$	370.3		$	1,035.10

	Purchase accounting and purchase price allocation is complete for the MacDermid Acquisition, and substantially complete for the Agriphar and CAS acquisition, with the exception of accounts receivable and inventory for both, as well as legal and environmental reserves for Agriphar, and intangible and tangible asset valuation related to the supply agreements with Chemtura for CAS. As a part of the CAS acquisition, the Company paid for a 15% equity interest in Certis Europe B.V. that has not been transferred because it is subject to Certis’ approval. Certis has the option to repurchase the shares at fair value or to approve the share transfer. The value of the equity interest is estimated at $15.0 million based on market multiples and is classified in other assets.

	Transaction related costs related to the Agriphar and CAS Acquisitions, as presented above, are recorded in “Selling, technical, general and administrative expenses,” and total $38.1 million for the year ended December 31, 2014. Transaction related costs related to the MacDermid Acquisition totaled $15.2 million for the Successor 2013 Period and $16.9 million for the Predecessor 2013 Period.

	The excess of the cost of the individual acquisitions over the net of amounts assigned to the fair values of the assets acquired and the liabilities assumed is recorded as goodwill. Of the $1.45 billion of goodwill recorded in connection with the Acquisitions, $194 million is expected to be deductible for tax purposes.

Identifiable intangible assets recorded in conjunction with the Acquisitions have been assigned the following useful lives: eight to 30 years for customer lists, five to 14 years for developed technology, five to 20 years for tradenames and one to five years for non-compete agreements, which results in weighted average useful lives of 20 years, 12 years, 20 years and five years, respectively, for an aggregate weighted average useful life of approximately 16 years at December 31, 2014.

Pro Forma Revenue and Earnings

The following unaudited pro forma summary presents consolidated information of the Company as if the Agriphar and CAS acquisitions had occurred on January 1, 2013:

		Revenue				Net Income (Loss)
						attributable to
						Shareholders

Pro Forma Year Ended 12/31/14		$	1,405.90			$	46.4

Pro Forma Year Ended 12/31/13		$	731.8			$	(229.5	)

In 2014, the Company incurred $29.8 million of acquisition-related expenses, net of taxes, which have been reflected in the pro forma earnings above as if they had been incurred in 2013. These pro forma amounts have been prepared to reflect fair value adjustments to intangible assets and the related amortization expense, net of tax, from January 1, 2013.

As the Company’s inception date was April 23, 2013, no pro-forma financial disclosures were necessary for the MacDermid Acquisition as all of the results of operations of MacDermid were included in the Successor and Predecessor 2013 Periods.

Other

During the year ended December 31, 2014, we also acquired a business for $30.5 million, after certain post-closing working capital and other adjustments (including the assumption of approximately $0.4 million of indebtedness), within our Performance Materials segment. Assets and liabilities of the acquired business were recorded as of the date of acquisition based on their estimated fair value as determined in a purchase price allocation. The Company’s allocation of purchase price for this acquisition included net current assets and current liabilities of $1.2 million each, property, plant and equipment of $0.2 million, deferred tax liability of $3.6 million, identifiable intangible assets of $18.0 million and goodwill of $16.3 million. No goodwill from this acquisition is expected to be deductible for tax purposes. Of the $18.0 million of acquired intangible assets, $14.6 million was assigned to customer lists, $1.9 million to non-compete agreements and $1.5 million to tradenames and developed technology. Pro forma revenue and earnings related to this business have not been presented as they were deemed not significant.

Arysta Acquisition

On February 13, 2015, we completed the Arysta Acquisition pursuant to a certain share purchase agreement, dated October 20, 2014, as amended, with the Original Seller, for $3.57 billion, consisting of $2.93 billion in cash, subject to working capital and other adjustments, and the issuance of $600 million of Platform’s Series B Preferred Stock to the Seller.

We acquired Arysta to expand our presence in the agrochemical business, complementing our recent acquisitions of Agriphar and CAS. Arysta has a solutions-oriented business model that focuses on product innovation to address grower needs. Arysta’s solutions are delivered on a local basis, utilizing globally managed patented and proprietary off-patent agrochemical AIs and biosolutions, complemented by a broad portfolio of regionally managed off-patent agrochemical offerings. Biosolutions includes biological stimulants, or biostimulants, innovative nutrition and biological control, or biocontrol, products. Arysta employs a targeted market strategy aimed at specific regions and crops where it is believed that its market position, product portfolio and capabilities enable Arysta to achieve sustainable high growth and a strong leadership position.

In connection with the Arysta Acquisition, the Company incurred $6.4 million in related expenses through December 31, 2014 that are included in “Selling, technical, general and administrative expenses” in the Consolidated Statement of Operations.

The initial purchase accounting and purchase price allocation for the Arysta Acquisition have not been completed at the date of this filing given the proximity to the acquisition date. The purchase price will be allocated to the assets acquired based on estimated fair values at the acquisition date, with the excess of purchase price over the estimated fair value of the net assets acquired recorded as goodwill.

Note_3_Inventories

Note 3 - Inventories	12 Months Ended
Note 3 - Inventories	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	3. INVENTORIES

	The major components of inventory were as follows:

		31-Dec-14		31-Dec-13

	Finished goods	$	154.9	$	58.3
	Raw materials and supplies		49.5		29.9
	Equipment		1.4		1.4
	Total inventory, net	$	205.8	$	89.6

	In connection with the Agriphar and CAS acquisitions, finished goods were marked up by $9.4 million and $36.1 million, respectively, to reflect fair value. Of the total mark up, $23.5 million was charged through the Consolidated Statement of Operations for the year ended December 31, 2014 based on our estimated inventory turnover. The remaining portion of the mark up of $22.0 million is included in finished goods at December 31, 2014.

	For the Successor 2013 Period, in connection with the MacDermid Acquisition, finished goods were marked up by $35.9 million to reflect fair value. Of this amount, $23.9 million was charged through the Consolidated Statement of Operations in the Successor 2013 Period based on our estimated inventory turnover, and the remaining $12.0 million was charged through the Consolidated Statement of Operations during 2014.

Note_4_Property_Plant_and_Equi

Note 4 - Property, Plant and Equipment	12 Months Ended
Note 4 - Property, Plant and Equipment	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	4. PROPERTY, PLANT AND EQUIPMENT

	The major components of property, plant and equipment were as follows:

		31-Dec-14			31-Dec-13

	Land and leasehold improvements	$	36.6		$	29.9
	Buildings and improvements		51.1			38.9
	Machinery, equipment, fixtures and software		101.2			63.5
			188.9			132.3
	Less: accumulated depreciation		(18.1	)		(3.9	)
			170.8			128.4
	Construction in process		4.2			7.8
	Property, plant and equipment, net	$	175		$	136.2

	For the year ended December 31, 2014, the Company recorded depreciation expense of $19.3 million. For the Successor and Predecessor 2013 Periods, the Company and the Predecessor recorded depreciation expense of $3.9 million and $10.5 million, respectively. For the year ended December 31, 2012, the Predecessor recorded depreciation expense of $15.1 million.

Note_5_Goodwill_and_Intangible

Note 5 - Goodwill and Intangible Assets	12 Months Ended
Note 5 - Goodwill and Intangible Assets	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	5. GOODWILL AND INTANGIBLE ASSETS

	The changes in the carrying amount of goodwill by segment are as follows:

		Performance Materials			Graphic Solutions			AgroSolutions			Total
	Predecessor:
	Balance, December 31, 2012	$	447.7		$	28.5		$	-		$	476.2
	Foreign currency translation and other		(4.4	)		-			-			(4.4	)
	Balance, October 31, 2013	$	443.3		$	28.5		$	-		$	471.8

	Successor:
	Balance, April 23, 2013 (Inception)	$	-		$	-		$	-		$	-
	Addition from acquisitions		761.5			228.7			-			990.2
	Foreign currency translation and other		(1.1	)		0.7			-			(0.4	)
	Balance, December 31, 2013		760.4			229.4			-			989.8
	Addition from acquisitions		16.3			-			459.6			475.9
	Foreign currency translation and other		(37.3	)		(7.6	)		(15.5	)		(60.4	)
	Balance, December 31, 2014	$	739.4		$	221.8		$	444.1		$	1,405.30

	During the fourth quarter of 2014, the Company performed its annual impairment analysis of goodwill at the reporting unit level. Our goodwill impairment testing analysis uses an income approach derived from a discounted cash flow model to estimate the fair value of our reporting units. Based on those projections and other assumptions used in the analysis, the Company concluded that the fair values of the reporting units exceeded the carrying values of their net assets. As a result, there was no impairment of goodwill in 2014. However, in performing the first step of the goodwill impairment test for the year ended December 31, 2014, the excess of the fair value of the Offshore and ASF Americas reporting units over their carrying values were 7.6% and 11.1% respectively. Goodwill assigned to the Offshore and ASF Americas reporting units totaled $364 million and $78.3 million, respectively. There were no other events or changes in circumstances which indicated that goodwill might be impaired.

	The carrying value of indefinite-lived intangible assets other than goodwill, which consists solely of tradenames, was $69.3 million and $70.9 million at December 31, 2014 and 2013, respectively.

	Intangible assets subject to amortization were as follows:

		31-Dec-14									31-Dec-13

		Gross Carrying Amount			Accumulated Amortization and Foreign Exchange			Net Book Value			Gross Carrying Amount			Accumulated Amortization and Foreign Exchange			Net Book Value

	Customer lists	$	613.6		$	(71.6	)	$	542		$	494		$	(6.4	)	$	487.6
	Developed technology		760.5			(50.8	)		709.7			164.2			(2.4	)		161.8
	Tradenames		19.7			(1.0	)		18.7			-			-			-
	Non-compete agreement		1.9			(0.1	)		1.8			-			-			-
	Total	$	1,395.70		$	(123.5	)	$	1,272.20		$	658.2		$	(8.8	)	$	649.4

	Useful lives range from eight to 30 years for customer lists, five to 14 years for developed technology, five to 20 years for tradenames and one to five years for non-compete agreements, which results in weighted average useful lives of 20 years, 12 years, 20 years and five years, respectively, for an aggregate weighted average useful life of approximately 16 years at December 31, 2014.

	For the year ended December 31, 2014, the Company recorded amortization expense on intangible assets of $67.4 million. For the Successor and Predecessor 2013 Periods, the Company and the Predecessor recorded amortization expense on intangible assets of $8.9 million and $22.4 million, respectively. For the year ended December 31, 2012, the Predecessor recorded amortization expense on intangible assets of $27.1 million.

	Estimated future amortization of intangible assets for each of the next five fiscal years from 2015 through 2019 is $111 million per year.

Note_6_Equity_Compensation_Pla

Note 6 - Equity Compensation Plans	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	6. EQUITY COMPENSATION PLANS

	On June 12, 2014, the Company’s stockholders approved the Platform Specialty Products Corporation Amended and Restated 2013 Incentive Compensation Plan. The 2013 Plan is to be administered by a committee designated by the Company’s Board consisting of not less than two directors; provided, however, that except as otherwise expressly provided in the 2013 Plan, the Board may exercise any power or authority granted to the committee under the 2013 Plan. At December 31, 2014, the total number of common shares of our Company that may be subject to the granting of awards under the 2013 Plan is equal to 15,500,000 shares (subject to increase in accordance with the terms of the 2013 Plan). As of December 31, 2014, 9,242 shares of common stock were issued under the Plan. As of December 31, 2014, five officers, six directors, 2,486 employees and one consultant were eligible to participate in the 2013 Plan.

	On March 6, 2014, the Board approved a grant of 329,823 RSUs, effective on June 12, 2014 with approval of the 2013 Plan, to certain employees that cliff vest on December 31, 2020. The RSUs are subject to an EBITDA performance condition and a share price market condition that are similar in terms to those discussed in Note 2 – “Acquisitions of Businesses” related to the MacDermid contingent consideration arrangement. Additionally, the number of shares of common stock to be issued is limited to a maximum cash value, requiring these awards to be classified as liabilities. The combined undiscounted maximum cash value of all RSU’s issued is approximately $7.1 million which is being recognized as compensation expense over the period from grant to the vesting date. Compensation expense associated with these awards was $0.6 million for the year ended December 31, 2014.

	On March 6, 2014, the Board approved a grant of 9,242 RSUs to certain directors of the Company, effective on June 12, 2014 with approval of the 2013 Plan, which immediately vested. Compensation expense of $0.3 million associated with these awards was fully recognized in 2014. On July 31, 2014 such RSUs were settled in shares of common stock and issued to such directors.

	During the year ended December 31, 2014, the Board approved grants totaling of 139,610 RSUs to certain employees of the Company and 2,500 RSUs to non-employees with approval of the 2013 Plan, with grant-date fair values ranging from $20.97 to $28.36 per share. Vesting periods range from 36 to 60 months for RSU’s issued to employees, and 10 month for those issued to non-employees. The RSUs are subject to an EBITDA performance condition that must be achieved in the final vesting year. For the year ended December 31, 2014, compensation expense associated with these awards totaled $0.4 million and administrative expense totaled less than $0.1 million.

	Effective March 6, 2014, the Board adopted the ESPP, which was approved by the Company’s stockholders on June 12, 2014. The Board approved a maximum of 5,178,815 shares of Common Stock, which were reserved and made available for issuance under the ESPP. As of December 31, 2014, 11,139 shares have been issued under, and 513 persons were eligible to participate in the ESPP.

	On May 17, 2013, MacDermid issued an aggregate 250,000 option deeds to its non-founder Directors with an exercise price of $11.50 per share, expiring five years from the date of completion of the MacDermid Acquisition and which vested as of the completion of the MacDermid Acquisition.

	The Company estimates the fair value of stock option grants using a Black-Scholes option pricing. In applying this model, the Company uses the following assumptions:

		•	Risk-Free Interest Rate: The Company determined the risk-free interest rate equivalent to the expected term based on the U.S. Treasury constant maturity rate.

		•	Expected Term: The Company determined the expected term equal to the life of the contract.

		•	Expected Dividend Rate: The Company has not paid and does not anticipate paying any cash dividends in the near future.

	The fair value of each option award was estimated on the grant date using the Black Scholes option-pricing model and expensed under the straight line method over the vesting period. The following assumptions were used: exercise price of $11.50, expected stock price volatility of 18.49%, risk free rate of interest of 0.37% and an expected life of options of 5.0 years. The options vested on October 31, 2013, the date of the MacDermid acquisition, with a weighted average remaining contractual life of 4.4 years. Stock based compensation expense from option deeds was $0.2 million for the Successor 2013 Period. The options vested and accordingly, the total value of the options at issuance was amortized over the period from inception to October 31, 2013.

	Predecessor Period

	On January 29, 2013, the Predecessor authorized for issuance 5,000,000 C Shares. The C Shares were allocated to three tranches of 1,666,666 shares each and defined as Class C-1 Junior Shares, Class C-2 Junior Shares and Class C-3 Junior Shares. The Class C-1 Junior Shares vested upon the grant date of January 29, 2013. Class C-2 Junior Shares were to vest on January 1, 2014 and the Class C-3 Junior Shares were to vest on January 1, 2015. The number of issued and awarded Class C Junior Shares was 4,890,000 shares or 1,630,000 shares each for the Class C-1 Junior Shares, Class C-2 Junior Shares and Class C-3 Junior Shares. The value of the C Shares was measured based upon the performance criteria in the operating agreement of MacDermid Holdings based on the estimated equity value of the Predecessor. The C Shares were to be paid in cash in accordance with the operating agreement of MacDermid Holdings upon a change in control, liquidating event or initial public offering. Payment for the C shares required continued employment through a change in control, liquidating event, or initial public offering. The C Shares were considered liability-classified awards with the related fair value recognized as compensation expense ratably over the performance period, with changes in the fair value of the award cumulatively adjusted through compensation expense each period. During the Predecessor 2013 Period, $9.0 million was recognized as compensation expense related to the C Shares due to the consummation of the MacDermid Acquisition eliminating the risk that consummation of the business combination will not occur.

Note_7_Pension_PostRetirement_

Note 7 - Pension, Post-Retirement and Post-Employment Plans	12 Months Ended
Note 7 - Pension, Post-Retirement and Post-Employment Plans	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	7. PENSION, POST-RETIREMENT AND POST-EMPLOYMENT PLANS

	The Company has multiple deferred compensation arrangements, which are described below. The Company has defined benefit pension plans for certain domestic and foreign employees, a SERP (supplemental executive retirement plan) for executive officers and a post-employment benefits program for certain domestic employees. Aggregate amounts charged to earnings for these plans by the Company for the year ended December 31, 2014 and the Successor and Predecessor 2013 Periods was ($2.1) million, ($2.7) million and $3.5 million, respectively. In connection with the MacDermid Acquisition as discussed in Note 2, the Pension Plan was closed to new participants. Credited service was frozen for all grandfathered employees. Credited service, average monthly compensation, final average compensation, and covered compensation were frozen for all non-grandfathered employees. The action resulted in a curtailment gain of $3.0 million, which was recorded in the Successor 2013 Period. For the year ended December 31, 2012, $3.2 million was charged to earnings.

	Domestic Defined Benefit Pension Plan

	The Pension Plan is a non-contributory domestic defined benefit pension plan. It provides retirement benefits based upon years of service and compensation levels. At December 31, 2014 and 2013, the projected benefit obligation for the Pension Plan was $150.5 million and $131.3 million, respectively. The measurement date used to determine pension and other postretirement benefits was December 31, 2014 and 2013, at which time the minimum contribution level for the following year was determined. The Company does not currently expect contributions will be required in 2015 or in each of the four years thereafter.

	An investment committee, appointed by the Board, manages Pension Plan assets in accordance with the Pension Plan’s investment policies. The Company’s investment policies incorporate an asset allocation strategy that emphasizes the long-term growth of capital and acceptable asset volatility as long as it is consistent with the volatility of the relevant market indexes. The investment policies attempt to achieve a mix of approximately 75% of plan investments for long-term growth and 25% for near-term benefit payments. The Company believes this strategy is consistent with the long-term nature of plan liabilities and ultimate cash needs of the plans. Plan assets consist primarily of corporate bond mutual funds, limited partnership interests, listed stocks and cash. The corporate bond mutual funds held by the Pension Plan include primarily corporate bonds from companies from diversified industries located in the U.S. The listed stocks are investments in large-cap and mid-cap companies located in the U.S. The limited partnership funds primarily include listed stocks located in the U.S. The weighted average asset allocation of the Pension Plan was 25% equity securities, 58% limited partnership interests and managed equity funds, 9% bond mutual fund holdings and 8% cash at December 31, 2014. As of December 31, 2013, the weighted average asset allocation of the Pension Plan was 22% equity securities, 65% limited partnership interests and managed equity funds, 9% bond mutual fund holdings and 4% cash.

	Actual pension expense and future contributions required to fund the Pension Plan will depend on future investment performance, changes in future discount rates, the level of contributions the Company makes and various other factors related to the populations participating in the Pension Plan. The Company will re-evaluate the Pension Plan’s actuarial assumptions, on an annual basis including the expected long-term rate of return on assets and discount rate, and will adjust the assumptions as necessary to ensure proper funding levels are maintained so the Pension Plan can meet its obligations as they become due.

	Supplemental Executive Retirement Plan

	The Company sponsors a SERP that entitles certain executive officers to the difference between the benefits actually paid to them and the benefits they would have received under the Pension Plan were it not for certain restrictions imposed by the Internal Revenue Service Code, which relate to the amount of annual compensation which may be taken into account in determining benefits under the SERP. Covered compensation under the SERP includes an employee’s annual salary and bonus. At December 31, 2014 and 2013, the projected benefit obligation under the SERP was $7.1 million and $6.1 million, respectively.

	Foreign Pension Plans

	The Company has a U.K. Pension Plan, which represents retirement and death benefit plans covering employees in the U.K. The U.K. Pension Plan is comprised of a defined benefit plan and a defined contribution plan. The defined benefit plan was closed to new entrants and, effective March 31, 2000, existing active members ceased accruing any further benefits exclusive of adjustments for an inflation factor. The defined contribution plan is structured whereby the Company contributes an amount equal to a specified percentage of each employee’s contribution up to an annual maximum contribution per participant.

	The projected benefit obligation of the U.K. Pension Plan was $83.2 million and $67.6 million at December 31, 2014 and 2013, respectively. The measurement date used to determine U.K. Pension Plan benefits is December 31. Effective October 13, 2014, the trustees of the U.K. Pension Plan entered into a “Buy-In” agreement with Pension Insurance Corporation plc, or PIC, to transfer the benefit obligation to PLC for approximately GBP 49.7 million. The “Buy-In” phase of the U.K. Pension Plan is expected to occur during the second half of 2015, at which point, the obligation will be settled and gain or loss will be recorded.

	As of December 31, 2014, 89% of the U.K. Pension Plan portfolio was replaced with an insurance “buy-in” policy, and included 10% pooled bond funds and 1% cash. As of December 31, 2013, the weighted-average asset allocation of the U.K. Pension Plan was 84% pooled bond funds, 13% pooled equity funds and 3% cash. An independent trustee committee, appointed by Company management and employees participating in the U.K. Pension Plan meet to assess risk factors, rates of return, and asset allocations prescribed by the committee’s investment policy statement. In addition, an annual review is conducted to ensure that proper funding levels are maintained so the U.K. Pension Plan can meet its obligations as they become due.

	The Company also has retirement and death benefit plans covering employees in Taiwan and certain former employees in Germany. The Company also has longevity plans covering employees in France. These plans are not significant, individually or in the aggregate, to the consolidated financial position, results of operations or cash flows. Information for these plans, along with the U.K. Pension Plan, is included in the tables below.

	Certain other foreign subsidiaries maintain benefit plans that are consistent with statutory practices but do not meet the criteria for accounting rules under defined benefit plans under ASC 715-30 Compensation – Retirement Benefits – Defined Benefit Plans - Pensions. These benefit plans had obligation balances of $4.1 million and $3.8 million as of December 31, 2014 and 2013, respectively and are excluded from Retirements Benefits and from the accompanying tables of pension benefits.

	Domestic Defined Benefit Post-Retirement Medical and Dental Plan

	The Company sponsors a defined benefit post-retirement medical and dental plan that covers all of its domestic full-time employees, hired prior to April 1, 1997, who retire after age fifty-five, with at least ten to twenty years of service (depending upon the date of hire).

	In 2010, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act were approved in the U.S. Such Health Care Acts include several provisions that may affect a company’s postretirement benefit plans. The Company has evaluated the effects of the Health Care Acts and has concluded that there was no current impact on the Company’s domestic defined benefit post-retirement medical and dental plans.

	Eligible employees receive a subsidy from the Company towards the purchase of their retiree medical benefits. The subsidy level is based on the date of retirement from MacDermid. The annual increase in the Company’s costs for post-retirement medical benefits is subject to a limit of 5% for those retiring prior to March 31, 1989 and 3% for those retiring after April 1, 1989. Retirees will be required to contribute to the plan costs in excess of their respective Company limits in addition to their other required contributions.

	The projected benefit obligation for the post-retirement plan at December 31, 2014 was comprised of 27% retirees, 40% fully eligible active participants and 33% other active participants. As described above, the annual increase in healthcare cost to the Company is subject to a defined limit of 2% or 4% for post-retirement medical benefits, based on the date of retirement; therefore, the healthcare trend rate assumption has no effect on the amounts reported.

	Domestic Defined Benefit Post-Employment Compensation Plan

	The Company sponsors a defined benefit post-employment compensation continuation plan that covers all full-time domestic employees. Employees who have completed at least six months of service, and become permanently disabled and are unable to return to work, are eligible to receive a benefit under the plan. The benefit may range from one week to a maximum of six months of compensation. The estimated ongoing after-tax annual cost is not material to the overall consolidated financial statements. The Company does not expect to make any cash contributions to the postretirement benefit plan in 2015 or in each of the four years thereafter.

	The components of net periodic benefit cost of the pension, SERP and post-employment benefit plans were as follows:

			For the year ended								For the period from								For the ten months								For the year ended
			31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
											2013) through
											31-Dec-13
			(Successor)								(Successor)								(Predecessor)								(Predecessor)

	Pension & SERP Benefits:		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

	Net periodic benefit expense:
	Service cost		$	-			$	0.8			$	0.7			$	0.1			$	3.6			$	0.6			$	3.6			$	0.7
	Interest cost on the projected benefit obligation			6.9				3				1.2				0.5				5.2				2.5				6.1				3.1
	Expected return on plan assets			(9.7	)			(3.5	)			(1.6	)			(0.7	)			(6.6	)			(4.1	)			(7.3	)			(4.5	)
	Amortization of prior service cost			-				-				-				-				0.1				-				0.1				-
	Amortization of net loss			-				-				-				-				1.6				0.4				0.6				0.5
	Plan curtailments			-				-				(3.0	)			-				-				-				-				0.1
	Net periodic (benefit) cost		$	(2.8	)		$	0.3			$	(2.7	)		$	(0.1	)		$	3.9			$	(0.6	)		$	3.1			$	(0.1	)

			For the year ended								For the period from								For the ten months								For the year ended
			31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
											2013) through
						31-Dec-13
				(Successor)									(Successor)								(Predecessor)								(Predecessor)

Post-retirement Benefits:		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Net periodic benefit expense:
Service cost		$	0.1			$	-			$	-			$	-			$	0.1			$	-			$	-			$	-
Interest cost on the projected benefit obligation			0.3				-				0.1				-				0.2				-				0.3				-
Amortization of prior service cost			-				-				-				-				(0.1	)			-				(0.1	)			-
Net periodic cost (benefit)		$	0.4			$	-			$	0.1			$	-			$	0.2			$	-			$	0.2			$	-

Unrecognized pre-tax actuarial (losses) income recorded in accumulated other comprehensive income were ($21.1) million, $3.5 million, ($30.9) million and ($17.3) million for the year ended December 31, 2014, the Successor 2013 Period, and the Predecessor 2013 and 2012 Periods, respectively. Effective October 13, 2014, the trustees of the U.K. Pension Plan entered into a “Buy-In” agreement with Pension Insurance Corporation plc, or PIC, to transfer the benefit obligation of the U.K. Pension Plan to PLC. As of December 31, 2014, $9.9 million is included in accumulated other comprehensive income related to the U.K. Pension Plan, which is expected to be recognized during the second half of 2015 in connection with the ”Buy-In” agreement.

Key assumptions used to determine the net periodic benefit expense of the pension and post-retirement benefit liabilities are as follows:

		Pension and SERP Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)

		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate			5.2	%			4.2	%			5.1	%			4.1	%			4.4	%			4.2	%			5.2	%			4.6	%
Rate of compensation increase			4	%			3.4	%			4	%			3.3	%			4	%			3.4	%			4	%			3.4	%
Long-term rate of return on assets			7.8	%			4.2	%			7.8	%			4.9	%			7.8	%			6.5	%			7.8	%			6.5	%

		Post-retirement Medical Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)

		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate			5.1	%			12.4	%			5	%			11.7	%			4.4	%			10.8	%			5.2	%			10.8	%
Long-term rate of return on assets			N/A				N/A				N/A				N/A				N/A				N/A				N/A				N/A

The following tables summarize changes in plan assets and funded status of the Company’s pension and SERP plans:

		Pension and SERP Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)
		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Change in Projected Benefit Obligation:
Beginning of period balance		$	137.4			$	73.1			$	-			$	-			$	144.3			$	75			$	121.5			$	67.6
Acquisitions			-				-				142				72.9				-				-				-				-
Service cost			-				0.8				0.7				0.1				3.6				0.6				3.6				0.7
Interest cost			6.9				3				1.2				0.5				5.2				2.5				6.1				3.1
Plan curtailment			-				-				(3.0	)			0.2				-				-				-				-
Actuarial (gain)/ loss due to assumption change			18.1				20.2				(2.8	)			(1.0	)			(7.1	)			1.6				15.4				3.9
Actuarial (gain)/ loss due to plan experience			(0.6	)			1.6				-				(0.2	)			(0.6	)			(3.2	)			1.5				0.5
Benefits and expenses paid			(4.2	)			(4.3	)			(0.7	)			(0.9	)			(3.4	)			(2.7	)			(3.8	)			(3.6	)
Settlement			-				(0.5	)			-				(0.5	)			-				-				-				(0.3	)
Translation adjustment			-				(5.6	)			-				2				-				(0.9	)			-				3.1
End of period balance		$	157.6			$	88.3			$	137.4			$	73.1			$	142			$	72.9			$	144.3			$	75

		Pension and SERP Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)
		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Change in Fair Value of Plan Assets:
Beginning of period balance		$	127			$	88.1			$	-			$	-			$	102.6			$	79.6			$	91			$	68.1
Acquisitions			-				-				123.3				86.8				-				-				-				-
Actual return on plan assets, net of expenses			11.2				16				4.4				(2.5	)			21.7				7.4				9.4				6.6
Employer contributions			-				0.2				-				2.5				2.3				2.7				6				5.1
Benefits paid			(4.2	)			(3.5	)			(0.7	)			(0.7	)			(3.3	)			(2.2	)			(3.8	)			(3.2	)
Settlement			-				(0.5	)			-				(0.6	)			-				-				-				(0.3	)
Translation adjustment			-				(5.8	)			-				2.6				-				(0.7	)							3.3
End of period balance		$	134			$	94.5			$	127			$	88.1			$	123.3			$	86.8			$	102.6			$	79.6

Funded status of plan		$	(23.6	)		$	6.2			$	(10.4	)		$	15			$	(18.8	)		$	13.9			$	(41.7	)		$	4.6

The accumulated benefit obligation for all defined benefit pension plans was $231.5 million and $191.8 million at December 31, 2014 and 2013, respectively.

The following table summarizes changes in the Company’s post-retirement medical benefit obligations:



		Post-retirement Medical Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)
		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Change in Accumulated Postretirement Benefit:
Beginning of period balance		$	6.8			$	0.3			$	-			$	-			$	6.9			$	0.4			$	6			$	-
Acquisitions			-				-				6.7				0.3				-				-				-				-
Service cost			0.1				-				-				-				-				-				0.1				-
Interest cost			0.3				-				0.1				-				0.2				-				0.3				-
Employee contributions			-				-				-				-				0.2				-				0.3				-
Actuarial loss/(gain) due to assumption change			0.5				-				0.1				-				(0.1	)			(0.1	)			0.6				-
Actuarial loss/(gain) due to plan experience			-				-				-				-				(0.1	)			-				0.2				-
Other			-				-				-				-				-				-				-				0.4
Benefits and expenses paid			(0.3	)			-				(0.1	)			-				(0.5	)			-				(0.6	)			-
End of period balance		$	7.4			$	0.3			$	6.8			$	0.3			$	6.6			$	0.3			$	6.9			$	0.4

		Post-retirement Medical Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)
		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Change in Fair Value of Plan Assets:
Beginning of period balance		$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-
Employer contributions			0.3				-				0.1				-				0.3				-				0.3				-
Employee contributions			-				-				-				-				0.2				-				0.3				-
Benefits paid			(0.3	)			-				(0.1	)			-				(0.5	)			-				(0.6	)			-
End of period balance		$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-
Funded status of plan		$	(7.4	)		$	(0.3	)		$	(6.8	)		$	(0.3	)		$	(6.6	)		$	(0.3	)		$	(6.9	)		$	(0.4	)

Amounts included in the Consolidated Balance Sheets consist of the following:

		31-Dec-14				31-Dec-13

Prepaid pension assets
Foreign pension		$	10.2			$	19.1
Total long term assets			10.2				19.1

Other current liabilities
Domestic pension			0.4				-
Total current liabilities			0.4				-

Retirement benefits, less current portion
Domestic pension & SERP			23.2				10.4
Foreign pensions			4				4
Domestic post-retirement medical benefits			7.4				6.8
Foreign post-retirement medical benefits			0.3				0.2
Total non-current liabilities		$	34.9			$	21.4

Key assumptions used to determine the benefit obligations in the actuarial valuations of the pension and post-retirement benefit liabilities are as follows:

		Pension and SERP Benefits
		31-Dec-14								31-Dec-13
		Domestic				Foreign				Domestic				Foreign
Weighted average assumptions used to measure benefit obligations at measurement date:
Discount rate			4.2	%			2.5	%			5.2	%			4.2	%
Rate of compensation increase			3.5	%			2.9	%			4	%			3.3	%

		Post-retirement Medical Benefits
		31-Dec-14								31-Dec-13
		Domestic				Foreign				Domestic				Foreign
Weighted average assumptions used to measure benefit obligations at measurement date:
Discount rate			4.2	%			12.5	%			5.1	%			12.4	%
Rate of compensation increase			-				-				-				-

Amounts recognized in Accumulated Other Comprehensive Income (Loss) consist of the following:

		Pension and SERP Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)
		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Net actuarial gain (loss)		$	(10.4	)		$	(10.1	)		$	5.7			$	(2.1	)		$	10.5			$	10.8			$	(35.0	)		$	(16.9	)
Prior service credits (costs)			-				-				-				-				0.6				-				(0.7	)			-
		$	(10.4	)		$	(10.1	)		$	5.7			$	(2.1	)		$	11.1			$	10.8			$	(35.7	)		$	(16.9	)

		Post-retirement Medical Benefits
		For the year ended								For the period from								For the ten months								For the year ended
		31-Dec-14								inception (April 23,								ended October 31, 2013								31-Dec-12
										2013) through
										31-Dec-13
		(Successor)								(Successor)								(Predecessor)								(Predecessor)
		Domestic				Foreign				Domestic				Foreign				Domestic				Foreign				Domestic				Foreign

Net actuarial (loss) gain		$	(0.6	)		$	-			$	(0.1	)		$	-			$	0.1			$	(0.1	)		$	0.3			$	-
Prior service (costs) credits			-				-				-				-				(0.5	)			0.3				(0.6	)			0.4
		$	(0.6	)		$	-			$	(0.1	)		$	-			$	(0.4	)		$	0.2			$	(0.3	)		$	0.4

The major categories of assets in the Company’s various defined benefit pension plans as of December 31, 2014 and 2013 are presented in the following tables. Assets are segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value (see Note 11 - Fair Value Measurements). The Company’s domestic and foreign post-retirement plans are unfunded.

						Fair Value Measurements Using
		31-Dec-14				Quoted prices in				Significant other				Significant
						active markets				observable inputs				unobservable
						(Level 1)				(Level 2)				inputs (Level 3)
Asset Category
Domestic equities		$	28.9			$	28.9			$	-			$	-
Pooled funds holding global fixed income securities			9.2				-				9.2				-
Mutual funds holding U.S. Treasury Securities			11.8				11.8				-				-
Mutual funds holding domestic securities			4.8				4.8				-				-
Limited partnership interests(a)			77.1				-				77.1				-
Designated benefit fund(b)			1.1				-				1.1				-
Insurance "Buy-In" Policy (c)			83.2				-				-				83.2
Cash and cash equivalents			12.4				12.4				-				-
Total		$	228.5			$	57.9			$	87.4			$	83.2

						Fair Value Measurements Using
		31-Dec-13				Quoted prices in				Significant other				Significant
						active markets				observable inputs				unobservable
						(Level 1)				(Level 2)				inputs (Level 3)
Asset Category
Domestic equities		$	23.2			$	23.2			$				$	-
Pooled funds holding global equity securities			10.9				-				10.9				-
Pooled funds holding global fixed income securities			72.8				-				72.8				-
Mutual funds holding U.S. Treasury Securities			11.8				11.8				-				-
Mutual funds holding domestic securities			4.2				4.2				-				-
Limited partnership interests(a)			82.4				-				82.4				-
Designated benefit fund(b)			1.5				-				1.5				-
Cash and cash equivalents			8.4				8.4				-				-
Total		$	215.2			$	47.6			$	167.6			$	-

(a)	This category represents limited partner investments with general partners that invest in equity securities.

(b)	This category includes assets held in a fund with the Bank of Taiwan as prescribed by the Taiwan government in accordance with local statutory rules.

(c)	This category represents assets in the U.K Pension Plan invested in insurance contract with PIC in connection with “Buy-In” of U.K Pension Plan.

The Company’s retirement plan assets are reported at fair value. Level 1 assets include investments in publicly traded equity securities and mutual funds. These securities are actively traded and valued using quoted prices for identical securities from the market exchanges. Level 2 assets consist of global fixed-income securities, limited partnership interests and commingled funds that are not actively traded or whose underlying investments are valued using observable marketplace inputs. The fair value of plan assets invested in fixed-income securities is generally determined using market approach pricing methodology, where observable prices are obtained by market transactions involving identical or comparable securities of issuers with similar credit ratings. Plan assets that are invested in limited partnership interests and commingled funds are valued using a unit price or net asset value (NAV) that is based on the underlying fair value of investments of the fund. During the Successor 2013 Period, Level 3 assets included investments in pooled funds holding real estate in the United Kingdom which were valued using discounted cash flow models which considered long-term lease estimates, future rental receipts and estimated residual values. Those assets were sold during the Successor 2013 Period.

As of December 31, 2014, expected future benefit payments related to the Company’s defined benefit plans were as follows:

Year End		Domestic				Foreign				Postretirement Benefits				Total
2015		$	8.5			$	3.3			$	0.4			$	12.2
2016			7.3				0.3				0.4				8
2017			6.7				0.3				0.4				7.4
2018			6.6				0.4				0.4				7.4
2019			7				0.4				0.4				7.8
Subsequent five years			40.2				2				2.2				44.4
Total		$	76.3			$	6.7			$	4.2			$	87.2

Note_8_Income_Taxes

Note 8 - Income Taxes	12 Months Ended
Note 8 - Income Taxes	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	8. INCOME TAXES

	(Loss) income before income taxes, non-controlling interests and dividends on preferred shares are as follows:

			For the year ended				For the period				For the ten months				For the year ended
			31-Dec-14				from inception				ended October 31,				31-Dec-12
							(April 23, 2013)				2013
							through December
							31, 2013
			(Successor)				(Successor)				(Predecessor)				(Predecessor)

	Domestic		$	(103.9	)		$	(7.9	)		$	(74.2	)		$	(36.8	)
	Foreign			73				(193.5	)			100.7				107.8
	Total		$	(30.9	)		$	(201.4	)		$	26.5			$	71

	Income tax (benefit) expense consisted of the following:

			For the year ended				For the period				For the ten months				For the year ended
			31-Dec-14				from inception				ended October 31,				31-Dec-12
							(April 23, 2013)				2013
							through December
							31, 2013
			(Successor)				(Successor)				(Predecessor)				(Predecessor)
	Current:
	U.S.:
	Federal		$	(0.6	)		$	0.3			$	(5.3	)		$	1.8
	State and local			0.4				0.1				0.3				0.5
	Foreign			36.7				1.3				22.8				30.7
	Total current			36.5				1.7				17.8				33
	Deferred:
	U.S.:
	Federal			(18.3	)			(2.1	)			(3.1	)			(4.9	)
	State and local			0.4				(0.3	)			0.1				0.1
	Foreign			(25.3	)			(5.1	)			(1.8	)			(3.5	)
	Total deferred			(43.2	)			(7.5	)			(4.8	)			(8.3	)
	(Benefit) Provision for income taxes		$	(6.7	)		$	(5.8	)		$	13			$	24.7

	Income tax (benefit) expense differed from the amounts computed by applying the U.S. Federal statutory tax rates to pretax income, as a result of the following:

			For the year ended				For the period from				For the ten months				For the year ended
			31-Dec-14				inception (April				ended October 31,				31-Dec-12
							23, 2013) through				2013
							December 31,
							2013
			(Successor)				(Successor)				(Predecessor)				(Predecessor)

	U.S. Federal Statutory tax rate			35	%			35	%			35	%			35	%

	Taxes computed at U.S. statutory rate		$	(10.8	)		$	(70.5	)		$	9.3			$	24.8

	State income taxes, net of Federal benefit			0.8				0.4				(2.2	)			(0.4	)
	Preferred dividend valuation			-				60.2				-				-
	Tax on foreign operations			(7.7	)			0.4				0.8				(11.6	)
	Net change in reserve			1.5				(0.7	)			(0.1	)			5.7
	Change in valuation allowances			0.2				(0.9	)			3.6				6.9
	Provision for tax on undistributed foreign earnings			(3.7	)			0.8				(0.7	)			0.2
	Change of tax rate			(0.5	)			-				(0.5	)			(1.0	)
	Non-deductible Transaction Costs			6.5				4.2				1.9				-
	Foreign exchange impact on provision			-				-				0.1				0.1
	Purchase Price Contigency			6.6				-				-				-
	Other, net			0.4				0.3				0.8				-
	Income tax (benefit) expense		$	(6.7	)		$	(5.8	)		$	13			$	24.7
	Effective tax rate			21.65	%			2.89	%			48.95	%			34.78	%

The Company has provided deferred taxes under ASC 740-30-25, formerly APB 23, for the presumed repatriation to the United States earnings from several non-U.S. subsidiaries. The indefinite reversal criterion of ASC 740-30-25 allows the Company to overcome that presumption to the extent the earnings are indefinitely reinvested outside the United States. The Company has not recognized a deferred tax liability for U.S. taxes on the undistributed earnings of certain foreign subsidiaries which have been determined to be indefinitely reinvested. The undistributed earnings of those subsidiaries were $264 million at December 31, 2014. The estimated tax liability related to the undistributed earnings of foreign subsidiaries that are indefinitely reinvested is approximately $43.5 million December 31, 2014.

The components of deferred income taxes at December 31, 2014 and 2013 are as follows:

		December 31,				December 31,
		2014				2013

Deferred tax assets:
Accounts receivable		$	5.9			$	1.7
Inventory			-				3.3
Accrued liabilities			9.7				3.7
Employee benefits			20.2				12.3
Research and development costs			11.2				14.1
Tax credits			39.3				34
Net operating losses			17.5				21.4
Goodwill			31.8				-
Other			12.5				8.2
Total deferred tax assets			148.1				98.7
Valuation allowance			(19.7	)			(15.8	)
Total gross deferred tax assets			128.4				82.9

Deferred tax liabilities:
Plant and equipment			19.7				17.5
Intangibles			280.7				210.4
Undistributed foreign earnings			2.6				6.3
Other			2.5				8
Total gross deferred tax liabilities			305.5				242.2

Net deferred tax liability		$	177.1			$	159.3

The following schedule presents net current and net long-term deferred tax assets and liabilities as of December 31, 2014 and 2013:

		December 31,				December 31,
		2014				2013

Net current deferred tax asset		$	18.7			$	11
Net noncurrent deferred tax asset			6.5				(0.5	)
			25.2				10.5

Net noncurrent deferred tax liability			202.3				169.8

Total net deferred tax liability		$	177.1			$	159.3

Net current deferred tax assets are included in prepaid expenses and other current assets and net noncurrent deferred tax assets are included in other assets on the Consolidated Balance Sheets.

Valuation allowances reflect our assessment that it is more likely than not that certain state deferred tax assets and foreign net operating losses will not be realized. The assessment of the need for a valuation allowance requires management to make estimates and assumptions about future earnings, reversal of existing temporary differences and available tax planning strategies. If actual experience differs from these estimates and assumptions, the recorded deferred tax asset may not be fully realized resulting in an increase to income tax expense in our results of operations. The valuation allowance for deferred tax assets was $19.7 million and $15.8 million at December 31, 2014 and 2013, respectively. A valuation allowance of $27.2 million will be raised in the first quarter of 2015 as it is more likely than not that the foreign tax credit carryover will no longer be realizable as a result of the Arysta Acquisition.

At December 31, 2014, the Company had state and foreign net operating loss carry forwards of approximately $314 million and $13.0 million, respectively. The majority of the state net operating loss carry-forwards expire between the years 2016 and 2029. The state net operating loss carry-forwards result in a deferred tax asset of $14.6 million. A valuation allowance of $14.6 million has been provided against the deferred tax asset because it is more likely than not that the Company will not be able to utilize the state net operating losses before they expire. The foreign tax net operating loss carry-forwards expire between the years 2016 through 2030, with some being unlimited in utilization. This results in a deferred tax asset of $3.0 million. A valuation allowance of $1.6 million has been provided against the deferred tax assets associated with certain foreign net operating loss carry-forwards because the recent results of the business units associated with the loss carry-forwards indicate that it is more likely than not that the benefits from the net operating loss carry-forwards will not be fully realized. A valuation allowance of $1.2 million has been provided against other deferred tax assets as it is more likely than not that the benefits will not be realized.

In addition, at December 31, 2014, the Company has approximately $27.2 million, $7.7 million, $2.1 million and $2.3 million of foreign tax credits, research and development credits, alternative minimum tax credits and state tax credits (net of federal tax), respectively, that are available for carryforward. These carry-forward periods range from ten years to an unlimited period of time. A valuation allowance of $2.3 million is provided for the state tax credits as the Company believes the benefits from the credits will not be realized.

Tax Uncertainties

The following table summarizes the activity related to the Company’s unrecognized tax benefits as of December 31, 2014, for the Successor and Predecessor 2013 Periods and the Predecessor 2012 Period:

		For the year ended				For the period from				For the ten months				For the year ended
		31-Dec-14				inception (April 23,				ended October 31,				31-Dec-12
						2013) through				2013
						31-Dec-13
		(Successor)				(Successor)				(Predecessor)				(Predecessor)

Unrecognized tax benefits at beginning of period		$	25.6			$	-			$	22.7			$	18.8
Additions based on current year tax positions			1.7				0.3				0.8				2.3
Additions based upon prior year tax positions (including acquired uncertain tax positions)			7.4				26.3				0.3				1.7
Reductions due to closed statutes			(6.7	)			(1.0	)			(0.3	)			(0.1	)
Reductions for settlements and payments			(0.3	)			-				-				-

Total Unrecognized Tax benefits at end of period		$	27.7			$	25.6			$	23.5			$	22.7

The Company has $27.7 million of total unrecognized tax benefits as of December 31, 2014, of which $17.6 million, if recognized, would impact the Company’s effective tax rate. The Company made payments in 2014 to settle uncertain tax liabilities of $0.3 million. Due to expected statute of limitations expirations, the Company estimates that $3.5 million of the total unrecognized benefits will reverse within the next twelve months.

The Company recognizes interest and/or penalties related to income tax matters as part of income tax expense. The Company has $4.7 million and $4.2 million accrued for interest and penalties as of December 31, 2014 and December 31, 2013, respectively. Changes in these balances are recorded in income tax expense or as a reduction of the balance for payments made.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax of multiple state and foreign jurisdictions. The Company has closed all U.S. federal tax matters for years through 2010. Federal income tax returns for 2011 through December 2014 are currently open to examination although no audits are ongoing. The Company is undergoing audits in the United Kingdom for the 2009 and 2011 tax years as well as a notification requesting that the 2008 tax year remain open for one subsidiary.

As of December 31, 2014 the following tax years remained subject to examination by the major tax jurisdictions indicated below:

Major Jurisdiction		Open Years
Brazil		2009 through current
Belgium		2011 through current
China		2011 through current
France		2011 through current
Germany		2010 through current
Italy		2010 through current
Japan		2009 through current
Netherlands		2009 through current
Singapore		2010 through current
United Kingdom		2008 through current
United States		2011 through current

Note_9_Longterm_Debt

Note 9 - Long-term Debt	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Debt and Capital Leases Disclosures [Text Block]	9. LONG-TERM DEBT

	The Company’s debt consisted of the following:

		31-Dec-14			31-Dec-13

	Borrowings under lines of credit	$	-		$	-
	First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at December 31, 2014		743.7			751.3
	USD Incremental Loans, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at December 31, 2014		294.9			-
	New Tranche B Term Loans, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at December 31, 2014		129			-
	Euro Tranche Term Loans, due 2020, interest at the greater of 4.25% or LIBOR plus 3.25%, weighted average interest rate of 4.25% at December 31, 2014		246.2			-
	Other		2.1			1
	Total debt		1,415.90			752.3
	Less: current portion debt		(15.1	)		(8.0	)
	Total long-term debt	$	1,400.80		$	744.3

	Minimum future principal payments on long-term debt are as follows:

	Year End
	2015	$	15.1
	2016		15
	2017		14.7
	2018		14.6
	2019		14.5
	Thereafter		1,342.00
	Total	$	1,415.90

	Predecessor Refinancing

	On June 7, 2013, we completed a refinancing arrangement whereby the outstanding Tranche B term loan, Tranche C term loan, revolving credit facility and senior subordinated notes payable were replaced with two new senior secured credit facilities. The new senior secured credit facilities consist of (i) a $805 million first lien credit facility allocated between a $755 million term loan denominated in U.S. Dollars, a $25.0 million revolving credit facility denominated in U.S. Dollars and $25.0 million multi-currency revolving credit facility and (ii) a $360 million second lien term loan credit facility denominated in U.S. Dollars. The first lien term loan and related revolving credit facilities accrue interest at the greater of 4.00% or LIBOR plus 3.00% and has quarterly principal payments of $1.9 million. The revolving credit facility portion of the first lien term loan matures June 7, 2018. The first lien term loan matures June 7, 2020. The second lien term loan accrued interest at the greater of 7.75% or LIBOR plus 6.75% and matures December 7, 2020. The first lien term loan was originally issued at a discount of $1.9 million and the second lien term loan was issued at a discount of $3.6 million. The new senior secured credit facilities are guaranteed by MacDermid Holdings and certain of its direct and indirect wholly owned domestic subsidiaries and are secured by the personal property now owned or hereafter acquired of MacDermid Holdings and certain of its direct and indirect wholly-owned domestic subsidiaries and also 65% of the stock of the Company’s first tier foreign subsidiaries, subject to customary exceptions, exclusions and release mechanisms.

	Amendments

	In connection with the MacDermid Acquisition, on October 31, 2013, MacDermid entered into Amendment No. 1 to the First Lien Credit Agreement and MacDermid paid $373 million in connection with the repayment of the $360 million in principal on the second lien credit facility. Pursuant to Amendment No. 1 Platform became a co-borrower on all obligations under the $50.0 million Revolving Credit Facility and the second term loan and the negative and affirmative covenants contained therein were modified to reflect the new corporate structure. Otherwise, the terms relating to the incremental facility, maturity, indicative margin, LIBOR floor, ranking, guarantors, mandatory prepayments and financial covenants remained unmodified by the amendment. In connection with the MacDermid Acquisition, the first lien term loan was marked to fair value by adding the original discount of $1.8 million to the carrying value at the time.

	Second Amended and Restated Credit Agreement

	On August 6, 2014, we amended and restated the Company’s senior secured credit facilities by entering into Amendment No. 2 to the First Lien Credit Agreement and the Second Amended and Restated Credit Agreement, and agreeing on the implementation of certain Further Amendments upon consummation of the CAS Acquisition to the Second Amended and Restated Credit Agreement. As amended by the Further Amendments, the Second Amended and Restated Credit Agreement generally provides for, among other things, (i) Platform as a borrower under the term loan facility, (ii) increased flexibility with respect to permitted acquisitions, (iii) the ability to request incremental facilities in currencies other than U.S. Dollars, and (iv) securing foreign assets in support of future term loans. The Second Amended and Restated Credit Agreement also allows us, subject to certain limitations, to extend the maturity of our term loans and/or revolving credit commitments.

	On October 1, 2014, we and MacDermid, as borrowers, MacDermid Holdings, certain subsidiaries of MacDermid Holdings and Platform party thereto, Barclays Bank PLC, as collateral agent and administrative agent, and the incremental lender entered into the Incremental Amendment to the Second Amended and Restated Credit Agreement for an increase in the Term Loan Facility of the Second Amended and Restated Credit Agreement in an aggregate principal amount of $300 million. Except as set forth in the Incremental Amendment, such USD Incremental Loans have identical terms as the existing Tranche B Term Loans and are otherwise subject to the provisions of the Second Amended and Restated Credit Agreement. The proceeds from the Incremental Amendment were used to finance the Agriphar Acquisition.

	Pursuant to Amendment No. 2, upon the consummation of the CAS Acquisition on November 3, 2014, the Further Amendments became effective and (i) we borrowed New Tranche B Term Loans in an aggregate principal amount of $130 million through an increase in our existing tranche B term loan facility, (ii) our existing U.S. Dollar revolving credit facility was increased by $62.5 million to $87.5 million and (iii) our existing multicurrency revolving credit facility was increased by $62.5 million to $87.5 million. On the date of the CAS Acquisition, we borrowed $60 million under the U.S. Dollar revolving credit facility and €55 million under the multicurrency revolving credit facility both of which were settled by December 31, 2014. In addition, Euro Tranche Term Loans in an aggregate amount of €205 million ($256 million) were borrowed by a newly formed indirect subsidiary of Platform, MAS Holdings and NAIP. Pursuant to the Further Amendments, MAS Holdings and NAIP were added as borrowers under the Second Amended and Restated Credit Agreement in respect of the Euro Tranche Term Loans and certain additional domestic and foreign subsidiaries of Platform and MacDermid, including MAS Holdings and NAIP, became guarantors under our Second Amended and Restated Credit Agreement, and in connection therewith, pledged certain additional collateral to secure the obligations incurred under the Euro Tranche Term Loans and/or other loans incurred under the facility.

	With the exception of the collateral package as noted above and the interest rate, the terms of the Euro Tranche Term Loans are substantially similar to Platform’s New Tranche B Term Loans and bear interest at a rate per annum equal to an applicable margin plus an adjusted Eurocurrency Rate, calculated as set forth in our Second Amended and Restated Credit Agreement, and mature on June 7, 2020.

	The Second Amended and Restated Credit Agreement, as amended by the Further Amendments, contains customary covenants including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. The Revolving Credit Facility also impose a financial covenant requiring us, if our borrowings under the Revolving Credit Facility and letter of credit obligations exceed 25% of the revolving credit commitments as of the last day of any fiscal quarter, to maintain a 6.5 to 1.0 ratio of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Second Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters, subject to a right to cure. As of December 31, 2014, the Company was in compliance with the debt covenants contained in its credit facilities.

	The Second Amended and Restated Credit Agreement also contains customary events of default that include, among others, non-payment of principal, interest or fees, violation of certain covenants, inaccuracy of representations and warranties, failure to make payment on certain other material indebtedness, bankruptcy and insolvency events, material judgments and a change of control of Platform. Upon the occurrence of an event of default, payment of any outstanding loans under the Second Amended and Restated Credit Agreement may be accelerated. Borrowings under the Second Amended and Restated Credit Agreement are also subject to mandatory prepayment from the proceeds of certain dispositions of assets and from certain insurance and condemnation proceeds, excess cash flow and debt incurrences, in each case, subject to customary carve-outs and exceptions.

	The Company also has letters of credit outstanding of $1.0 million and $4.6 million at December 31, 2014 and 2013, respectively. The letters of credit reduce the borrowings available under the new revolving credit facility.

	Predecessor Retired Senior Secured Credit Facility

	On April 12, 2007, the Predecessor closed three new senior secured credit facilities consisting of (i) a $360 million tranche B term loan credit facility denominated in U.S. Dollars, (ii) a $250 million tranche C term loan credit facility denominated in Euro and (iii) a $50.0 million revolving credit facility denominated in U.S. Dollars.

	During the Predecessor 2013 Period, interest payments of $2.1 million and $1.5 million were made on the tranche B and trance C term loans, respectively.

	During the Predecessor 2013 Period, principal payments of $218 million were made on the tranche B term loan. The tranche B principal payments for the Predecessor 2013 Period consisted of a quarterly payment of $0.9 million, excess cash flow prepayment of $10.3 million and the retirement payoff of the outstanding balance of $206 million.

	During the Predecessor 2013 Period, principal payments of $146 million were made on the tranche C term loan. The principal payments for the Predecessor 2013 Period consist of a quarterly payment of $0.6 million, excess cash flow prepayment of $6.8 million and the payoff of the outstanding balance of $139 million.

	During the Predecessor 2013 Period, the Company recorded $1.1 million of other income related to the remeasurement gain on the foreign currency denominated tranche C term loan.

	During the year ended December 31, 2012, $3.6 million and $5.1 million of principal and interest payments, respectively, were made on the tranche B term loan and $2.6 million and $3.9 million of principal and interest payments, respectively, were made on the tranche C loan.

During the year ended December 31, 2012, the Predecessor recorded $2.7 million of other expense related to the remeasurement loss on the foreign currency denominated tranche C term loan.

Predecessor Retired Revolving Credit Facility

As discussed above, on April 12, 2007, the Predecessor entered into a $50.0 million revolving credit facility. In May 2012, the revolving credit facility was amended and extended; the facility was retired on June 7, 2013 as part of the refinancing. There were no balances outstanding under the revolving credit facility on the retirement date or as of December 31, 2012. During the Predecessor 2013 and 2012 Periods, the Company paid commitment fees of $0.1 million and $0.3 million, respectively, for the revolving credit facility.

The Predecessor had letters of credit outstanding of $3.9 million at December 31, 2012. The letters of credit reduced the borrowings available under the revolving credit facility. Upon the retirement of this revolving credit facility, the outstanding letters of credit were reissued under the new revolving credit facility.

Predecessor Senior Subordinated Notes

On April 12, 2007, the Predecessor issued $350 million of senior subordinated notes with a fixed interest rate of 9.50% at par. As discussed above and as part of the refinance and recapitalization, the senior subordinated notes were called on June 7, 2013 and $250 million of principal and a redemption premium of $9.4 million were paid to retire the tendered senior subordinated notes. Additionally, $106 million of the new debt proceeds from the refinance and recapitalization were escrowed to pay the outstanding called senior subordinated notes of $101 million. Additionally, proceeds from the refinance were escrowed for a redemption premium of $3.2 million on the called senior subordinated notes outstanding and accrued interest of $2.2 million related to these called senior subordinated notes. The escrowed funds were paid to the holders of the remaining senior subordinated note holders on July 8, 2013.

During the Predecessor 2013 and 2012 Periods, the Company made interest payments of $20.0 million and $33.3 million, respectively, under the senior subordinated notes.

Japanese Senior Secured Bank Debt

In February 2007, the Predecessor borrowed $15.0 million denominated in Japanese Yen in three separate notes that were paid in full by their respective maturity dates between 2009 and 2013. In May 2007, the Predecessor borrowed an additional $7.6 million, denominated in Japanese Yen, which was paid in full in May 2012. In September 2007, the Predecessor borrowed an additional $2.5 million, denominated in Japanese Yen which was paid in full in July 2013. In October 2009, the Predecessor borrowed $5.6 million denominated in Japanese Yen which was paid in full in October 2013.

During the Predecessor 2013 Period, the Company made principal and interest payments of $4.2 million and $0.1 million, respectively, on Japanese senior secured bank debt. During the year ended December 31, 2012, $4.6 million and $0.1 million of principal and interest payments, respectively, were made on the Japanese senior secured bank debt.

Other Debt Facilities

The Company carries various short-term debt facilities worldwide which are used to fund short-term cash needs. As of December 31, 2014 and 2013, there were no borrowings under these other debt facilities. The Company also has various overdraft facilities available. At December 31, 2014 and 2013, the capacity under these overdraft facilities was approximately $20.9 million and $22.1 million, respectively. As of December 31, 2014, the Company’s overdraft lines bore interest rates ranging from 1% to 6.25%.

Note_10_Derivative_Instruments

Note 10 - Derivative Instruments	12 Months Ended
Note 10 - Derivative Instruments	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	10. DERIVATIVE INSTRUMENTS

	In the normal course of business, the Company is exposed to risks relating to changes in foreign currency exchange rates, interest rates and commodity prices. Derivative financial instruments, such as foreign currency exchange rate instruments are used to manage changes in market conditions related to foreign currency exchange rate volatility. All derivatives are recognized on the consolidated balance sheets at fair value at the end of each year. The counterparty to the Company’s derivative agreements is a major international financial institution. The Company continually monitors its positions and the credit ratings of its counterparties and does not anticipate nonperformance by the counterparties.

	Foreign Currency

	The Company conducts a significant portion of its business in currencies other than the U.S. Dollar, the currency in which the consolidated financial statements are reported, and as a result, the Company’s operating results are affected by foreign currency exchange rate volatility relative to the U.S. dollar.

	The Company’s Autotype subsidiary in the United Kingdom uses the British Pound Sterling, or GBP, as its functional currency while, currently, approximately 35% of its revenues are denominated in U.S. Dollars. In order to protect against the risk of a strengthening GBP, the Corporate Treasury Group entered into forward contracts in each of the last three years on behalf of the Autotype subsidiary to deliver U.S. dollars at a fixed GBP rate and to receive GBP in exchange for the U.S. dollar. As of December 31, 2014, the aggregate U.S. Dollar notional amount of foreign currency forward contracts, none of which were designated as hedges, was $14.0 million, to be settled within one year. The Company uses the discounted period-end forward rates methodology to determine market value of its forward contracts. As of December 31, 2014, the fair value of these contracts was a current liability of $0.1 million that was recorded as an unrealized loss under other (expense) income in the accompanying Consolidated Statement of Operations.

	On September 23, 2014, in connection with the Agriphar and CAS Acquisitions, the Company entered into two separate foreign exchange forward contracts. The first contract was for the Company to buy €277 million at a rate of 1.287845, which was settled on October 1, 2014 with a realized loss of $7.0 million that was recorded as a part of other (expense) income in the accompanying Consolidated Statements of Operations. The second contract was for the Company to sell €204 million at a rate of 1.284 which was settled upon closing of the CAS acquisition on November 3, 2014 with a realized gain of $7.3 million that was also recorded as a part of other (expense) income in the accompanying Consolidated Statements of Operations.

	During the Successor and Predecessor 2013 Periods, $0.2 million and ($0.4) million, respectively, of unrealized gains (losses) were recorded in other comprehensive income relating to foreign currency exchange contracts. During the Successor and Predecessor 2013 Periods, the Company recorded realized gains (losses) of $0.1 million and ($0.4) million, respectively, in other income (expense) related to the settlement of foreign exchange contracts. During the year ended December 31, 2012, unrealized gains and (losses) of $0.5 million, net of tax, was recorded to other comprehensive income related to foreign currency hedges. During the years ended December 31, 2012, the Predecessor recorded realized gains of $0.1 million in other income (expense) related to the settlement of hedged foreign exchange contracts.

	Interest Rates (Predecessor)

	The Predecessor entered into an interest rate collar agreement in June 2007 to protect against interest rate changes on its floating rate U.S. Dollar denominated debt. Such interest rate collar agreement had a floor of 5.20% and a ceiling of 6.25%, a notional amount of $100 million and covered the period from June 30, 2010 through June 30, 2012.

	Changes in the fair value of a derivative that is designated as, and meets all the required criteria for, a cash flow hedge are recorded in accumulated other comprehensive income (loss) and reclassified into earnings as the underlying hedged item affects earnings. Amounts reclassified into earnings related to the interest rate collar agreement are included in interest expense. For the year ended December 31, 2012, the expense recorded in the statement of operations for hedge ineffectiveness was de minimus. For the year ended December 31, 2012, the Predecessor recorded $1.5 million of unrealized gains, net of tax, to Other Comprehensive Income.

	During the year ended December 31, 2012, the Company made payments of $2.4 million related to the difference between the interest rate collar agreement rate of 5.20% and the actual interest rate on the Company’s floating rate U.S. Dollar denominated debt. These payments were recorded as interest expense in the Consolidated Statement of Operations.

Note_11_Fair_Value_Measurement

Note 11 - Fair Value Measurements	12 Months Ended
Note 11 - Fair Value Measurements	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	11. FAIR VALUE MEASUREMENTS

	The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction related costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company has used the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction related costs. However, when using the most advantageous market, transaction related costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement.

	Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.

	The three levels of the fair value hierarchy are as follows:

		·	Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

		·	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model derived valuations whose inputs are observable or whose significant valuation drivers are observable.

		·	Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions.

	The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis:

					Fair Value Measurement Using
			31-Dec-14		Quoted prices in		Significant		Significant
					active markets		other observable		unobservable
					(Level 1)		inputs (Level 2)		inputs (Level 3)

	Asset Category
	Money market accounts		$	15.4	$	15.4	$	-	$	-
	Available for sale equity securities			2.3		1.5		0.8		-
	Derivatives			0.1		-		0.1		-
	Total		$	17.8	$	16.9	$	0.9	$	-

	Liability Category
	Long term contingent consideration		$	63.9	$	-	$	-	$	63.9

					Fair Value Measurement Using
			31-Dec-13		Quoted prices in		Significant		Significant
					active markets		other observable		unobservable
					(Level 1)		inputs (Level 2)		inputs (Level 3)

	Asset Category
	Money market accounts		$	78.6	$	78.6	$	-	$	-
	Available for sale equity securities			2.3		1.5		0.8		-
	Derivatives			0.2		-		0.2		-
	Total		$	81.1	$	80.1	$	1	$	-

	Liability Category
	Long term contingent consideration		$	34.8	$	-	$	-	$	34.8

	Money market accounts are included in cash and cash equivalents in the balance sheet. Available for sale equity securities and acquired investments are included in other long term assets in the balance sheet.

	The following table presents the carrying value and estimated fair value of the Company’s long term debt:

			31-Dec-14				31-Dec-13
			Carrying		Fair		Carrying		Fair
			Value		Value		Value		Value

	First lien secured credit facility, including current portion		$	743.7	$	728.8	$	751.3	$	752.6
	USD Incremental Loans, including current portion			294.9		289		-		-
	New Tranche B Term Loan, including current portion			129		126.5		-		-
	Euro Tranche Term Loans, including current portion			246.2		241.3		-		-
	Other			2.1		2		-		-
			$	1,415.90	$	1,387.60	$	751.3	$	752.6

	The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities:

	Money market accounts - The Company invests in various money market funds which are managed by financial institutions. These money market funds are not publicly traded, but historically have been highly liquid. The fair value of the money market accounts is determined by the banks based upon the funds’ net asset values, or NAV. All of the money market accounts currently permit daily investments and redemptions at $1.00 NAV.

	Available for sale equity securities - Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held, and are categorized as Level 1 instruments, whereas shares of unit investment trusts are categorized as Level 2 instruments.

Derivatives - The fair values of foreign currency derivatives were determined using pricing models based upon observable market inputs including both forward and spot prices for the underlying currencies.

First Lien, USD Incremental Loans, New Tranche B Term Loan and Euro Tranche Term Loans– These financial instruments are measured using quoted market prices at the reporting date multiplied by the carrying amount of the related debt. Such instruments are valued using Level 2 inputs.

Note_12_Stockholders_Equity

Note 12 - Stockholders' Equity	12 Months Ended
Note 12 - Stockholders' Equity	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	12. STOCKHOLDERS’ EQUITY

	Successor

	Series A Preferred Stock

	On April 25, 2013, the Company issued two preferred shares, one to each of the Founder Entities for $20. In connection with the Initial Public Offering on May 22, 2013, the Founder Entities purchased an additional 1,999,998 preferred shares for $20,000. Upon the Domestication, such preferred shares were automatically converted into shares of our Series A Preferred Stock. As a result, the Founder Entities are the current holders of our outstanding 2,000,000 shares of Series A Preferred Stock. Holders of our Series A Preferred Stock are entitled to receive dividends on their Series A Preferred Stock in the form of shares of our common stock. On December 31, 2014, we approved a stock dividend of 10,050,290 shares of our common stock with respect to our outstanding Series A Preferred Stock, which represented 20% of the appreciation of the market price of our common stock over the Initial Public Offering price of $10.00 multiplied by the total Initial Public Offering shares. The dividend price was $22.85 (calculated based upon the average of the last ten trading days of the year’s volume weighted average share prices), and the shares were issued on January 2, 2015 based on the volume weighted average price of $23.16 on December 31, 2014. In subsequent years, the dividend amount will be calculated based on the appreciated stock price compared to the highest dividend price previously used in calculating the Series A Preferred Stock dividends.

	Shares of Series A Preferred Stock will be automatically converted into shares of common stock on a one for one basis (i) in the event of a change of control of the Company following an acquisition or (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition, being December 31, 2020 (extendable by our Board for three additional years). Each share of Series A Preferred Stock is convertible into one share of common stock at the option of the holder until December 31, 2020 and has certain voting rights.

	During the Successor 2013 Period, the Company recognized a non-cash charge related to the fair value of the preferred dividend rights of $172.0 million. The fair value of the preferred dividend rights was measured based on significant inputs not observable in the market (Level 3 inputs). Key assumptions included the fair value of the common stock and an assumption of volatility. The fair value was calculated using a Monte-Carlo simulation.

	Underwritten Public Offering

	On November 11, 2014, we entered into an underwriting agreement with Barclays Capital Inc. and Credit Suisse Securities (USA) LLC, as representatives of several underwriters relating to the underwritten public offering of 16,445,000 shares of our common stock at a public offering price of $24.50 per share. This number of shares includes 2,145,000 shares sold to the underwriters upon exercise in full of their option to purchase additional shares. This offering was registered with the SEC pursuant to a registration statement on Form S-1, as amended (File Nos. 333-199816 and 333-200093), initially filed by Platform on November 3, 2014. The offering closed on November 17, 2014 and resulted in gross proceeds to Platform of approximately $403 million, before underwriting discounts, commissions and offering expenses of $14.1 million.

	Issuance of Securities in Connection with Acquisitions

	In connection with the Agriphar Acquisition, on October 1, 2014, we issued to a representative of Percival 711,551 restricted shares of our common stock, which will become unrestricted beginning January 2, 2018 unless agreed otherwise in accordance with the terms of the acquisition agreement. These shares can also be transferred back to us within six-months after the closing of the Agriphar Acquisition for €15 million ($18.2 million based on the December 31, 2014 exchange rate of $1.21 per €1.00).

	In connection with the CAS Acquisition, on November 3, 2014, we issued to Chemtura 2,000,000 shares of our common stock restricted under Rule 144.

	Private Placements

	On October 8, 2014 and November 6, 2014, we completed the October/November Private Placement to certain qualified institutional buyers and a limited number of institutional accredited investors of an aggregate of 16,060,960 shares and 9,404,064 shares, respectively, of our common stock at a price of $25.59 per share. In the October/November Private Placement, we received proceeds of $652 million, gross of transaction fees and offering expenses of $0.3 million.

	On May 20, 2014, we completed the May Private Placement to certain investors of an aggregate of 15,800,000 shares of the Company’s common stock for an aggregate consideration of $300 million, gross of transaction related costs of $13.8 million.

	Warrant Mandatory Redemption

	On March 4, 2014, a mandatory redemption event occurred with respect to all of the Company’s outstanding warrants. The Company fixed April 3, 2014 as the date of the mandatory redemption of the warrants, and accordingly, on or after that date, holders of warrants had no further rights with regard to such warrants except to receive $0.01 per warrant. During the year ended December 31, 2014, the Company issued 16,244,694 shares of common stock in connection with the exercise of a total of 48,734,082 warrants resulting in proceeds to the Company of $187 million. On April 3, 2014, Platform completed the mandatory redemption of the remaining 8,580 outstanding warrants for $0.01 per warrant.

	Ordinary Shares (Pre-Domestication)

	MacDermid Acquisition

	In connection with the MacDermid Acquisition, the Company agreed to apply to list its shares on the NYSE and to change its jurisdiction of incorporation from the British Virgin Islands to Delaware. The Company filed a registration statement on Form S-4 with the SEC to effect these changes. The registration statement was declared effective on January 22, 2014 and on that same date the Company completed the Domestication. On January 23, 2014, the Company’s common stock began trading on the NYSE under the ticker symbol “PAH.” On March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between the Company and the fiduciaries of the 401K, the Company acquired the remaining 3% of MacDermid for approximately $2.6 million in cash (which is reflected in “Acquisition of business, net” in the accompanying Condensed Consolidated Statements of Cash Flows) and 1,670,386 shares of the Company’s common stock.

	In connection with the Domestication, (i) each ordinary share of the Company that was issued and outstanding immediately prior to the Domestication was automatically converted into one share of common stock (par value $0.01) of the Company, (ii) outstanding options, warrants and other rights to acquire ordinary shares became options, warrants or rights to acquire the corresponding shares of common stock of the Company, and (iii) each share held by the Founder Entities that was issued and outstanding immediately prior to the Domestication was automatically converted into one share of Series A Preferred Stock of the Company.

	Initial Public Offering

	In connection with the Initial Public Offering on May 22, 2013, the Company issued 88,500,000 common shares (no par value) for gross proceeds of $885 million. Also, on May 22, 2013, the Company issued an aggregate of 29,500 common shares to non-founder directors for $10.00 per share. Each common share has voting rights and winding-up rights.

	Each of the 2,000,000 preferred shares, 88,500,000 common shares issued in connection with the Initial Public Offering as well as the 29,500 common shares issued to the non-founder directors was issued with a warrant (90,529,500 warrants in aggregate), entitling the holder of each warrant to purchase one-third of common shares with a strike price of $11.50 per common share. Each warrant was exercisable until three years from the date of an acquisition, unless mandatorily redeemed by the Company. The warrants were mandatorily redeemable by the Company at a price of $0.01 should the average market price of a common share exceed $18.00 for 10 consecutive trading days. In order to fund a portion of the cash consideration for the MacDermid Acquisition in November 2013, the Company conducted an offer to issue shares of common stock of the Company in exchange for $10.50 and 3 warrants, up to a maximum of half of the warrants outstanding in which 40,386,840 warrants (representing $141 million cash) were exercised and 13,462,280 underlying shares of common stock were issued. In conjunction with this Warrant Exchange Offer not being fully subscribed, on November 13, 2013, the Company issued 380,952 shares at $10.50 per share to the Founder Entities and issued 190,476 shares each to two of its independent directors at $10.50 per share.

	Non-Controlling Interest

	In connection with the MacDermid Acquisition, approximately $97.5 million was raised in new equity consisting of shares of PDH Common Stock that may be exchanged for shares of common stock at a rate of 25% per year over a four year period.

	The PDH Common Stock is classified as a non-controlling interest on the Consolidated Balance Sheets at December 31, 2014 and 2013 and will continue to be until such time as it is exchanged for shares of common stock. The total number of shares of common stock originally issuable upon the exchange of PDH Common Stock pursuant to the RHSA was approximately 8.8 million. As of December 31, 2014, 134,044 shares of our common stock were issued in connection with the exchange of PDH Common Stock.

	Approximately $6.4 million of the 2014 net loss and $1.4 million of Successor 2013 net loss has been allocated to the Retaining Holders as included in the Consolidated Statements of Operations, representing non-controlling interest of 6.66% and 6.76% at December 31, 2014 and 2013, respectively.

	Predecessor

	The Predecessor had previously issued 50,000,000 shares at $1.00 par value per share of common share prior to the MacDermid Acquisition. As of December 31, 2012, there were 49,582,936 common shares outstanding.

	The Predecessor also issued 316,000 preferred shares at $1,000 original cost per share. The preferred shares accrued a 9% cumulative payment in kind dividend compounded quarterly. At December 31, 2012, the amount of the cumulative payment in kind dividend was $209 million. At December 31, 2012, there were 315,144 preferred shares outstanding. The preferred shares were not redeemable and had no voting rights, covenants or restrictions. Upon liquidation, the preferred shares would first receive, to the extent funds are available, proceeds equal to the payment in kind dividend then the unreturned preferred share original cost, which was $1,000 per share. Then, the holders of the common shares will receive the unreturned common share original issue cost, which was $1.00 per share. The holders of the common shares and A and B Shares shall be entitled to receive the remaining portion of the proceeds from liquidation. Based on the MacDermid Acquisition described in Note 2, the respective shareholders were paid in accordance with these terms.

Note_13_Earnings_Per_Share

Note 13 - Earnings Per Share	12 Months Ended
Note 13 - Earnings Per Share	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	13. EARNINGS PER SHARE

	A computation of the weighted average shares outstanding for the year ended December 31, 2014 and Successor 2013 Period follows. No such computation is necessary for the Predecessor 2013 Period or for the year ended December 31, 2012.

	(in millions)	2014		2013
	Weighted average shares outstanding:
	Basic	$	135.3	$	92.6
	Convertible securities (1)		-		-
	Diluted	$	135.3	$	92.6

	(1) No share adjustments are included in the dilutive weighted average shares outstanding computation as the year ended December 31, 2014 and the Successor 2013 Period resulted in net losses.

	The following equity instruments were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:

	(in thousands)	2014		2013
	Number of shares contingently issuable for founder preferred share dividend rights		10,453		-
	Number of shares issuable upon conversion of warrants		-		16,248
	Number of shares issuable upon conversion of the PDH non-controlling interest		8,641		-
	Number of shares issuable upon conversion of founder preferred shares		2,000		-
	Number of shares contingently issuable for the contingent consideration		1,503		-
	Number of shares issuable upon conversion of the 401k exchange rights		270		-
	Number of stock options		89		-
	Number of restricted stock shares and units		70		-
			23,026		16,248

Note_14_Operating_Lease_Commit

Note 14 - Operating Lease Commitments	12 Months Ended
Note 14 - Operating Lease Commitments	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Commitments Disclosure [Text Block]	14. OPERATING LEASE COMMITMENTS

	The Company leases certain land, office space, warehouse space and equipment under agreements which are classified as operating leases for financial statement purposes. Certain of these leases provide for payment of real estate taxes, common area maintenance, insurance and certain other expenses. Lease terms may have escalating rent provisions and rent holidays which are recognized on a straight-line basis over the term of the lease. The leases expire at various dates through 2047. Total rental expense for leases for the year ended December 31, 2014, the Successor 2013 Period and Predecessor 2013 and 2012 Periods was $11.3 million, $1.5 million, $9.1 million and $9.7 million, respectively. The fixed operating lease commitments detailed below assume that the Company continues the leases through their initial lease terms.

	Minimum future non-cancelable operating lease commitments are as follows:

	2015	$	9.3
	2016		6.3
	2017		4.4
	2018		3.5
	2019		3.4
	Thereafter		15.5
		$	42.4

Note_15_Other_Expense_Income_N

Note 15 - Other (Expense) Income, Net	12 Months Ended
Note 15 - Other (Expense) Income, Net	Dec. 31, 2014
Other Income and Expenses [Abstract]
Other Income and Other Expense Disclosure [Text Block]	15. OTHER (EXPENSE) INCOME, NET

	For the year ended December 31, 2014, Net other expense totaled $2.5 million, consisting primarily of net foreign exchange losses of $3.0 million. For the Successor 2013 Period, Net other expense totaled $0.4 million, consisting primarily of net foreign exchange losses of $0.6 million.

	For the Predecessor 2013 Period, Net other expense totaled $0.5 million, consisting primarily of net losses on derivative contracts of $0.4 million. For the Predecessor 2012 Period, Net other income totaled $5.0 million consisting primarily of net foreign exchange gains of $4.7 million.

Note_16_Contingencies_Environm

Note 16 - Contingencies, Environmental And Legal Matters	12 Months Ended
Note 16 - Contingencies, Environmental And Legal Matters	Dec. 31, 2014
Loss Contingency [Abstract]
Contingencies Disclosure [Text Block]	16. CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS

	Asset Retirement Obligations

	The Company has recognized asset retirement obligations, or AROs, for properties where it can make a reasonable estimate of the future expenditures necessary to satisfy the related obligations. The Company considers identified legally enforceable obligations, estimated settlement dates and appropriate discount and inflation rates in calculating the fair value of its AROs. At December 31, 2014 and 2013, the Company has accrued $18.5 million and $4.8 million, respectively, for its AROs at sites primarily in Europe, Latin America and North America.

	The AROs are included in the other long-term liabilities in the Consolidated Balance Sheets as of December 31, 2014 and December 31, 2013. Changes in the Company’s AROs are as follows:

	Successor:
	Balance, April 23, 2013 (inception)	$	-
	Acquisitions		4.8
	Balance, December 31, 2013		4.8

	Acquisitions		13.2
	Additional obligations incurred		0.5
	Accretion expense		0.7
	Payments		(0.2	)
	Foreign currency adjustments		(0.5	)
	Balance, December 31, 2014	$	18.5


	Predecessor:
	Balance, December 31, 2012	$	2.3
	Settlements		(0.1	)
	Accretion expense		0.1
	Foreign currency adjustments		(0.1	)
	Balance, October 31, 2013	$	2.2

	Environmental

	The Company is a manufacturer and distributor of specialty chemical products, and is exposed to claims with respect to environmental cleanup or other matters, including those in connection with the disposal of hazardous materials. The Company is subject to extensive domestic and foreign laws and regulations relating to environmental protection and worker health and safety, including those governing discharges of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated properties. The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and regulations. Additional costs could be incurred, including cleanup costs, fines, sanctions, and third-party claims, as a result of violations of or liabilities under environmental laws.

	Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. Some of the facilities and former facilities of the Company have been environmentally impacted from historic operations and some facilities are in the process of being investigated and remediated. As of December 31, 2014 and 2013, $4.5 million and $2.9 million, respectively, was accrued for various environmental matters, not discounted to their present value, all of which we consider to be non-material. Ultimate costs may vary from current estimates, and the discovery of additional contaminants at these facilities or other sites, or the imposition of additional cleanup obligations or third-party claims relating thereto could result in additional costs. The Company’s management believes that any possible losses related to environmental remediation in addition to the amounts recorded as of December 31, 2014 and 2013 would not be material to our consolidated financial position, results of operations or cash flows.

	Legal Proceedings

	From time to time, the Company is involved in various legal proceedings in the normal course of its business. We believe that the resolution of these claims, to the extent not covered by insurance, will not individually or in the aggregate, have a material adverse effect on its consolidated financial position, results of operations or cash flows. As of December 31, 2014 and 2013, the Company has reserved approximately $4.4 million and $2.9 million, respectively, for its outstanding legal proceedings.

	On July 8, 2014, a federal court jury found in favor of MacDermid Printing Solutions LLC in litigation against Cortron, Inc. and awarded MacDermid Printing Solutions LLC $3.9 million in anti-trust damages; $7.9 million in breach of contract damages; $3.8 million in additional punitive damages for misappropriation of trade secrets, and $11.9 million plus additional punitive damages for unfair trade practices. The actual aggregate amount of damages, including the amount of punitive damages and an award of attorney fees will be determined by the presiding judge after post-trial briefing by the parties. Cortron, Inc. may appeal the verdict; accordingly, MacDermid Printing Solutions LLC’s ability to collect on the judgment is uncertain. All proceeds from this litigation are subject to the pending litigation provisions of our Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

	On September 22, 2014, the United States District Court for the District of New Jersey rendered a verdict in favor of MacDermid in this patent litigation with E.I. du Pont de Nemours and Company. The Court issued summary judgment rulings in favor of MacDermid finding certain E.I. du Pont de Nemours and Company’s patents invalid and not infringed. These rulings summarily find against E.I. du Pont de Nemours and Company on all of the patent claims asserted by E.I. du Pont de Nemours and Company in this lawsuit. The ruling, however, leaves all counterclaims made by MacDermid against E.I. du Pont de Nemours and Company in place. All proceeds from this litigation are subject to the pending litigation provisions of our Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

	On February 19, 2015, MacDermid, as plaintiff, settled litigation with Cookson Group plc, Enthone Inc., Cookson Electronics and David North, as defendants, for $25.0 million. The litigation related to certain corporate activities that occurred between MacDermid and the defendants in 2006 and 2007. All proceeds from this litigation are subject to the pending litigation provisions of our Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

Note_17_Related_Party_Transact

Note 17 - Related Party Transactions	12 Months Ended
Note 17 - Related Party Transactions	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	17. RELATED PARTY TRANSACTIONS

	RHSA

	Immediately prior to the closing of the MacDermid Acquisition, each Retaining Holder of equity interest in MacDermid Holdings not owned by Platform , including certain officers of MacDermid, executed a RHSA with the Company pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for shares of PDH Common Stock, at an exchange rate of $11.00 per share plus, with respect to the common, class A and class B unit equity interests of MacDermid Holdings held by the Retaining Holder (i) a proportionate share of a contingent interest in certain pending litigation, and (ii) a proportionate share of up to $100 million of contingent purchase price payable upon the attainment of certain EBITDA and stock trading price performance metrics during the seven-year period following the Closing Date as discussed further in Note 2. Immediately prior to the closing of the MacDermid Acquisition, members of MacDermid management and certain affiliates, including certain officers of MacDermid, contributed all or a portion of their MacDermid Holdings interests to Tartan, and Tartan agreed to receive the PDH Common Stock in exchange for such MacDermid Holdings equity interests. The resulting non-controlling interest percentage for the Retaining Holders was 6.76% at December 31, 2013 and 6.66% at December 31, 2014.

	Pursuant to the RHSA, until the earlier of (1) the seventh anniversary of the MacDermid Acquisition (that is October 31, 2020) and (2) such date on which all shares of PDH Common Stock held by Tartan have been exchanged for common stock, Platform has agreed to, among certain other covenants, obtain the prior written consent of Tartan prior to issuing additional securities, or instruments convertible, exchangeable or exercisable for securities.

	Advisory Services Agreement

	On October 31, 2013, the Company entered into an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of our founder directors. Under this agreement, Mariposa Capital, LLC provides certain advisory services to the Company and is entitled to receive an annual fee equal to $2.0 million, payable in quarterly installments. This agreement expired on October 31, 2014 but was automatically renewed for successive one-year terms unless either party notifies the other party in writing of its intention not to renew this agreement no later than 90 days prior to the expiration of the term. This agreement may only be terminated by the Company upon a vote of a majority of its directors. In the event that this agreement is terminated by the Company, the effective date of the termination will be six months following the expiration of the initial term or a renewal term, as the case may be. The Company incurred $2.0 million and $0.4 million during 2014 and 2013, respectively, under this agreement.

	Registration Rights Agreements

	On November 7, 2013, we entered into a registration rights agreement with Pershing Square on behalf of funds managed by Pershing Square pursuant to which we agreed to file a resale registration statement for the resale of the shares those funds own from time to time promptly after becoming eligible to utilize a Form S-3. We became eligible to file a registration statement on Form S-3 on January 23, 2015, and initially filed a registration statement on February 2, 2015 as required by this registration rights agreement. This registration statement was amended on February 12, 2015 and was declared effective on February 20, 2015.

	On May 20, 2014, we completed the May Private Placement. Blue Ridge Limited Partnership, a stockholder of more than five percent (5%) of our issued and outstanding common stock as of February 12, 2015, along with one of its affiliates, Blue Ridge Offshore Master Limited Partnership, purchased an aggregate 1,000,000 shares of our common stock issued in the May Private Placement, at a per share price of $19.00. In connection with the May Private Placement, we granted registration rights to each investor, including Blue Ridge Limited Partnership and Blue Ridge Offshore Master Limited Partnership. Pursuant to these registration rights agreements, on May 23, 2014, we initially filed the May Resale Registration Statement to register the resale of all of the shares sold in the May Private Placement. Such May Resale Registration Statement was amended on June 13, 2014 and declared effective on June 19, 2014.

	In connection with the October/November Private Placement, Blue Ridge Limited Partnership and Blue Ridge Offshore Master Limited Partnership, purchased an additional aggregate 1,953,888 shares of our common stock, at a per share price of $25.59. In addition, Pershing Square, through the Pershing Square Funds, purchased 9,404,064 shares, at a per share price of $25.59. A partner of Pershing Square is a member of Platform’s board of directors. In connection with the October/November Private Placement, we entered into registration rights agreements with each investor, including Blue Ridge Limited Partnership, Blue Ridge Offshore Master Limited Partnership and Pershing Square on behalf of its funds. Pursuant to these registration rights agreements, on November 3, 2014, we initially filed the November Resale Registration Statement to register the resale of all of the shares sold in the October/November Private Placement, including the 9,404,064 shares issued to the Pershing Square’s funds upon stockholder approval on November 6, 2014. The November Resale Registration Statement was declared effective on November 10, 2014.

	Support Agreements

	In connection with the October/November Private Placement, on October 3, 2014, Platform entered into separate support agreements with certain stockholders of Platform holding, in the aggregate, approximately 28.5% of our common stock as of such date. Such stockholders included Blue Ridge Limited Partnership, Berggruen Acquisition Holdings IV Ltd, Daniel H. Leever (Platform’s Chief Executive Officer, President and Vice Chairman), Mariposa Acquisition, LLC and Wellington Management Company, LLP, as investment advisor to certain stockholders.

	Under their respective support agreement, each stockholder agreed to vote at our special meeting of stockholders held on November 6, 2014, all of the shares of common stock they beneficially owned as of the record date for the special meeting (i) in favor of the approval of a proposal to approve the issuance to certain funds managed by Pershing Square of 9,404,064 shares of our common stock in the October/November Private Placement, and (ii) without limitation of the preceding clause (i), in favor of any proposal to adjourn or postpone the special meeting to a later date if there are not sufficient votes for approval of such matters on the date on which the special meeting is held.

	Predecessor Transactions

	For the Predecessor 2013 Period, the Company paid management fees of $7.5 million to Court Square Capital Partners II LP, an investor. For the years ended December 31, 2012, the Predecessor paid management fees of $0.3 million to Court Square Capital Partners II LP. Three of MacDermid’s board members prior to the MacDermid Acquisition were employees of Court Square Capital Partners II LP. The significant increase in management fees paid compared to the year ended December 31, 2012 was due to a final payment made to Court Square Capital Partners II LP in connection with the consummation of the MacDermid Acquisition and per the terms of the management agreement.

	For the Predecessor 2013 Period, the Company paid management fees to Weston Presidio, an investor, of $1.7 million. For the year ended December 31, 2012, the Predecessor paid management fees to Weston Presidio of $0.1 million.

	On August 26, 2013, MacDermid loaned $0.3 million to an officer in exchange for a promissory note bearing interest at Prime plus 1% per annum. As collateral, the note was secured by real estate owned by the officer. The principal amount of the loan and the accrued interest was repaid in full on October 31, 2013.

	On October 31, 2013, in order to complete the MacDermid Acquisition, Platform advanced $33.3 million to MacDermid representing the portion of the cash consideration required to purchase the equity held by MacDermid employee shares in connection with the MacDermid Acquisition. Also in conjunction with closing of the MacDermid Acquisition, Platform paid $5.0 million of interest on the first and second lien credit facilities on MacDermid’s behalf.

Note_18_Restructuring_Activiti

Note 18 - Restructuring Activities	12 Months Ended
Note 18 - Restructuring Activities	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	18. RESTRUCTURING ACTIVITIES

	The Company continuously evaluates all operations to identify opportunities to improve profitability by leveraging existing infrastructure to reduce operating costs and respond to overall economic conditions. The Predecessor implemented certain restructuring actions which were intended to better align manufacturing capacity, eliminate excess capacity by lowering operating costs, and streamline the organizational structure for improved long-term profitability. The restructuring actions consisted of facility consolidations and closures and employee terminations. The restructuring plans initiated in 2014 primarily related to the elimination of certain positions as well as several small initiatives aimed at cost reduction opportunities. The restructuring plans initiated during the Predecessor 2013 Period primarily related to the consolidation of manufacturing processes which affected a manufacturing facility in the Graphic Solutions segment.

	For the year ended December 31, 2014, the Successor 2013 Period and the Predecessor 2013 Period, $3.0 million, $0.8 million and $3.6 million of restructuring expense was recorded, respectively. At December 31, 2014, the Company’s restructuring liability totaled $1.6 million, which is anticipated to be fully utilized with the subsequent twelve months.

	For the Predecessor 2012 Period, the MacDermid recorded $0.3 million of restructuring expense primarily relating to the elimination of certain positions in the Performance Materials Europe reporting unit.

Note_19_Segment_Information

Note 19 - Segment Information	12 Months Ended
Note 19 - Segment Information	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	19. SEGMENT INFORMATION

	The Company’s operations are organized into three reportable segments: Performance Materials, Graphic Solutions and AgroSolutions. The segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president who report to the CODM.

	The Performance Materials segment manufactures and markets dynamic chemistry solutions that are used in the electronics, automotive and oil and gas production and drilling industries. We operate in the Americas, Asia and Europe. In conjunction with the sale of our products, we provide extensive technical service and support to ensure superior performance of their application. Within this segment, the Company provides specialty chemicals to three industries; Electronics, Industrial and Offshore. For the electronics industry, we design and formulate a complete line of proprietary “wet” dynamic chemistries that our customers use to process the surface of the printed circuit boards and other electronic components they manufacture. For the industrials, our dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the offshore industry, we produce water-based hydraulic control fluids for major oil companies and drilling contractors for offshore deep water production and drilling applications.

	The Graphic Solutions segment primarily produces and markets photopolymers through an extensive line of flexographic plates that are used in the commercial packaging and printing industries. Our products are used to improve print quality and printing productivity. We manufacture photopolymers used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, we also produce photopolymer printing plates for the flexographic and letterpress newspaper and publications markets.

	The AgroSolutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. This operating segment was created during the fourth quarter of 2014 to manage our newly acquired agrochemical vertical, which now includes Agriphar’s and CAS’ complementary businesses, as well as the recently acquired Arysta’s business. We offer a wide variety of proven plant health and pest control products to growers, which are comprised of specific target applications in the following major product lines: adjuvants; fungicides; herbicides; home applications (home and garden and ectoparasiticides); honey bee health; insecticides; miticides; plant growth regulators; and seed treatments. Our product portfolio also includes biosolutions (biostimulants, innovative nutrition and biocontrol), and regional off-patent AIs that complement our principal product lines.

	The Company evaluates the performance of its operating segments based on net sales and adjusted EBITDA. Adjusted EBITDA for each segment is calculated by taking net income and adding back interest expense, income tax expense (benefit), depreciation expense and amortization expense. This amount is further adjusted for acquisition-related expenses. Adjusted EBITDA for each segment also includes an allocation of corporate costs such as corporate salary, wages, equity compensation expense and legal costs.

	Segment assets primarily include cash, receivables, inventories, prepaid expenses and other current assets, property, plant and equipment, goodwill, intangible assets, deferred taxes and other long term assets. Segment assets primarily exclude corporate assets, which consist of cash and cash equivalents, corporate property, plant and equipment, and deferred taxes.

	The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented:

			For the year ended				For the				For the ten months ended				For the year ended
			31-Dec-14				period from inception				31-Oct-13				31-Dec-12
							(April 23, 2013) through
							31-Dec-13
			(Successor)				(Successor)				(Predecessor)				(Predecessor)

	Net Sales:
	Performance Materials		$	589.3			$	92.6			$	481.8			$	559.5
	Graphic Solutions			165.9				25.6				145.9				171.7
	AgroSolutions			88				-				-				-
	Consolidated net sales			843.2				118.2				627.7				731.2

	Depreciation and amortization:
	Performance Materials			55				9.7				26.5				34
	Graphic Solutions			21.3				3.1				6.3				8.2
	AgroSolutions			11.7				-				-				-
	Consolidated depreciation and amortization			88				12.8				32.8				42.2

	Adjusted EBITDA
	Performance Materials			148.7				21.6				115				118.6
	Graphic Solutions			47.5				5.8				37.7				43.6
	AgroSolutions			16				-				-				-
	Adjusted EBITDA		$	212.2			$	27.4			$	152.7			$	162.2

	The following table reconciles Net (loss) income attributable to common shareholders to Adjusted EBITDA:

	(in $ millions)		For the year ended				For the				For the ten months ended				For the year ended
			31-Dec-14				period from inception				31-Oct-13				31-Dec-12
							(April 23, 2013) through
							31-Dec-13
			Successor				Successor				Predecessor				Predecessor

	Adjusted EBITDA		$	212.2			$	27.4			$	152.7			$	162.2
	Adjustments to reconcile net (loss) income:
	Income tax benefit (provision)			6.7				5.8				(13.0	)			(24.7	)
	Interest expense			(38.7	)			(5.5	)			(46.3	)			(49.7	)
	Depreciation and amortization expense			(88.0	)			(12.8	)			(32.8	)			(42.2	)
	Non-cash charges related to preferred dividend rights			-				(172.0	)			-				-
	Equity based compensation			(1.3	)			(0.5	)			(9.3	)			(0.2	)
	Restructuring and related expenses			(3.0	)			(3.5	)			(4.5	)			(1.2	)
	Manufacturer's profit in inventory adjustment			(35.5	)			(23.9	)			-				-
	Non-cash fair value adjustment to contingent consideration			(29.1	)			0.7				-				-
	Acquisition transaction costs			(47.8	)			(15.2	)			(16.9	)			-
	Debt extinguishment			-				-				(18.8	)			-
	Other (expense) income			(5.4	)			5.3				2.1				1.8

	Net (loss) income attributable to common shareholders		$	(29.9	)		$	(194.2	)		$	13.2			$	46

The following tables provide information for those countries that represent 10% or more of net sales and long-lived assets:

		For the year ended				For the				For the ten months ended				For the year ended
		31-Dec-14				period from inception				31-Oct-13				31-Dec-12
						(April 23, 2013) through
						31-Dec-13
		(Successor)				(Successor)				(Predecessor)				(Predecessor)

Net Sales*:
United States		$	217.4				31.5			$	176.4			$	205.6

Foreign Net Sales:
United Kingdom			119.1				17.8				93.4				115.2
China			87.8				13.5				64.2				66.3
Other countries			418.9				55.4				293.7				344.1
Total Foreign Net Sales			625.8				86.7				451.3				525.6
Total consolidated net sales		$	843.2			$	118.2			$	627.7			$	731.2

* Net sales are attributed to countries based on the country which generates the sale.

		31-Dec-14
Long lived assets, net (1)

United States		$	64.8

Foreign countries
Belgium			28.9
United Kingdom			28
Other countries			53.3
			110.2
Total long lived assets, net		$	175

		31-Dec-13

United States		$	56.5

Foreign countries
United Kingdom			30
China			17.4
Italy			13.8
Other countries			18.5
			79.7
Total long lived assets, net		$	136.2

(1)Long-lived assets represent property, plant and equipment, net.

Total assets by reportable segment as of December 31, 2014 and 2013 are not presented as they not utilized by the CODM for purpose of allocating resources and evaluating performance.

The following table shows the Company's external party sales by product for the periods presented:

		For the year ended				For the period from inception				For the ten months ended				For the year ended
		31-Dec-14				(April 23, 2013) through				31-Oct-13				31-Dec-12
						31-Dec-13
		(Successor)				(Successor)				(Predecessor)				(Predecessor)

Performance Materials
Industrial Group		$	429.4			$	67.7			$	353.4			$	411.1
Electronics Group			159.9				24.9				128.4				148.4
			589.3				92.6				481.8				559.5

Graphic Solutions			165.9				25.6				145.9				171.7

AgroSolutions			88				-				-				-

Total consolidated net sales		$	843.2			$	118.2			$	627.7			$	731.2

Note_20_Subsequent_Events

Note 20 - Subsequent Events	12 Months Ended
Note 20 - Subsequent Events	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	20. SUBSEQUENT EVENTS

	Series A Preferred Stock Dividend

	As discussed in Note 12 (Stockholders’ Equity) 10,050,290 shares of our common stock were issued on January 2, 2015 as a dividend on the Series A Preferred Stock.

	Arysta Acquisition and Series B Preferred Stock

	On February 13, 2015, we completed the Arysta Acquisition for approximately $3.57 billion, consisting of $2.93 billion in cash, subject to working capital and other adjustments, and $600 million of Platform’s Series B Preferred Stock issued to the Seller.

	The Series B Preferred Stock may be converted into a maximum of 22,107,590 shares of our common stock. To the extent that the aggregate value of such 22,107,590 shares of common stock is less than $600 million (based on a 10-day volume weighted average price), then, such shortfall would be payable in cash by Platform as additional purchase price.

	In connection with the Arysta Acquisition and the issuance of the Series B Preferred Stock, we entered into a registration rights agreement with the Seller dated February 17, 2015, pursuant to which we agreed to (i) file a registration statement with the SEC covering the resale of a maximum of 22,107,590 shares of common stock issuable upon conversion of the Series B Preferred Stock, as soon as reasonably practicable following the issuance of the Series B Preferred Stock, and (ii) use our commercially reasonable efforts to cause the SEC to declare such registration statement effective by not later than six months following the date of the registration rights agreement. On February 25, 2015, we filed the Seller Resale Registration Statement to register the resale of a maximum of 22,107,590 shares of common stock. Such resale registration statement was amended on March 20, 2015 and is expected to be declared effective in early April 2015.

	Notes Offering

	In connection with the Arysta Acquisition, on February 2, 2015, we completed the private offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022, and €350 million aggregate principal amount of 6.00% EUR Notes due 2023. The Notes are governed by an indenture, dated February 2, 2015, as amended on February 13, 2015. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 will mature on February 1, 2022 and February 1, 2023, respectively, unless earlier redeemed. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 will bear interest at a rate of 6.50% and 6.00% per year, respectively, until maturity. Interest will be payable in cash, semi-annually in arrears, on February 1 and August 1 of each year, beginning on August 1, 2015. Platform will make each interest payment to the holders of record to be determined on the immediately preceding January 15 and July 15.

	The Notes are (i) Platform’s senior unsecured obligations, will rank equally in right of payment with all of Platform’s existing and future senior unsecured debt and will rank senior in right of payment to all of Platform’s existing and future unsecured subordinated debt; (ii) effectively subordinated to Platform’s secured indebtedness, including the debt outstanding under Platform’s amended and restated credit agreement, to the extent of the value of the assets securing such debt, and will be structurally subordinated to indebtedness and other liabilities, including trade payables, of Platform’s non-guarantor subsidiaries; and (iii) jointly and severally, fully and unconditionally guaranteed on a senior unsecured basis generally by our current and future direct and indirect domestic subsidiaries that guarantee our Amended and Restated Credit Agreement.

	Amendment to Amended and Restated Credit Agreement

	On February 13, 2015, we entered into and closed the transactions contemplated by an Amendment No. 3 to the Amended and Restated Credit Agreement which, among other things, provided for (i) New Tranche B-2 of Term Loans denominated in U.S. dollars in an aggregate principal amount of up to $500 million, (ii) an increase in the size of the existing Euro Tranche Term Loan facility by €83.0 million to €287 million (iii) an increase in the size of the existing U.S. Dollar revolving credit facility by $75.0 million to $163 million, and (iv) an increase in the size of the existing multicurrency revolving credit facility by $75.0 million to $163 million. Concurrently with the closing of the Arysta Acquisition, the additional $500 million of New Tranche B-2 Term Loans (less original issue discount of 1%), the additional €83.0 million of Euro Tranche Term Loan facility (less original issue discount of 2%) and $160 million under the U.S. Dollar revolving credit facility were borrowed to fund a portion of the cash consideration for the Arysta Acquisition.

	The New Tranche B-2 Term Loans bear interest at a rate per annum equal to 3.75% plus an adjusted Euro currency rate, or 2.75% plus an adjusted base rate, calculated as set forth in the Amended and Restated Credit Agreement, and mature on June 7, 2020. Pursuant to Amendment No.3, the previously existing Tranche B term loans will bear interest at 3.50% per annum plus an adjusted Euro currency rate, or 2.50% plus an adjusted base rate, calculated as set forth in the Amended and Restated Credit Agreement. Revolving loans bear interest at a rate per annum equal to 3.00% plus an adjusted Euro currency rate, or 2.00% plus an adjusted base rate, each as calculated as set forth in the Amended and Restated Credit Agreement, and mature on June 7, 2018.

	Except as set forth in Amendment No. 3 and above, the New Tranche B-2 Term Loans shall have identical terms as the existing Tranche B term loans and shall be otherwise subject to the provisions of the Amended and Restated Credit Agreement.

	Amendment No. 3 also, among other things, provides additional flexibility with respect to certain negative covenants, including by increasing certain dollar baskets.

	Option Exercise

	On April 23, 2013 (date of our inception), Alun Cathcart, a former non-founder director, was granted a five year option to acquire 75,000 ordinary shares. This option is fully vested and, upon our Domestication into Delaware on January 22, 2014, became an option to acquire shares of our common stock. On March 16, 2015, Mr. Cathcart exercised his option and 75,000 shares of our common stock were issued to him on March 19, 2015.

	Additional Stock Issuances to Certain Directors

	On March 17, 2015, effective March 25, 2015, as contemplated by the Director Compensation Policy previously adopted by the Board on October 31, 2013, the Board approved the grant to each of Michael F. Goss and E. Stanley O’Neal, directors of Platform, of 3,821 RSUs that will vest on March 17, 2016, provided that each of them continues to serve as a director of Platform through and on such vesting date. Each RSU represents a contingent right to receive one share of our common stock.

	Legal Proceedings

	On February 19, 2015, MacDermid, as plaintiff, settled a litigation with Cookson Group plc, Enthone Inc., Cookson Electronics and David North, as defendants, for $25.0 million. The litigation related to certain corporate activities that occurred between MacDermid and the defendants in 2006 and 2007. All proceeds from this litigation are subject to the pending litigation provisions of our Business Combination Agreement and Plan of Merger dated as of October 10, 2013.

	Other

	The Company has evaluated subsequent events through the date of the filing of this Annual Report. There were no other events or transactions during this evaluation that require recognition or disclosure in the financial statements.

Note_21_Supplementary_Data

Note 21 - Supplementary Data	12 Months Ended
Note 21 - Supplementary Data	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information [Text Block]	21. SUPPLEMENTARY DATA

	Selected Quarterly Financial Data (Unaudited)
	(in millions, except per share amounts)		Successor
			2014
			First Quarter			Second Quarter			Third Quarter			Fourth Quarter (c)

	Net sales		$	183.7		$	189.1		$	196.8		$	273.6
	Gross profit			84.2			96.7			103.2			112.4
	Net (loss) income attributable to shareholders			(7.4	)		(0.4	)		11.9			(34.0	)
	Net (loss) income attributable to common shareholders			(7.4	)		(0.4	)		11.9			(266.7	)
	Basic earnings (loss) per share (a)			(0.07	)		0			0.09			(1.59	)
	Diluted earnings (loss) per share (a)			(0.07	)		0			0.08			(1.59	)

			Successor
			2013
			Period from			Third Quarter			Fourth Quarter (b)
			Inception (April 23,
			2013) to June 30,
			2013

	Net sales		$	-		$	-		$	118.2
	Gross profit			-			-			35.7
	Net (loss) income attributable to shareholders			(0.1	)		(4.7	)		(189.4	)
	Net (loss) income attributable to common shareholders			(0.1	)		(4.7	)		(189.4	)
	Basic loss per share (a)			-			(0.05	)		(2.05	)
	Diluted loss per share (a)			-			(0.05	)		(2.05	)

	Selected Quarterly Financial Data (Unaudited)
	(in millions, except per share amounts)		Predecessor
			2013
			First Quarter			Second Quarter			Third Quarter			Fourth Quarter (c)

	Net sales		$	182.1		$	190		$	188.4		$	67.2
	Gross profit			93.3			96.5			99			34
	Net income (loss) attributable to MacDermid, Inc.			15.2			(5.9	)		14.5			(10.7	)
	Basic earnings (loss) per share (a)			n/a			n/a			n/a			n/a
	Diluted earnings (loss) per share (a)			n/a			n/a			n/a			n/a

			Predecessor
			2012
			First Quarter			Second Quarter			Third Quarter			Fourth Quarter

	Net sales		$	182.2		$	186.2		$	180.4		$	182.4
	Gross profit			86.3			90.3			89.7			88.8
	Net income attributable to MacDermid, Inc.			4.9			25.5			10			5.5
	Basic earnings (loss) per share (a)			n/a			n/a			n/a			n/a
	Diluted earnings (loss) per share (a)			n/a			n/a			n/a			n/a

	(a)	Earnings per share calculations for each quarter are based on the weighted average number of shares outstanding for each period. As MacDermid was not a Registrant prior to the Successor 2013 Period, no earnings per share data is presented;
	(b)	Platform's fourth quarter includes the results of MacDermid from November 1, 2013 through December 31, 2013; and
	(c)	MacDermid's fourth quarter includes results from October 1, 2013 through October 31, 2013.

Note_22_Valuation_and_Qualifyi

Note 22 - Valuation and Qualifying Accounts and Reserves	12 Months Ended
Note 22 - Valuation and Qualifying Accounts and Reserves	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	Schedule II

	Platform Specialty Products Corporation

	Valuation and Qualifying Accounts and Reserves

	(in millions)

			Balance at			Charges to			Deductions		Other (2)			Balance at
			beginning of			costs and			from					end of period
			period			expense			reserves
	Reserves against accounts receivable (1):
	Successor
	December 31, 2013 to December 31, 2014		$	(10.1	)	$	(1.2	)	$	0.9	$	0.8		$	(9.6	)
	April 23, 2013 (Inception) to December 31, 2013)			-			(0.3	)		0.6		(10.4	)		(10.1	)


	Predecessor
	December 31, 2012 to October 31, 2013			(8.8	)		(2.1	)		0.6		(0.1	)		(10.4	)
	December 31, 2011 to December 31, 2012			(8.7	)		(1.7	)		1.7		(0.1	)		(8.8	)


	Valuation allowances against deferred tax assets:
	Successor
	December 31, 2013 to December 31, 2014			(15.8	)		(2.0	)		-		(1.9	)		(19.7	)
	April 23, 2013 (Inception) to December 31, 2013)			-			0.9			-		(16.7	)(3)		(15.8	)


	Predecessor
	December 31, 2012 to October 31, 2013			(41.4	)		(3.6	)		-		-			(45.0	)
	December 31, 2011 to December 31, 2012		$	(34.5	)	$	(6.9	)	$	-	$	-		$	(41.4	)

	-1	Principally consisting of reserves for uncollectable accounts and sales returns and allowances.

	-2	Principally consisting of the opening balance sheet as a result of the MacDermid Acquisition.
	-3	Revised to reflect final purchase price allocation as presented in updates to our annual report on Form 10-K for fiscal year ended December 31, 2013, as reported in our current report on Form 8-K filed with the SEC on September 26, 2014.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation – The accompanying consolidated financial statements include the accounts of the Successor or the Predecessor, as applicable, and all of its majority-owned domestic and foreign subsidiaries. All intercompany accounts and transactions were eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates – In preparing the consolidated financial statements in conformity with U.S. GAAP, company management must undertake decisions that impact the reported amounts and related disclosures. Such decisions include the selection of the appropriate accounting principles to be applied and assumptions upon which accounting estimates are based. The Company applies judgment based on its understanding and analysis of the relevant circumstances to reach these decisions. By their nature, these judgments are subject to an inherent degree of uncertainty. Accordingly, actual results could differ significantly from the estimates applied. Significant items subject to such estimates and assumptions include: the useful lives of fixed assets, allowances for doubtful accounts and sales returns, deferred tax asset valuation allowances, inventory valuation, stock-based compensation, liabilities for employee benefit obligations, environmental liabilities, income tax uncertainties, valuation of goodwill, acquisition-related contingent consideration, as discussed in Note 2 below, and other contingencies.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents – The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents.

	The Company is required to maintain cash deposits with certain banks with respect to contractual obligations related to our acquisition activity. As of December 31, 2014, $600 million of cash was restricted related to the Arysta Acquisition. As of December 31, 2013, the Company was not required to maintain any restricted cash deposits.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Credit Risk Management – The Company’s products are sold primarily to customers in the agricultural, automotive, oil, electronic and printing industries. We are exposed to certain collection risks which are subject to a variety of factors, including economic and technological change within these industries. As is common industry practice, the Company generally does not require collateral or other security as a condition of sale, rather relying on credit approval, balance limitation and monitoring procedures to control credit risk on trade accounts receivable. The Company establishes reserves against estimated uncollectible amounts based on historical experience and specific knowledge regarding customers’ ability to pay.
Derivatives, Policy [Policy Text Block]	Derivatives – The Company operates internationally, with manufacturing and sales facilities in various locations around the world, and uses certain financial instruments to manage its foreign currency exposures. To qualify a derivative as a hedge at inception and throughout the hedge period, the Company formally documents the nature and relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategies for undertaking various hedge transactions, and the method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of a forecasted transaction are specifically identified, and the likelihood of each forecasted transactions of occurring is deemed probable. If it is determined that the forecasted transaction will not occur, the gain or loss is recognized in current earnings. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. The Company does not engage in trading or other speculative use of financial instruments.

	The Company has used and may use forward contracts and options to mitigate its exposure to changes in foreign currency exchange rates on third party and intercompany forecasted transactions. If hedge accounting is applied, the effective portion of unrealized gains and losses associated with forward contracts and the intrinsic value of option contracts are deferred as a component of other comprehensive income until the underlying hedged transactions are reported in the Company’s Consolidated Statements of Operations.

	The Company has also used and may use contracts and options to mitigate its exposure in the precious metals markets. Such contracts are designated as Normal Purchases, the effects of which are not deferred as components of other comprehensive income.
Inventory, Policy [Policy Text Block]	Inventories – Inventories are stated at the lower of cost or market with cost being determined principally by the first-in/first-out method. The Company regularly reviews inventories for obsolescence and excess quantities and calculates a reserve based on historical write-offs, customer demand, product evolution, usage rates and quantities of stock on hand. Inventory in excess of estimated usage requirements is written down to its estimated net realizable value.
Property, Plant and Equipment, Policy [Policy Text Block]	Property, Plant and Equipment – Property, plant and equipment are stated at cost less accumulated depreciation. Equipment under capital lease arrangements is stated at the net present value of minimum lease payments. The Company records depreciation on a straight-line basis over the estimated useful life of each asset. Estimated useful lives by asset class are as follows:

	Buildings and building improvements (years) -	5	to	20
	Machinery, equipment and fixtures (years) -	3	to	15
	Computer hardware and software (years) -	3	to	5
	Leasehold improvements -	Lesser of useful life
		or lease life

	Maintenance and repair costs are charged directly to expense; renewals and betterments which significantly extend the useful life of the asset are capitalized. Costs and accumulated depreciation on assets retired or disposed of are removed from the accounts and any resulting gains or losses are recorded to earnings in the period of disposal.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Indefinite-Lived Purchased Intangible Assets – Goodwill represents the excess of the acquisition cost over the fair value of the identifiable net assets of an acquired business. The Company does not amortize goodwill and other intangible assets that have indefinite useful lives; rather, goodwill and other intangible assets with indefinite lives are tested for impairment. Goodwill is tested for impairment at the reporting unit level annually, or when events or changes in circumstances indicate that goodwill might be impaired in accordance with ASC 350-20 “Intangibles—Goodwill and Other”. MacDermid’s annual test for goodwill impairment was historically performed as of April 1. Our annual impairment testing date for goodwill is October 1.

	A two-step impairment test is performed at the reporting unit level. In the first step of impairment testing, the fair value of each reporting unit is compared to its carrying value. The fair value of each reporting unit is determined using the income approach based on the present value of discounted future cash flows of those units using the twelve months ended preceding the date of impairment testing. The cash flows utilized in goodwill impairment testing differ from actual consolidated cash flows due to exclusion of non-recurring charges. The cash flow model utilized in the goodwill impairment test involves significant judgments related to future growth rates, working capital needs, discount rates and tax rates, among other considerations. The Company relies on data developed by business unit management as well as macroeconomic data in making these calculations. The discounted cash flow model utilizes a risk adjusted weighted average cost of capital to discount estimated future cash flows. Changes in these estimates can impact the present value of the expected cash flow that is used in determining the fair value of a given reporting unit. If the fair value of a reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and no further testing is required. If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the second step of the impairment test is performed to determine the implied fair value of the reporting unit’s goodwill. The implied fair value of goodwill is determined by measuring the excess of the estimated fair value of the reporting unit over the estimated fair values of the individual assets, liabilities and identifiable intangibles as if the reporting unit was being acquired in a business combination. If the carrying value of the reporting unit’s goodwill exceeds its implied fair value, an impairment charge is recorded equal to the difference. Platform performed its annual goodwill assessment on October 1, and no goodwill impairment charges were recorded for the year ended December 31, 2014.

	However, in performing the first step of the goodwill impairment test for the year ended December 31, 2014, the excess of the fair value of the Offshore and ASF Americas reporting units over their carrying values were 7.6% and 11.1% respectively. Goodwill assigned to the Offshore and ASF Americas reporting units totaled $364 million and $78.3 million, respectively. We determine the fair value of these reporting units as follows:

		·	Valuation Techniques - we use discounted cash flow analyses, which require assumptions about short and long-term net cash flows, growth rates, as well as discount rates. Additionally, we consider guideline company and guideline transaction information, where available, to aid in the valuation of the reporting units.

		·	Growth Assumptions - Multi-year financial forecasts are developed for each reporting unit by considering several key business drivers such as new business initiatives, client service and retention standards, market share changes, historical performance, and industry and economic trends, among other considerations. The annual revenue growth rates used in the initial seven year period range from (0.7%) to 9% for Offshore and 2.3% to 5.9% for ASF Americas. The long-term growth rates used in determining the terminal value of the Offshore and ASF Americas reporting units were estimated at 3.5% and 3.0%, respectively based on management's assessment of the minimum expected terminal growth rate of each reporting unit, as well as broader economic considerations such as gross domestic product and inflation.

		·	Discount Rate Assumptions - Discount rates are estimated based on a Weighted Average Cost of Capital, or WACC. The WACC combines the required return on equity, based on a Modified Capital Asset Pricing Model, which considers the risk-free interest rate, market risk premium, beta, small stock risk premium and a company specific risk premium, with the cost of debt, based on BBB rated corporate bonds, adjusted using an income tax factor. The calculation resulted in a WACC rate of 10.5% for both offshore and ASF Americas.

		·	Estimated Fair Value and Sensitivities - The estimated fair value of each reporting unit is derived from the valuation techniques described above. The estimated fair value of each reporting unit is analyzed in relation to numerous market and historical factors, including current economic and market conditions, company-specific growth opportunities, and guideline company information.

	The estimated fair value of the reporting unit is highly sensitive to changes in these estimates and assumptions; therefore, in some instances, changes in these assumptions could impact whether the fair value of a reporting unit is greater than its carrying value. We perform sensitivity analyses around these assumptions in order to assess the reasonableness of the assumptions and the resulting estimated fair values. Based on the sensitivity analysis performed for the Offshore reporting unit, a 1% decrease it the terminal growth rate or a 1% increase in the WACC rate would have resulted in the carrying value of the net assets to exceed their fair value, making it necessary to proceed to the second step of the impairment test. For ASF Americas, a 1% decrease it the terminal growth rate does not result in the carrying value exceeding their fair value, however, a 1% increase in the WACC rate would have resulted in the carrying value of the net assets to exceed their fair value, making it necessary to proceed to the second step of the impairment test. Ultimately, if any of these assumptions do not materialize in a manner consistent with the Company’s expectations, including discounts rates, annual revenue growth rates and terminal growth rates, there is risk of impairment to recorded goodwill.

	Indefinite-lived intangible assets consist of certain tradenames which are reviewed for potential impairment on an annual basis, or when events or changes in circumstances indicate that indefinite-lived intangible assets might be impaired. MacDermid’s annual test for indefinite-lived intangible assets impairment was historically performed as of April 1. Our annual impairment testing date for indefinite-lived intangible assets is October 1. Indefinite-lived intangible assets are reviewed for impairment by comparing the estimated fair value of the indefinite-lived intangible assets to the carrying value. The estimated fair value of these intangible assets is determined using the “relief from royalty” approach. An impairment loss is recognized when the estimated fair value of an indefinite-lived intangible asset is less than the carrying value.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Finite-Lived Intangible Assets – Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives, which currently range from eight to 30 years for customer lists, five to 14 years for developed technology, five to 20 years for tradenames and one to five years for non-compete agreements. The Company evaluates long-lived assets, such as property, plant and equipment and intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. If circumstances require a long-lived asset group to be tested for possible impairment, the Company first determines if the estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. When an impairment is identified, the carrying amount of the asset is reduced to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values.
Asset Retirement Obligations, Policy [Policy Text Block]	Asset Retirement Obligations – The Company records the fair value of legal obligations associated with the retirement of tangible long-lived assets in the period in which they are incurred, if a reasonable estimate of fair value can be made. Upon initial recognition of a liability, the Company capitalizes the cost of the asset retirement obligation by increasing the carrying amount of the related long-lived asset. Over time, the liability is increased for changes in its present value as accretion through interest expense and the capitalized cost is depreciated over the useful life of the related asset.
Pension and Other Postretirement Plans, Policy [Policy Text Block]	Employee Benefits – The Company sponsors a variety of employee benefit programs, some of which are non-contributory. The accounting policies used to account for these plans are as follows:

	Retirement – The Company provides non-contributory defined benefit plans to domestic and certain foreign employees. The projected unit credit actuarial method is used for financial reporting purposes. The Company recognizes the funded status; the difference between the fair value of the plan assets and the projected benefit obligation (pension plans) or the accumulated postretirement benefit obligation (other postretirement plan) in its Consolidated Balance Sheets. The Company’s funding policy for qualified plans is consistent with federal or other local regulations and customarily equals the amount deductible for federal and local income tax purposes. Foreign subsidiaries contribute to other plans, which may be administered privately or by government agencies in accordance with local regulations.

	Effective January 1, 2014, the Company also provides benefits under the Platform Specialty Products Employee Savings & 401(k) Plan, or PSP 401(k) Plan, for substantially all domestic employees, which consists of two components: a profit-sharing/ non-elective component funded by the Company as well as a defined contribution 401(k) component. Under the discretionary profit sharing and/or non-elective component, the Company made a non-elective contribution to the MacDermid, Incorporated Employee Savings and 401(k) Plan of $1.4 million during the first quarter of 2015 for the year ended December 31, 2014. Under the 401(k) component, on a yearly basis, the Company may determine to make contributions that match some or all of the participants’ contributions and contributed $0.7 million to the plan in 2014.

	The Predecessor also provided a defined contribution 401K Plan (401(a), (k) and 501(a)) for substantially all domestic employees, with the ability to make discretionary contributions to the 401K Plan. Effective with the MacDermid Acquisition on October 31, 2013, this 401K Plan was terminated. There were no such discretionary contributions made for the Predecessor 2013 and 2012 Periods.

	Post-retirement – The Company currently accrues for post-retirement health care benefits for U.S. employees hired prior to April 1, 1997. The post-retirement health care plan is unfunded.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial Instruments – The Company’s financial instruments consist primarily of cash and cash equivalents, restricted cash, accounts receivable, investments, accounts payable, contingent consideration and current and long-term debt. The Company believes that the carrying value of the cash and cash equivalents, restricted cash, accounts receivable and accounts payable are representative of their respective fair values because of the short maturities of these instruments. Available for sale equity investments are carried at fair value with net unrealized gains or losses reported as a component of accumulated other comprehensive (loss) income. See Note 11 for the fair value of the Company’s financial instruments.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation – Primarily all of the Company’s foreign subsidiaries use their local currency as their functional currency. The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. Dollars using foreign currency exchange rates prevailing as of the balance sheet dates. Revenue and expense accounts are translated at weighted-average foreign currency exchange rates for the periods presented. Cumulative currency translation adjustments are included in other comprehensive income (loss) in the stockholders’ equity section of the Consolidated Balance Sheets. Net gains and losses from transactions denominated in a currency other than the functional currency of the entity are included in Other (expense) income in the Consolidated Statements of Operations.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition – The Company recognizes revenue, including freight charged to customers, net of applicable rebates, estimates for sales returns and allowances and discounts, when the earnings process is complete. This occurs when products are shipped to or received by the customer in accordance with the terms of the agreement, title and risk of loss have been transferred, collectability is probable and pricing is fixed or determinable. Shipping terms are customarily “FOB shipping point” and do not include right of inspection or acceptance provisions. Equipment sales arrangements may include right of inspection or acceptance provisions, in which case revenue is deferred until these provisions are satisfied.
Cost of Sales, Policy [Policy Text Block]	Cost of Sales – Cost of sales consists primarily of raw material costs and related purchasing and receiving costs used in the manufacturing process, direct salary and wages and related fringe benefits, packaging costs, shipping and handling costs, plant overhead and other costs associated with the manufacture and distribution of the Company’s products. For the year ended December 31, 2014, cost of sales included a manufacturer’s profit in inventory adjustment of $35.5 million associated with inventory revaluations related to the MacDermid, Agriphar and CAS Acquisitions, and for the Successor 2013 Period, cost of sales included a manufacturer’s profit in inventory adjustment of $23.9 million related to the MacDermid Acquisition.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and Handling Costs – Costs related to shipping and handling are recognized as incurred and included in cost of sales in the Consolidated Statements of Operations.
Selling, General and Administrative Expenses, Policy [Policy Text Block]	Selling, technical, general and administrative expenses – Selling, technical, general and administrative expenses consist primarily of personnel and travel costs, advertising and marketing expenses, administrative expenses associated with accounting, finance, legal, human resource, amortization of intangible assets, risk management and overhead associated with these functions.
Research and Development Expense, Policy [Policy Text Block]	Research and development – Research and development costs, primarily relating to internal salaries, are expensed as incurred.
Income Tax, Policy [Policy Text Block]	Income Taxes – The provision for income taxes includes federal, foreign, state and local income taxes currently payable as well as the net change in deferred tax assets and liabilities during the period. Deferred income taxes are recorded at currently enacted tax rates for temporary differences between the financial reporting and income tax basis of assets and liabilities. A valuation allowance is assessed and recorded when it is estimated that it becomes more likely that not than the full value of a deferred tax asset may not be realized. Deferred federal and state income taxes are not provided on the undistributed earnings of certain foreign subsidiaries where management has determined that such earnings have been permanently reinvested.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-based Compensation Plans – The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation - Stock Compensation”. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based awards that are ultimately expected to vest. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. The fair value of restricted stock is determined based on the number of share granted and the closing price of the Company's common stock on the date of grant. Compensation expense for all share-based payment awards is recognized using the straight-line amortization method over the vesting period.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) Per Common Share – Basic earnings (loss) per common share excludes dilution and is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net (loss) income per common share assumes the issuance of all potentially dilutive share equivalents using the if converted or treasury stock method, if the effect is not anti-dilutive. For stock options, it is assumed that the proceeds will be used to buy back shares. Such proceeds equal the average unrecognized compensation plus the assumed exercise of weighted average number of options outstanding and windfall tax benefits. For unvested restricted shares, the assumed proceeds equal the average unrecognized compensation expense plus windfall tax benefits.
New Accounting Pronouncements, Policy [Policy Text Block]	New Accounting Standards

	Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-01, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015, but entities may apply the guidance retrospectively to all prior periods presented in the financial statements. The Company does not expect this ASU to have a material impact on its financial statements.

	Derivatives and Hedging (Topic 815) - In November 2014, the FASB issued ASU No. 2014-16, “Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity (a consensus of the FASB Emerging Issues Task Force).” Under current practice, there were predominantly two methods used to evaluate whether the nature of the host contract in a hybrid financial instrument is more akin to debt or equity: one considered all the features including the embedded and the other excluded the embedded derivative in the consideration. This update eliminates the difference in practice by clarify that the evaluation should be based on all the instrument’s features, including the embedded derivative, and that no single term or feature would necessarily determine the economic characteristics and risks of the host contract. The guidance is effective for fiscal years and interim periods beginning after December 15, 2015 and is applied in a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of our fiscal year 2016. The Company is in the process of evaluating the impact of this new ASU.

	Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company does not expect this ASU to have a material impact on its financial statements.

	Revenue from Contracts with Customers (Topic 606) - In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” which (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016. The Company is continuing to evaluate the impact of this new ASU.
Reclassification, Policy [Policy Text Block]	Reclassifications

	Certain prior year amounts have been reclassified to conform to the current year’s presentation.

Note_2_Acquisitions_of_Busines1

Note 2 - Acquisitions of Businesses (Tables)	12 Months Ended
Note 2 - Acquisitions of Businesses (Tables)	Dec. 31, 2014
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]		MacDermid			Agriphar			CAS
	Consideration
	Cash, net	$	916.5		$	350.2		$	983.1
	Equity Instruments		115.4			16.6			52
	Long-term debt		754.2			-			-
	Derivative liability		-			3.5			-
	Contingent Consideration		35.5			-			-
	Total Consideration		1,821.60			370.3			1,035.10

	Transaction related costs		15.2			4.2			33.9

	Identifiable Assets acquired and Liabilities Assumed
	Accounts receivable		147.4			57.6			150.7
	Inventories		115.3			41.5			129.3
	Other current assets		26.2			1.6			15.5
	Property, plant and equipment		140.9			31.7			11.6
	Identifiable intangible assets		729			183			534
	Other assets		28.3			5.4			21.5
	Current Liabilities		(117.9	)		(48.3	)		(69.9	)
	Non-current deferred tax liability		(171.2	)		(64.9	)		(25.3	)
	Other long term liabilities		(66.6	)		(15.9	)		(13.3	)
	Total identifiable net assets		831.4			191.7			754.1

	Goodwill		990.2			178.6			281

	Total purchase price	$	1,821.60		$	370.3		$	1,035.10
Business Acquisition, Pro Forma Information [Table Text Block]		Revenue			Net Income (Loss)
					attributable to
					Shareholders

	Pro Forma Year Ended 12/31/14	$	1,405.90		$	46.4

	Pro Forma Year Ended 12/31/13	$	731.8		$	(229.5	)

Note_3_Inventories_Tables

Note 3 - Inventories (Tables)	12 Months Ended
Note 3 - Inventories (Tables)	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]		31-Dec-14		31-Dec-13

	Finished goods	$	154.9	$	58.3
	Raw materials and supplies		49.5		29.9
	Equipment		1.4		1.4
	Total inventory, net	$	205.8	$	89.6

Note_4_Property_Plant_and_Equi1

Note 4 - Property, Plant and Equipment (Tables)	12 Months Ended
Note 4 - Property, Plant and Equipment (Tables)	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		31-Dec-14			31-Dec-13

	Land and leasehold improvements	$	36.6		$	29.9
	Buildings and improvements		51.1			38.9
	Machinery, equipment, fixtures and software		101.2			63.5
			188.9			132.3
	Less: accumulated depreciation		(18.1	)		(3.9	)
			170.8			128.4
	Construction in process		4.2			7.8
	Property, plant and equipment, net	$	175		$	136.2

Note_5_Goodwill_and_Intangible1

Note 5 - Goodwill and Intangible Assets (Tables)	12 Months Ended
Note 5 - Goodwill and Intangible Assets (Tables)	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]		Performance Materials			Graphic Solutions			AgroSolutions			Total
	Predecessor:
	Balance, December 31, 2012	$	447.7		$	28.5		$	-		$	476.2
	Foreign currency translation and other		(4.4	)		-			-			(4.4	)
	Balance, October 31, 2013	$	443.3		$	28.5		$	-		$	471.8

	Successor:
	Balance, April 23, 2013 (Inception)	$	-		$	-		$	-		$	-
	Addition from acquisitions		761.5			228.7			-			990.2
	Foreign currency translation and other		(1.1	)		0.7			-			(0.4	)
	Balance, December 31, 2013		760.4			229.4			-			989.8
	Addition from acquisitions		16.3			-			459.6			475.9
	Foreign currency translation and other		(37.3	)		(7.6	)		(15.5	)		(60.4	)
	Balance, December 31, 2014	$	739.4		$	221.8		$	444.1		$	1,405.30
Schedule of Finite-Lived Intangible Assets [Table Text Block]		31-Dec-14									31-Dec-13

		Gross Carrying Amount			Accumulated Amortization and Foreign Exchange			Net Book Value			Gross Carrying Amount			Accumulated Amortization and Foreign Exchange			Net Book Value

	Customer lists	$	613.6		$	(71.6	)	$	542		$	494		$	(6.4	)	$	487.6
	Developed technology		760.5			(50.8	)		709.7			164.2			(2.4	)		161.8
	Tradenames		19.7			(1.0	)		18.7			-			-			-
	Non-compete agreement		1.9			(0.1	)		1.8			-			-			-
	Total	$	1,395.70		$	(123.5	)	$	1,272.20		$	658.2		$	(8.8	)	$	649.4

Note_7_Pension_PostRetirement_1

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Tables)	12 Months Ended
	Dec. 31, 2014
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Tables) [Line Items]
Schedule of Net Benefit Costs [Table Text Block]		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)

	Pension & SERP Benefits:	Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Net periodic benefit expense:
	Service cost	$	-		$	0.8		$	0.7		$	0.1		$	3.6		$	0.6		$	3.6		$	0.7
	Interest cost on the projected benefit obligation		6.9			3			1.2			0.5			5.2			2.5			6.1			3.1
	Expected return on plan assets		(9.7	)		(3.5	)		(1.6	)		(0.7	)		(6.6	)		(4.1	)		(7.3	)		(4.5	)
	Amortization of prior service cost		-			-			-			-			0.1			-			0.1			-
	Amortization of net loss		-			-			-			-			1.6			0.4			0.6			0.5
	Plan curtailments		-			-			(3.0	)		-			-			-			-			0.1
	Net periodic (benefit) cost	$	(2.8	)	$	0.3		$	(2.7	)	$	(0.1	)	$	3.9		$	(0.6	)	$	3.1		$	(0.1	)
Schedule of Assumptions Used [Table Text Block]		Pension and SERP Benefits
		31-Dec-14						31-Dec-13
		Domestic			Foreign			Domestic			Foreign
	Weighted average assumptions used to measure benefit obligations at measurement date:
	Discount rate		4.2	%		2.5	%		5.2	%		4.2	%
	Rate of compensation increase		3.5	%		2.9	%		4	%		3.3	%
		Post-retirement Medical Benefits
		31-Dec-14						31-Dec-13
		Domestic			Foreign			Domestic			Foreign
	Weighted average assumptions used to measure benefit obligations at measurement date:
	Discount rate		4.2	%		12.5	%		5.1	%		12.4	%
	Rate of compensation increase		-			-			-			-
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]		Pension and SERP Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)
		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Change in Projected Benefit Obligation:
	Beginning of period balance	$	137.4		$	73.1		$	-		$	-		$	144.3		$	75		$	121.5		$	67.6
	Acquisitions		-			-			142			72.9			-			-			-			-
	Service cost		-			0.8			0.7			0.1			3.6			0.6			3.6			0.7
	Interest cost		6.9			3			1.2			0.5			5.2			2.5			6.1			3.1
	Plan curtailment		-			-			(3.0	)		0.2			-			-			-			-
	Actuarial (gain)/ loss due to assumption change		18.1			20.2			(2.8	)		(1.0	)		(7.1	)		1.6			15.4			3.9
	Actuarial (gain)/ loss due to plan experience		(0.6	)		1.6			-			(0.2	)		(0.6	)		(3.2	)		1.5			0.5
	Benefits and expenses paid		(4.2	)		(4.3	)		(0.7	)		(0.9	)		(3.4	)		(2.7	)		(3.8	)		(3.6	)
	Settlement		-			(0.5	)		-			(0.5	)		-			-			-			(0.3	)
	Translation adjustment		-			(5.6	)		-			2			-			(0.9	)		-			3.1
	End of period balance	$	157.6		$	88.3		$	137.4		$	73.1		$	142		$	72.9		$	144.3		$	75
		Pension and SERP Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)
		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Change in Fair Value of Plan Assets:
	Beginning of period balance	$	127		$	88.1		$	-		$	-		$	102.6		$	79.6		$	91		$	68.1
	Acquisitions		-			-			123.3			86.8			-			-			-			-
	Actual return on plan assets, net of expenses		11.2			16			4.4			(2.5	)		21.7			7.4			9.4			6.6
	Employer contributions		-			0.2			-			2.5			2.3			2.7			6			5.1
	Benefits paid		(4.2	)		(3.5	)		(0.7	)		(0.7	)		(3.3	)		(2.2	)		(3.8	)		(3.2	)
	Settlement		-			(0.5	)		-			(0.6	)		-			-			-			(0.3	)
	Translation adjustment		-			(5.8	)		-			2.6			-			(0.7	)					3.3
	End of period balance	$	134		$	94.5		$	127		$	88.1		$	123.3		$	86.8		$	102.6		$	79.6

	Funded status of plan	$	(23.6	)	$	6.2		$	(10.4	)	$	15		$	(18.8	)	$	13.9		$	(41.7	)	$	4.6
Schedule of Changes in Accumulated Postemployment Benefit Obligations [Table Text Block]		Post-retirement Medical Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)
		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Change in Accumulated Postretirement Benefit:
	Beginning of period balance	$	6.8		$	0.3		$	-		$	-		$	6.9		$	0.4		$	6		$	-
	Acquisitions		-			-			6.7			0.3			-			-			-			-
	Service cost		0.1			-			-			-			-			-			0.1			-
	Interest cost		0.3			-			0.1			-			0.2			-			0.3			-
	Employee contributions		-			-			-			-			0.2			-			0.3			-
	Actuarial loss/(gain) due to assumption change		0.5			-			0.1			-			(0.1	)		(0.1	)		0.6			-
	Actuarial loss/(gain) due to plan experience		-			-			-			-			(0.1	)		-			0.2			-
	Other		-			-			-			-			-			-			-			0.4
	Benefits and expenses paid		(0.3	)		-			(0.1	)		-			(0.5	)		-			(0.6	)		-
	End of period balance	$	7.4		$	0.3		$	6.8		$	0.3		$	6.6		$	0.3		$	6.9		$	0.4
Schedule of Changes in Fair Value of Plan Assets [Table Text Block]		Post-retirement Medical Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)
		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Change in Fair Value of Plan Assets:
	Beginning of period balance	$	-		$	-		$	-		$	-		$	-		$	-		$	-		$	-
	Employer contributions		0.3			-			0.1			-			0.3			-			0.3			-
	Employee contributions		-			-			-			-			0.2			-			0.3			-
	Benefits paid		(0.3	)		-			(0.1	)		-			(0.5	)		-			(0.6	)		-
	End of period balance	$	-		$	-		$	-		$	-		$	-		$	-		$	-		$	-
	Funded status of plan	$	(7.4	)	$	(0.3	)	$	(6.8	)	$	(0.3	)	$	(6.6	)	$	(0.3	)	$	(6.9	)	$	(0.4	)
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]		31-Dec-14			31-Dec-13

	Prepaid pension assets
	Foreign pension	$	10.2		$	19.1
	Total long term assets		10.2			19.1

	Other current liabilities
	Domestic pension		0.4			-
	Total current liabilities		0.4			-

	Retirement benefits, less current portion
	Domestic pension & SERP		23.2			10.4
	Foreign pensions		4			4
	Domestic post-retirement medical benefits		7.4			6.8
	Foreign post-retirement medical benefits		0.3			0.2
	Total non-current liabilities	$	34.9		$	21.4
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]		Pension and SERP Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)
		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Net actuarial gain (loss)	$	(10.4	)	$	(10.1	)	$	5.7		$	(2.1	)	$	10.5		$	10.8		$	(35.0	)	$	(16.9	)
	Prior service credits (costs)		-			-			-			-			0.6			-			(0.7	)		-
		$	(10.4	)	$	(10.1	)	$	5.7		$	(2.1	)	$	11.1		$	10.8		$	(35.7	)	$	(16.9	)
		Post-retirement Medical Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)
		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Net actuarial (loss) gain	$	(0.6	)	$	-		$	(0.1	)	$	-		$	0.1		$	(0.1	)	$	0.3		$	-
	Prior service (costs) credits		-			-			-			-			(0.5	)		0.3			(0.6	)		0.4
		$	(0.6	)	$	-		$	(0.1	)	$	-		$	(0.4	)	$	0.2		$	(0.3	)	$	0.4
Schedule of Allocation of Plan Assets [Table Text Block]					Fair Value Measurements Using
		31-Dec-14			Quoted prices in			Significant other			Significant
					active markets			observable inputs			unobservable
					(Level 1)			(Level 2)			inputs (Level 3)
	Asset Category
	Domestic equities	$	28.9		$	28.9		$	-		$	-
	Pooled funds holding global fixed income securities		9.2			-			9.2			-
	Mutual funds holding U.S. Treasury Securities		11.8			11.8			-			-
	Mutual funds holding domestic securities		4.8			4.8			-			-
	Limited partnership interests(a)		77.1			-			77.1			-
	Designated benefit fund(b)		1.1			-			1.1			-
	Insurance "Buy-In" Policy (c)		83.2			-			-			83.2
	Cash and cash equivalents		12.4			12.4			-			-
	Total	$	228.5		$	57.9		$	87.4		$	83.2
					Fair Value Measurements Using
		31-Dec-13			Quoted prices in			Significant other			Significant
					active markets			observable inputs			unobservable
					(Level 1)			(Level 2)			inputs (Level 3)
	Asset Category
	Domestic equities	$	23.2		$	23.2		$			$	-
	Pooled funds holding global equity securities		10.9			-			10.9			-
	Pooled funds holding global fixed income securities		72.8			-			72.8			-
	Mutual funds holding U.S. Treasury Securities		11.8			11.8			-			-
	Mutual funds holding domestic securities		4.2			4.2			-			-
	Limited partnership interests(a)		82.4			-			82.4			-
	Designated benefit fund(b)		1.5			-			1.5			-
	Cash and cash equivalents		8.4			8.4			-			-
	Total	$	215.2		$	47.6		$	167.6		$	-
Schedule of Expected Benefit Payments [Table Text Block]	Year End	Domestic			Foreign			Postretirement Benefits			Total
	2015	$	8.5		$	3.3		$	0.4		$	12.2
	2016		7.3			0.3			0.4			8
	2017		6.7			0.3			0.4			7.4
	2018		6.6			0.4			0.4			7.4
	2019		7			0.4			0.4			7.8
	Subsequent five years		40.2			2			2.2			44.4
	Total	$	76.3		$	6.7		$	4.2		$	87.2
Other Postretirement Benefit Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Tables) [Line Items]
Schedule of Net Benefit Costs [Table Text Block]		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)

	Post-retirement Benefits:	Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign

	Net periodic benefit expense:
	Service cost	$	0.1		$	-		$	-		$	-		$	0.1		$	-		$	-		$	-
	Interest cost on the projected benefit obligation		0.3			-			0.1			-			0.2			-			0.3			-
	Amortization of prior service cost		-			-			-			-			(0.1	)		-			(0.1	)		-
	Net periodic cost (benefit)	$	0.4		$	-		$	0.1		$	-		$	0.2		$	-		$	0.2		$	-
Schedule of Assumptions Used [Table Text Block]		Post-retirement Medical Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)

		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign
	Weighted average assumptions used to determine net periodic benefit cost:
	Discount rate		5.1	%		12.4	%		5	%		11.7	%		4.4	%		10.8	%		5.2	%		10.8	%
	Long-term rate of return on assets		N/A			N/A			N/A			N/A			N/A			N/A			N/A			N/A
Pension Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Tables) [Line Items]
Schedule of Assumptions Used [Table Text Block]		Pension and SERP Benefits
		For the year ended						For the period from						For the ten months						For the year ended
		31-Dec-14						inception (April 23,						ended October 31, 2013						31-Dec-12
								2013) through
								31-Dec-13
		(Successor)						(Successor)						(Predecessor)						(Predecessor)

		Domestic			Foreign			Domestic			Foreign			Domestic			Foreign			Domestic			Foreign
	Weighted average assumptions used to determine net periodic benefit cost:
	Discount rate		5.2	%		4.2	%		5.1	%		4.1	%		4.4	%		4.2	%		5.2	%		4.6	%
	Rate of compensation increase		4	%		3.4	%		4	%		3.3	%		4	%		3.4	%		4	%		3.4	%
	Long-term rate of return on assets		7.8	%		4.2	%		7.8	%		4.9	%		7.8	%		6.5	%		7.8	%		6.5	%

Note_8_Income_Taxes_Tables

Note 8 - Income Taxes (Tables)	12 Months Ended
Note 8 - Income Taxes (Tables)	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]		For the year ended			For the period			For the ten months			For the year ended
		31-Dec-14			from inception			ended October 31,			31-Dec-12
					(April 23, 2013)			2013
					through December
					31, 2013
		(Successor)			(Successor)			(Predecessor)			(Predecessor)

	Domestic	$	(103.9	)	$	(7.9	)	$	(74.2	)	$	(36.8	)
	Foreign		73			(193.5	)		100.7			107.8
	Total	$	(30.9	)	$	(201.4	)	$	26.5		$	71
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]		For the year ended			For the period			For the ten months			For the year ended
		31-Dec-14			from inception			ended October 31,			31-Dec-12
					(April 23, 2013)			2013
					through December
					31, 2013
		(Successor)			(Successor)			(Predecessor)			(Predecessor)
	Current:
	U.S.:
	Federal	$	(0.6	)	$	0.3		$	(5.3	)	$	1.8
	State and local		0.4			0.1			0.3			0.5
	Foreign		36.7			1.3			22.8			30.7
	Total current		36.5			1.7			17.8			33
	Deferred:
	U.S.:
	Federal		(18.3	)		(2.1	)		(3.1	)		(4.9	)
	State and local		0.4			(0.3	)		0.1			0.1
	Foreign		(25.3	)		(5.1	)		(1.8	)		(3.5	)
	Total deferred		(43.2	)		(7.5	)		(4.8	)		(8.3	)
	(Benefit) Provision for income taxes	$	(6.7	)	$	(5.8	)	$	13		$	24.7
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]		For the year ended			For the period from			For the ten months			For the year ended
		31-Dec-14			inception (April			ended October 31,			31-Dec-12
					23, 2013) through			2013
					December 31,
					2013
		(Successor)			(Successor)			(Predecessor)			(Predecessor)

	U.S. Federal Statutory tax rate		35	%		35	%		35	%		35	%

	Taxes computed at U.S. statutory rate	$	(10.8	)	$	(70.5	)	$	9.3		$	24.8

	State income taxes, net of Federal benefit		0.8			0.4			(2.2	)		(0.4	)
	Preferred dividend valuation		-			60.2			-			-
	Tax on foreign operations		(7.7	)		0.4			0.8			(11.6	)
	Net change in reserve		1.5			(0.7	)		(0.1	)		5.7
	Change in valuation allowances		0.2			(0.9	)		3.6			6.9
	Provision for tax on undistributed foreign earnings		(3.7	)		0.8			(0.7	)		0.2
	Change of tax rate		(0.5	)		-			(0.5	)		(1.0	)
	Non-deductible Transaction Costs		6.5			4.2			1.9			-
	Foreign exchange impact on provision		-			-			0.1			0.1
	Purchase Price Contigency		6.6			-			-			-
	Other, net		0.4			0.3			0.8			-
	Income tax (benefit) expense	$	(6.7	)	$	(5.8	)	$	13		$	24.7
	Effective tax rate		21.65	%		2.89	%		48.95	%		34.78	%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]		December 31,			December 31,
		2014			2013

	Deferred tax assets:
	Accounts receivable	$	5.9		$	1.7
	Inventory		-			3.3
	Accrued liabilities		9.7			3.7
	Employee benefits		20.2			12.3
	Research and development costs		11.2			14.1
	Tax credits		39.3			34
	Net operating losses		17.5			21.4
	Goodwill		31.8			-
	Other		12.5			8.2
	Total deferred tax assets		148.1			98.7
	Valuation allowance		(19.7	)		(15.8	)
	Total gross deferred tax assets		128.4			82.9

	Deferred tax liabilities:
	Plant and equipment		19.7			17.5
	Intangibles		280.7			210.4
	Undistributed foreign earnings		2.6			6.3
	Other		2.5			8
	Total gross deferred tax liabilities		305.5			242.2

	Net deferred tax liability	$	177.1		$	159.3
Condensed Balance Sheet [Table Text Block]		December 31,			December 31,
		2014			2013

	Net current deferred tax asset	$	18.7		$	11
	Net noncurrent deferred tax asset		6.5			(0.5	)
			25.2			10.5

	Net noncurrent deferred tax liability		202.3			169.8

	Total net deferred tax liability	$	177.1		$	159.3
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]		For the year ended			For the period from			For the ten months			For the year ended
		31-Dec-14			inception (April 23,			ended October 31,			31-Dec-12
					2013) through			2013
					31-Dec-13
		(Successor)			(Successor)			(Predecessor)			(Predecessor)

	Unrecognized tax benefits at beginning of period	$	25.6		$	-		$	22.7		$	18.8
	Additions based on current year tax positions		1.7			0.3			0.8			2.3
	Additions based upon prior year tax positions (including acquired uncertain tax positions)		7.4			26.3			0.3			1.7
	Reductions due to closed statutes		(6.7	)		(1.0	)		(0.3	)		(0.1	)
	Reductions for settlements and payments		(0.3	)		-			-			-

	Total Unrecognized Tax benefits at end of period	$	27.7		$	25.6		$	23.5		$	22.7
Summary of Income Tax Examinations [Table Text Block]	Major Jurisdiction	Open Years
	Brazil	2009 through current
	Belgium	2011 through current
	China	2011 through current
	France	2011 through current
	Germany	2010 through current
	Italy	2010 through current
	Japan	2009 through current
	Netherlands	2009 through current
	Singapore	2010 through current
	United Kingdom	2008 through current
	United States	2011 through current

Note_9_Longterm_Debt_Tables

Note 9 - Long-term Debt (Tables)	12 Months Ended
Note 9 - Long-term Debt (Tables)	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Debt And Capital Lease Obligations [Table Text Block]		31-Dec-14			31-Dec-13

	Borrowings under lines of credit	$	-		$	-
	First lien secured credit facility, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at December 31, 2014		743.7			751.3
	USD Incremental Loans, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at December 31, 2014		294.9			-
	New Tranche B Term Loans, due 2020, interest at the greater of 4.00% or LIBOR plus 3.00%, weighted average interest rate of 4.00% at December 31, 2014		129			-
	Euro Tranche Term Loans, due 2020, interest at the greater of 4.25% or LIBOR plus 3.25%, weighted average interest rate of 4.25% at December 31, 2014		246.2			-
	Other		2.1			1
	Total debt		1,415.90			752.3
	Less: current portion debt		(15.1	)		(8.0	)
	Total long-term debt	$	1,400.80		$	744.3
Minimum Future Principle Payments On Short Term Debt Long Term Debt And Capital Leases [Table Text Block]	Year End
	2015	$	15.1
	2016		15
	2017		14.7
	2018		14.6
	2019		14.5
	Thereafter		1,342.00
	Total	$	1,415.90

Note_11_Fair_Value_Measurement1

Note 11 - Fair Value Measurements (Tables)	12 Months Ended
Note 11 - Fair Value Measurements (Tables)	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis [Table Text Block]				Fair Value Measurement Using
		31-Dec-14		Quoted prices in		Significant		Significant
				active markets		other observable		unobservable
				(Level 1)		inputs (Level 2)		inputs (Level 3)

	Asset Category
	Money market accounts	$	15.4	$	15.4	$	-	$	-
	Available for sale equity securities		2.3		1.5		0.8		-
	Derivatives		0.1		-		0.1		-
	Total	$	17.8	$	16.9	$	0.9	$	-

	Liability Category
	Long term contingent consideration	$	63.9	$	-	$	-	$	63.9
				Fair Value Measurement Using
		31-Dec-13		Quoted prices in		Significant		Significant
				active markets		other observable		unobservable
				(Level 1)		inputs (Level 2)		inputs (Level 3)

	Asset Category
	Money market accounts	$	78.6	$	78.6	$	-	$	-
	Available for sale equity securities		2.3		1.5		0.8		-
	Derivatives		0.2		-		0.2		-
	Total	$	81.1	$	80.1	$	1	$	-

	Liability Category
	Long term contingent consideration	$	34.8	$	-	$	-	$	34.8
Fair Value Measurements, Nonrecurring [Table Text Block]		31-Dec-14				31-Dec-13
		Carrying		Fair		Carrying		Fair
		Value		Value		Value		Value

	First lien secured credit facility, including current portion	$	743.7	$	728.8	$	751.3	$	752.6
	USD Incremental Loans, including current portion		294.9		289		-		-
	New Tranche B Term Loan, including current portion		129		126.5		-		-
	Euro Tranche Term Loans, including current portion		246.2		241.3		-		-
	Other		2.1		2		-		-
		$	1,415.90	$	1,387.60	$	751.3	$	752.6

Note_13_Earnings_Per_Share_Tab

Note 13 - Earnings Per Share (Tables)	12 Months Ended
Note 13 - Earnings Per Share (Tables)	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	(in millions)	2014		2013
	Weighted average shares outstanding:
	Basic	$	135.3	$	92.6
	Convertible securities (1)		-		-
	Diluted	$	135.3	$	92.6
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	(in thousands)	2014		2013
	Number of shares contingently issuable for founder preferred share dividend rights		10,453		-
	Number of shares issuable upon conversion of warrants		-		16,248
	Number of shares issuable upon conversion of the PDH non-controlling interest		8,641		-
	Number of shares issuable upon conversion of founder preferred shares		2,000		-
	Number of shares contingently issuable for the contingent consideration		1,503		-
	Number of shares issuable upon conversion of the 401k exchange rights		270		-
	Number of stock options		89		-
	Number of restricted stock shares and units		70		-
			23,026		16,248

Note_14_Operating_Lease_Commit1

Note 14 - Operating Lease Commitments (Tables)	12 Months Ended
Note 14 - Operating Lease Commitments (Tables)	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2015	$	9.3
	2016		6.3
	2017		4.4
	2018		3.5
	2019		3.4
	Thereafter		15.5
		$	42.4

Note_16_Contingencies_Environm1

Note 16 - Contingencies, Environmental And Legal Matters (Tables)	12 Months Ended
	Dec. 31, 2014
Loss Contingency [Abstract]
Schedule of Change in Asset Retirement Obligation [Table Text Block]	Successor:
	Balance, April 23, 2013 (inception)	$	-
	Acquisitions		4.8
	Balance, December 31, 2013		4.8

	Acquisitions		13.2
	Additional obligations incurred		0.5
	Accretion expense		0.7
	Payments		(0.2	)
	Foreign currency adjustments		(0.5	)
	Balance, December 31, 2014	$	18.5


	Predecessor:
	Balance, December 31, 2012	$	2.3
	Settlements		(0.1	)
	Accretion expense		0.1
	Foreign currency adjustments		(0.1	)
	Balance, October 31, 2013	$	2.2

Note_19_Segment_Information_Ta

Note 19 - Segment Information (Tables)	12 Months Ended
Note 19 - Segment Information (Tables)	Dec. 31, 2014
Note 19 - Segment Information (Tables) [Line Items]
Schedule Reconciling Net (Loss) Income To Adjusted EBITDA [Table Text Block]	(in $ millions)	For the year ended			For the			For the ten months ended			For the year ended
		31-Dec-14			period from inception			31-Oct-13			31-Dec-12
					(April 23, 2013) through
					31-Dec-13
		Successor			Successor			Predecessor			Predecessor

	Adjusted EBITDA	$	212.2		$	27.4		$	152.7		$	162.2
	Adjustments to reconcile net (loss) income:
	Income tax benefit (provision)		6.7			5.8			(13.0	)		(24.7	)
	Interest expense		(38.7	)		(5.5	)		(46.3	)		(49.7	)
	Depreciation and amortization expense		(88.0	)		(12.8	)		(32.8	)		(42.2	)
	Non-cash charges related to preferred dividend rights		-			(172.0	)		-			-
	Equity based compensation		(1.3	)		(0.5	)		(9.3	)		(0.2	)
	Restructuring and related expenses		(3.0	)		(3.5	)		(4.5	)		(1.2	)
	Manufacturer's profit in inventory adjustment		(35.5	)		(23.9	)		-			-
	Non-cash fair value adjustment to contingent consideration		(29.1	)		0.7			-			-
	Acquisition transaction costs		(47.8	)		(15.2	)		(16.9	)		-
	Debt extinguishment		-			-			(18.8	)		-
	Other (expense) income		(5.4	)		5.3			2.1			1.8

	Net (loss) income attributable to common shareholders	$	(29.9	)	$	(194.2	)	$	13.2		$	46
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]		For the year ended			For the			For the ten months ended			For the year ended
		31-Dec-14			period from inception			31-Oct-13			31-Dec-12
					(April 23, 2013) through
					31-Dec-13
		(Successor)			(Successor)			(Predecessor)			(Predecessor)

	Net Sales*:
	United States	$	217.4			31.5		$	176.4		$	205.6

	Foreign Net Sales:
	United Kingdom		119.1			17.8			93.4			115.2
	China		87.8			13.5			64.2			66.3
	Other countries		418.9			55.4			293.7			344.1
	Total Foreign Net Sales		625.8			86.7			451.3			525.6
	Total consolidated net sales	$	843.2		$	118.2		$	627.7		$	731.2
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]		31-Dec-14
	Long lived assets, net (1)

	United States	$	64.8

	Foreign countries
	Belgium		28.9
	United Kingdom		28
	Other countries		53.3
			110.2
	Total long lived assets, net	$	175
		31-Dec-13

	United States	$	56.5

	Foreign countries
	United Kingdom		30
	China		17.4
	Italy		13.8
	Other countries		18.5
			79.7
	Total long lived assets, net	$	136.2
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]		For the year ended			For the period from inception			For the ten months ended			For the year ended
		31-Dec-14			(April 23, 2013) through			31-Oct-13			31-Dec-12
					31-Dec-13
		(Successor)			(Successor)			(Predecessor)			(Predecessor)

	Performance Materials
	Industrial Group	$	429.4		$	67.7		$	353.4		$	411.1
	Electronics Group		159.9			24.9			128.4			148.4
			589.3			92.6			481.8			559.5

	Graphic Solutions		165.9			25.6			145.9			171.7

	AgroSolutions		88			-			-			-

	Total consolidated net sales	$	843.2		$	118.2		$	627.7		$	731.2
Operations [Member]
Note 19 - Segment Information (Tables) [Line Items]
Schedule of Segment Reporting Information, by Segment [Table Text Block]		For the year ended			For the			For the ten months ended			For the year ended
		31-Dec-14			period from inception			31-Oct-13			31-Dec-12
					(April 23, 2013) through
					31-Dec-13
		(Successor)			(Successor)			(Predecessor)			(Predecessor)

	Net Sales:
	Performance Materials	$	589.3		$	92.6		$	481.8		$	559.5
	Graphic Solutions		165.9			25.6			145.9			171.7
	AgroSolutions		88			-			-			-
	Consolidated net sales		843.2			118.2			627.7			731.2

	Depreciation and amortization:
	Performance Materials		55			9.7			26.5			34
	Graphic Solutions		21.3			3.1			6.3			8.2
	AgroSolutions		11.7			-			-			-
	Consolidated depreciation and amortization		88			12.8			32.8			42.2

	Adjusted EBITDA
	Performance Materials		148.7			21.6			115			118.6
	Graphic Solutions		47.5			5.8			37.7			43.6
	AgroSolutions		16			-			-			-
	Adjusted EBITDA	$	212.2		$	27.4		$	152.7		$	162.2

Note_21_Supplementary_Data_Tab

Note 21 - Supplementary Data (Tables)	12 Months Ended
Note 21 - Supplementary Data (Tables)	Dec. 31, 2014
Successor [Member]
Note 21 - Supplementary Data (Tables) [Line Items]
Schedule of Quarterly Financial Information [Table Text Block]	Selected Quarterly Financial Data (Unaudited)
	(in millions, except per share amounts)	Successor
		2014
		First Quarter			Second Quarter			Third Quarter			Fourth Quarter (c)

	Net sales	$	183.7		$	189.1		$	196.8		$	273.6
	Gross profit		84.2			96.7			103.2			112.4
	Net (loss) income attributable to shareholders		(7.4	)		(0.4	)		11.9			(34.0	)
	Net (loss) income attributable to common shareholders		(7.4	)		(0.4	)		11.9			(266.7	)
	Basic earnings (loss) per share (a)		(0.07	)		0			0.09			(1.59	)
	Diluted earnings (loss) per share (a)		(0.07	)		0			0.08			(1.59	)
		Successor
		2013
		Period from			Third Quarter			Fourth Quarter (b)
		Inception (April 23,
		2013) to June 30,
		2013

	Net sales	$	-		$	-		$	118.2
	Gross profit		-			-			35.7
	Net (loss) income attributable to shareholders		(0.1	)		(4.7	)		(189.4	)
	Net (loss) income attributable to common shareholders		(0.1	)		(4.7	)		(189.4	)
	Basic loss per share (a)		-			(0.05	)		(2.05	)
	Diluted loss per share (a)		-			(0.05	)		(2.05	)
Predecessor [Member]
Note 21 - Supplementary Data (Tables) [Line Items]
Schedule of Quarterly Financial Information [Table Text Block]	Selected Quarterly Financial Data (Unaudited)
	(in millions, except per share amounts)	Predecessor
		2013
		First Quarter			Second Quarter			Third Quarter			Fourth Quarter (c)

	Net sales	$	182.1		$	190		$	188.4		$	67.2
	Gross profit		93.3			96.5			99			34
	Net income (loss) attributable to MacDermid, Inc.		15.2			(5.9	)		14.5			(10.7	)
	Basic earnings (loss) per share (a)		n/a			n/a			n/a			n/a
	Diluted earnings (loss) per share (a)		n/a			n/a			n/a			n/a
		Predecessor
		2012
		First Quarter			Second Quarter			Third Quarter			Fourth Quarter

	Net sales	$	182.2		$	186.2		$	180.4		$	182.4
	Gross profit		86.3			90.3			89.7			88.8
	Net income attributable to MacDermid, Inc.		4.9			25.5			10			5.5
	Basic earnings (loss) per share (a)		n/a			n/a			n/a			n/a
	Diluted earnings (loss) per share (a)		n/a			n/a			n/a			n/a

Note_1_Basis_of_Presentation_a1

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended	0 Months Ended		1 Months Ended	3 Months Ended
	Dec. 31, 2014	Mar. 04, 2014	Oct. 31, 2013	Jan. 31, 2014	Mar. 31, 2015	Jan. 23, 2014	Dec. 31, 2013
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Share Price (in Dollars per share)						$0.01
Goodwill, Impairment Loss (in Dollars)	$0
Goodwill (in Dollars)	1,405,300,000						989,800,000
Inventory Adjustments (in Dollars)	35,500,000						23,900,000
Weighted Average Cost Of Capital, WACC [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value Inputs, Discount Rate	10.50%
Building and Building Improvements [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Building and Building Improvements [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	20 years
Machinery and Equipment [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Machinery and Equipment [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	15 years
Computer Hardware And software [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Computer Hardware And software [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Offshore [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value Inputs, Long-term Revenue Growth Rate	-0.70%
Offshore [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value Inputs, Long-term Revenue Growth Rate	9.00%
Offshore [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	7.60%
Goodwill (in Dollars)	364,000,000
Fair Value Inputs, Long-term Revenue Growth Rate	3.50%
ASF Americas [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value Inputs, Long-term Revenue Growth Rate	2.30%
ASF Americas [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value Inputs, Long-term Revenue Growth Rate	5.90%
ASF Americas [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	11.10%
Goodwill (in Dollars)	78,300,000
Fair Value Inputs, Long-term Revenue Growth Rate	3.00%
ASF Americas and Offshore [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value Inputs, Long-term Growth Term	7 years
Customer Lists [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	8 years
Customer Lists [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	30 years
Developed Technology Rights [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Developed Technology Rights [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Trade Names [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Trade Names [Member] \| Maximum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Noncompete Agreements [Member] \| Minimum [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
MacDermid [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Business Acquisition, Percentage of Ownership		3.00%	97.00%
Goodwill (in Dollars)	990,200,000
Fair Value Inputs, Discount Rate				2.00%
Arysta [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Restricted Cash and Cash Equivalents (in Dollars)	600,000,000
MacDermid, Incorporated Employee Savings And 401(k) Plan [Member]
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Defined Benefit Plans, Estimated Future Employer Contributions in Next Fiscal Year (in Dollars)					1,400,000
Defined Benefit Plan, Contributions by Employer (in Dollars)	$700,000

Note_2_Acquisitions_of_Busines2

Note 2 - Acquisitions of Businesses (Details)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

10 Months Ended

12 Months Ended

0 Months Ended

2 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

6 Months Ended

0 Months Ended

1 Months Ended

6 Months Ended

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Apr. 16, 2014

Oct. 01, 2014

Dec. 31, 2014

Feb. 13, 2015

Oct. 01, 2014

Feb. 13, 2015

Jan. 31, 2014

Dec. 31, 2014

Oct. 25, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

22-May-13

Dec. 31, 2013

Dec. 31, 2014

Apr. 22, 2013

Dec. 31, 2014

Oct. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Mar. 04, 2014

Apr. 16, 2014

Dec. 31, 2014

Apr. 16, 2014

Oct. 01, 2014

Dec. 31, 2014

Mar. 04, 2014

Oct. 31, 2013

Mar. 04, 2014

Oct. 31, 2013

Jan. 31, 2014

Oct. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

USD ($)

Selling, General and Administrative Expenses [Member]

Series B Preferred Stock [Member]

Restricted Stock [Member]

Subsequent Event [Member]

At the Inception [Member]

Successor [Member]

Predecessor [Member]

United States of America, Dollars

Euro Member Countries, Euro

Customer Relationships [Member]

Customer Lists [Member]

Developed Technology Rights [Member]

Trade Names [Member]

Noncompete Agreements [Member]

Tradenames and Developed Technology [Member]

CAS [Member]

Agriphar [Member]

MacDermid [Member]

Agriphar And CAS [Member]

Undisclosed Name of Business [Member]

PDH [Member]

CAS [Member]

Agriphar [Member]

MacDermid [Member]

Agriphar And CAS [Member]

Arysta [Member]

Subsequent Event [Member]

Agriphar [Member]

Arysta [Member]

MacDermid [Member]

United States of America, Dollars

Euro Member Countries, Euro

MacDermid [Member]

Minimum [Member]

Maximum [Member]

USD ($)

MacDermid [Member]

USD ($)

Agriphar [Member]

MacDermid [Member]

Minimum [Member]

Maximum [Member]

Agriphar And CAS [Member]

Undisclosed Name of Business [Member]

Minimum [Member]

Maximum [Member]

Agriphar And CAS [Member]

Minimum [Member]

Maximum [Member]

Agriphar And CAS [Member]

Minimum [Member]

Maximum [Member]

Agriphar And CAS [Member]

Undisclosed Name of Business [Member]

Minimum [Member]

Maximum [Member]

Undisclosed Name of Business [Member]

Certis Europe B.V. [Member]

USD ($)

EUR (€)

USD ($)

MacDermid Savings Plan [Member]

USD ($)

Arysta [Member]

USD ($)

Agriphar [Member]

USD ($)

PDH [Member]

USD ($)

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

USD ($)

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

USD ($)

Note 2 - Acquisitions of Businesses (Details) [Line Items]

Business Combination, Consideration Transferred

$3,570,000,000

$2,600,000

$1,040,000,000

$1,035,100,000

$370,000,000

€ 300,000,000

$370,300,000

$1,800,000,000

$1,821,600,000

$30,500,000

Payments to Acquire Businesses, Gross

2,930,000,000

983,000,000

983,100,000

350,000,000

350,200,000

2,600,000

916,500,000

Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)

2,000,000

1,670,386

Business Combination Consideration Adjustment To Preliminary Estimated Working Capital

-15,000,000

Asset Retirement Obligation

18,500,000

4,800,000

4,800

18,500

2,200

2,300

13,200,000

Business Combination, Agreement Termination Advance Notice Term

4 years

Number of Major Product Lines

Business Combination, Acquisition Related Costs

33,900,000

4,200,000

38,100,000

6,400,000

15,200,000

47,800,000

16,900,000

33,900,000

4,200,000

15,200,000

29,800,000

Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual

61,900,000

26,100,000

Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual

-20,500,000

-8,300,000

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable

711,551

600,000,000

Business Combination Consideration Payable Shares to be Issued

15,000,000

18,200,000

Foreign Currency Exchange Rate, Translation

1.21

Business Combination, Contingent Consideration, Liability

63,900,000

34,800,000

35,500,000

3,400,000

35,500,000

34,800,000

Business Acquisition, Percentage of Ownership

3.00%

97.00%

Business Combination, Consideration Transferred, Liabilities Incurred

754,000,000

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

100,000,000

Proceeds from Previous Acquisition

8,500,000

Fair Value Inputs, Discount Rate

2.00%

Fair Value Inputs, Future Value of Cash Payments

60,000,000

Contingent Consideration Classified as Equity, Fair Value Disclosure

63,900,000

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

29,100,000

-700,000

29,100,000

Business Combination, Contingent Consideration Arrangement, Change Related to Achievement of Stock Performance

18,800,000

Business Combination, Contingent Consideration Arrangements, Change in Value Due to Compensation Expense

10,300,000

Business Acquisition, Share Price (in Dollars per share)

$11

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

6.66%

6.76%

Annual Maximum Percentage of Holdings Exchanged

25.00%

Common Stock, Capital Shares Reserved for Future Issuance (in Shares)

8,800,000

Stock Issued During Period, Shares, New Issues (in Shares)

88,500,000

134,044

Redeemable 401k Plan Interest

21,000,000

Business Combination, Equity Interest Acquired Affliated Company, Percentage

15.00%

Business Combination Equity Interest Acquired Affiliated Company, Value

15,000,000

Goodwill, Acquired During Period

990,200,000

475,900,000

1,450,000,000

Business Acquisition, Goodwill, Expected Tax Deductible Amount

194,000,000

Finite-Lived Intangible Asset, Useful Life

8 years

30 years

8 years

30 years

5 years

14 years

5 years

20 years

1 year

20 years

1 year

5 years

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

16 years

8 years

30 years

20 years

12 years

5 years

14 years

12 years

20 years

5 years

20 years

5 years

1 year

5 years

16 years

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt

754,200,000

400,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets

1,200,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment

11,600,000

31,700,000

140,900,000

200,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent

25,300,000

64,900,000

171,200,000

3,600,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets

18,000,000

Goodwill

1,405,300,000

989,800,000

1,405,300,000

471,800,000

476,200,000

281,000,000

178,600,000

990,200,000

16,300,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles

14,600,000

1,900,000

1,500,000

18,000,000

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned

$600,000,000

$97,500,000

$52,000,000

$16,600,000

$115,400,000

Note_2_Acquisitions_of_Busines3

Note 2 - Acquisitions of Businesses (Details) - Preliminary Purchase Price Allocation for Businesses Acquired	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Oct. 01, 2014	Oct. 01, 2014	Dec. 31, 2014	Apr. 16, 2014	Dec. 31, 2014
In Millions, unless otherwise specified	USD ($)	USD ($)	MacDermid [Member]	MacDermid [Member]	MacDermid [Member]	Agriphar [Member]	Agriphar [Member]	Agriphar [Member]	CAS [Member]	CAS [Member]
			USD ($)	USD ($)	USD ($)	USD ($)	EUR (€)	USD ($)	USD ($)	USD ($)
Consideration
Cash, net				$916.50		$350		$350.20	$983	$983.10
Equity Instruments				115.4				16.6		52
Long-term debt				754.2
Derivative liability								3.5
Contingent Consideration	63.9	34.8		35.5	34.8			3.4
Total Consideration			1,800	1,821.60		370	300	370.3	1,040	1,035.10
Transaction related costs				15.2				4.2		33.9
Identifiable Assets acquired and Liabilities Assumed
Accounts receivable				147.4				57.6		150.7
Inventories				115.3				41.5		129.3
Other current assets				26.2				1.6		15.5
Property, plant and equipment				140.9				31.7		11.6
Identifiable intangible assets				729				183		534
Other assets				28.3				5.4		21.5
Current Liabilities				-117.9				-48.3		-69.9
Non-current deferred tax liability				-171.2				-64.9		-25.3
Other long term liabilities				-66.6				-15.9		-13.3
Total identifiable net assets				831.4				191.7		754.1
Goodwill	1,405.30	989.8		990.2				178.6		281
Total purchase price				$1,821.60				$370.30		$1,035.10

Note_2_Acquisitions_of_Busines4

Note 2 - Acquisitions of Businesses (Details) - Pro Forma Revenue and Earnings (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Pro Forma Revenue and Earnings [Abstract]
Revenue	$1,405.90	$731.80
Earnings	$46.40	($229.50)

Note_3_Inventories_Details

Note 3 - Inventories (Details) (USD $)	12 Months Ended		3 Months Ended	2 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2014
Finish Goods [Member] \| Successor [Member] \| Fair Value Adjustment to Inventory [Member] \| MacDermid [Member]
Note 3 - Inventories (Details) [Line Items]
Assets, Fair Value Adjustment	$12	$23.90
Finish Goods [Member] \| Successor [Member] \| MacDermid [Member]
Note 3 - Inventories (Details) [Line Items]
Assets, Fair Value Adjustment		35.9
Finish Goods [Member] \| Fair Value Adjustment to Inventory [Member] \| Agriphar [Member]
Note 3 - Inventories (Details) [Line Items]
Assets, Fair Value Adjustment			9.4
Finish Goods [Member] \| Fair Value Adjustment to Inventory [Member] \| CAS [Member]
Note 3 - Inventories (Details) [Line Items]
Assets, Fair Value Adjustment				36.1
Finish Goods [Member] \| Fair Value Adjustment to Inventory [Member] \| Agriphar And CAS [Member]
Note 3 - Inventories (Details) [Line Items]
Assets, Fair Value Adjustment	22
Fair Value Adjustment to Inventory [Member] \| Agriphar And CAS [Member]
Note 3 - Inventories (Details) [Line Items]
Assets, Fair Value Adjustment	$23.50

Note_3_Inventories_Details_Com

Note 3 - Inventories (Details) - Components of Inventory (USD $)	Dec. 31, 2014	Dec. 31, 2013
Inventory [Line Items]
Total inventory, net	$205,800,000	$89,600,000
Successor [Member]
Inventory [Line Items]
Finished goods	154,900
Raw materials and supplies	49,500
Equipment	1,400
Total inventory, net	205,800
Predecessor [Member]
Inventory [Line Items]
Finished goods		58,300
Raw materials and supplies		29,900
Equipment		1,400
Total inventory, net		$89,600

Note_4_Property_Plant_and_Equi2

Note 4 - Property, Plant and Equipment (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 4 - Property, Plant and Equipment (Details) [Line Items]
Depreciation	$19.30
Successor [Member]
Note 4 - Property, Plant and Equipment (Details) [Line Items]
Depreciation		3.9
Predecessor [Member]
Note 4 - Property, Plant and Equipment (Details) [Line Items]
Depreciation		$10.50	$15.10

Note_4_Property_Plant_and_Equi3

Note 4 - Property, Plant and Equipment (Details) - Components of Property, Plant and Equipment (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	$188.90		$132.30
Less: accumulated depreciation	-18.1		-3.9
Property, plant and equipment, net	175	[1]	136.2	[1]
Construction in process	4.2		7.8
Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	36.6		29.9
Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	51.1		38.9
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, gross	101.2		63.5
Excluding Construction in Process [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	$170.80		$128.40

[1]	Long-lived assets represent property, plant and equipment, net.

Note_5_Goodwill_and_Intangible2

Note 5 - Goodwill and Intangible Assets (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2012	Dec. 31, 2013	Oct. 31, 2013
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Goodwill	$1,405.30		$989.80
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	16 years
Amortization of Intangible Assets	67.4	27.1
Finite-Lived Intangible Assets, Amortization Expense, Year Four	111
Finite-Lived Intangible Assets, Amortization Expense, Year Five	111
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	111
Finite-Lived Intangible Assets, Amortization Expense, Year Two	111
Finite-Lived Intangible Assets, Amortization Expense, Year Three	111
Trade Names [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	69.3		70.9
Predecessor [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Goodwill		476.2		471.8
Amortization of Intangible Assets			8.9
Successor [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Goodwill	1,405.30		989.8
Amortization of Intangible Assets			22.4
Offshore [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	7.60%
Goodwill	364
ASF Americas [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	11.10%
Goodwill	$78.30
Customer Relationships [Member] \| Minimum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	8 years
Customer Relationships [Member] \| Maximum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	30 years
Customer Relationships [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	20 years
Developed Technology Rights [Member] \| Minimum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	5 years
Developed Technology Rights [Member] \| Maximum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	14 years
Developed Technology Rights [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	12 years
Trade Names [Member] \| Minimum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	5 years
Trade Names [Member] \| Maximum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	20 years
Trade Names [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	20 years
Noncompete Agreements [Member] \| Minimum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	1 year
Noncompete Agreements [Member] \| Maximum [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	5 years
Noncompete Agreements [Member]
Note 5 - Goodwill and Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	5 years

Note_5_Goodwill_and_Intangible3

Note 5 - Goodwill and Intangible Assets (Details) - Changes in the Carrying Amount of Goodwill by Segment (USD $)	10 Months Ended	9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2012
Goodwill [Line Items]
Goodwill Balance		$989.80	$1,405.30
Predecessor [Member] \| Performance Materials [Member]
Goodwill [Line Items]
Goodwill Balance	447.7
Foreign currency translation and other	-4.4
Goodwill Balance	443.3
Predecessor [Member] \| Graphic Solutions [Member]
Goodwill [Line Items]
Goodwill Balance				28.5
Goodwill Balance	28.5			28.5
Predecessor [Member]
Goodwill [Line Items]
Goodwill Balance	476.2
Foreign currency translation and other	-4.4
Goodwill Balance	471.8
Successor [Member] \| Performance Materials [Member]
Goodwill [Line Items]
Goodwill Balance			760.4
Addition from acquisitions		761.5	16.3
Foreign currency translation and other		-1.1	-37.3
Goodwill Balance		760.4	739.4
Successor [Member] \| Graphic Solutions [Member]
Goodwill [Line Items]
Goodwill Balance			229.4
Addition from acquisitions		228.7
Foreign currency translation and other		0.7	-7.6
Goodwill Balance		229.4	221.8
Successor [Member] \| Agro Solutions [Member]
Goodwill [Line Items]
Addition from acquisitions			459.6
Foreign currency translation and other			-15.5
Goodwill Balance			444.1
Successor [Member]
Goodwill [Line Items]
Goodwill Balance			989.8
Addition from acquisitions		990.2	475.9
Foreign currency translation and other		-0.4	-60.4
Goodwill Balance		$989.80	$1,405.30

Note_5_Goodwill_and_Intangible4

Note 5 - Goodwill and Intangible Assets (Details) - Intangible Assets Subject to Amortization (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Successor [Member] \| Customer Lists [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$613.60
Accumulated Amortization and Foreign Exchange	-71.6
Net Book Value	542
Successor [Member] \| Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	760.5
Accumulated Amortization and Foreign Exchange	-50.8
Net Book Value	709.7
Successor [Member] \| Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	19.7
Accumulated Amortization and Foreign Exchange	-1
Net Book Value	18.7
Successor [Member] \| Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1.9
Accumulated Amortization and Foreign Exchange	-0.1
Net Book Value	1.8
Successor [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,395.70
Accumulated Amortization and Foreign Exchange	-123.5
Net Book Value	1,272.20
Predecessor [Member] \| Customer Lists [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		494
Accumulated Amortization and Foreign Exchange		-6.4
Net Book Value		487.6
Predecessor [Member] \| Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		164.2
Accumulated Amortization and Foreign Exchange		-2.4
Net Book Value		161.8
Predecessor [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		658.2
Accumulated Amortization and Foreign Exchange		-8.8
Net Book Value		$649.40

Note_6_Equity_Compensation_Pla1

Note 6 - Equity Compensation Plans (Details) (USD $)	12 Months Ended	0 Months Ended	12 Months Ended	0 Months Ended		9 Months Ended	0 Months Ended
Note 6 - Equity Compensation Plans (Details) (USD $)	Dec. 31, 2014	Jan. 29, 2013	Dec. 31, 2013	Jun. 12, 2014	Mar. 06, 2014	Dec. 31, 2013	Oct. 31, 2013	17-May-13
Note 6 - Equity Compensation Plans (Details) [Line Items]
Stock Issued During Period, Value, Employee Stock Purchase Plan (in Dollars)	$11,139,000
Class C Junior Shares [Member] \| Restricted Stock [Member] \| Predecessor [Member] \| MacDermid [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		5,000,000
Class C Junior Shares [Member] \| Predecessor [Member] \| MacDermid [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)			9,000,000
Class C Junior Shares [Member] \| MacDermid [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		4,890,000
Class C-1 Junior Shares [Member] \| Predecessor [Member] \| MacDermid [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		1,666,666
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		1,630,000
Class C-2 Junior Shares [Member] \| Predecessor [Member] \| MacDermid [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		1,666,666
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		1,630,000
Class C-3 Junior Shares [Member] \| Predecessor [Member] \| MacDermid [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		1,666,666
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		1,630,000
Restricted Stock Units (RSUs) [Member] \| Minimum [Member] \| Certain Employees [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	36 months
Restricted Stock Units (RSUs) [Member] \| Minimum [Member] \| Non-Employees [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$20.97
Restricted Stock Units (RSUs) [Member] \| Maximum [Member] \| Certain Employees [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	60 months
Restricted Stock Units (RSUs) [Member] \| Maximum [Member] \| Non-Employees [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$28.36
Restricted Stock Units (RSUs) [Member] \| Administrative Expense [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)	100,000
Restricted Stock Units (RSUs) [Member] \| Director [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				9,242
Allocated Share-based Compensation Expense (in Dollars)	300,000
Restricted Stock Units (RSUs) [Member] \| Certain Employees [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	139,610
Allocated Share-based Compensation Expense (in Dollars)	600,000
Restricted Stock Units (RSUs) [Member] \| Non-Employees [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	2,500
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	10 months
Restricted Stock Units (RSUs) [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					329,823
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options (in Dollars)	7,100,000
Allocated Share-based Compensation Expense (in Dollars)	400,000
Employee Stock Option [Member] \| Successor [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)						200,000
Employee Stock Option [Member] \| Non-founder Directors [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period								5 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in Dollars per share)								$11.50
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate								18.49%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate								0.37%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term								5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term							4 years 146 days
Successor [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Stock Issued During Period, Value, Employee Stock Purchase Plan (in Dollars)	$200,000
Officer [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number Of Participants	5
Director [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number Of Participants	6
Consultant [Member] \| The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number Of Participants	1
Non-founder Directors [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross								250,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)								$11.50
The 2013 Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			15,500,000			15,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period	9,242
Share-based Compensation Arrangement by Share-based Payment Award, Number Of Participants	2,486
Employee Stock Purchase Plan [Member]
Note 6 - Equity Compensation Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number Of Participants	513
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized					5,178,815

Note_7_Pension_PostRetirement_2

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details)

12 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Oct. 13, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

USD ($)

Long-term Growth [Member]

Near-term Benefit Payments [Member]

Equity Securities [Member]

Limited Partnership Interests and Managed Equity Funds [Member]

Bond Mutual Fund Holdings [Member]

Cash [Member]

Equity Funds [Member]

Insurance Buy In Policy [Member]

Bond Funds [Member]

Bond Option [Member]

Successor 2013 Period [Member]

Retiring Prior to March 31, 1989 [Member]

Retiring After April 1, 1989 [Member]

Predecessor 2013 Period [Member]

Minimum [Member]

Maximum [Member]

Pension Plan [Member]

SERP [Member]

U.K. Pension Plan [Member]

Other Foreign Defined Benefit Plans [Member]

Other Postretirement Benefit Plan [Member]

Domestic Defined Benefit Post-Employment Compensation Plan [Member]

Domestic And Foreign Employees [Member]

SERP [Member]

MacDermid, Incorporated Employees' Pension Plan [Member]

U.K. Pension Plan [Member]

MacDermid [Member]

USD ($)

Medical And Dental Plan [Member]

Other Postretirement Benefit Plan [Member]

Medical And Dental Plan [Member]

Other Postretirement Benefit Plan [Member]

USD ($)

GBP (£)

USD ($)

Other Current Liabilities [Member]

USD ($)

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) [Line Items]

Defined Benefit Plan, Net Periodic Benefit Cost

$2,100,000

$2,700,000

$3,500,000

Defined Benefit Plan, Recognized Net Gain (Loss) Due to Curtailments

3,000,000

Pension and Other Postretirement Benefit Expense

3,200,000

Defined Benefit Plan, Benefit Obligation

150,500,000

131,300,000

7,100,000

6,100,000

83,200,000

67,600,000

3,800,000

4,100,000

Defined Benefit Plan, Expected Contributions in Fiscal Year Four

Defined Benefit Plan, Expected Contributions in Fiscal Year Two

Defined Benefit Plan, Expected Contributions in Fiscal Year Three

Defined Benefit Plan, Expected Contributions in Next Fiscal Year

Defined Benefit Plan, Expected Contributions in Fiscal Year Five

Defined Benefit Plan, Target Plan Asset Allocations

75.00%

25.00%

Defined Benefit Plan, Actual Plan Asset Allocations

25.00%

58.00%

65.00%

9.00%

1.00%

3.00%

8.00%

4.00%

13.00%

22.00%

89.00%

10.00%

84.00%

Defined Benefit Plan, Benefit Obligation, Transferred (in Pounds)

49,700,000

Defined Benefit And Postretirement Plan Service Period

10 years

20 years

Annual Cost Increase for Post-retirement Medical Benefits, Limit

5.00%

3.00%

2.00%

4.00%

Defined Benefit Plan, Benefit Obligation, Percentage Allocated to Retirees

27.00%

Defined Benefit Plan, Benefit Obligation, Percentage Allocated to Fully Eligible Active Participants

40.00%

Defined Benefit Plan, Benefit Obligation, Percentage Allocated to Other Active Participants

33.00%

Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Net Gains (Losses), before Tax

-17,300,000

-21,100,000

3,500,000

-30,900,000

9,900,000

Defined Benefit Plan, Accumulated Benefit Obligation

$231,500,000

$191,800,000

Note_7_Pension_PostRetirement_3

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Components of Net Periodic Benefit Cost (USD $)	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Successor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Net periodic benefit expense:
Service cost	$0.70
Interest cost on the projected benefit obligation	1.2	6.9
Expected return on plan assets		-9.7
Plan curtailments	-3
Net periodic (benefit) cost		-2.8
Successor [Member] \| Foreign Pension Plan [Member]
Net periodic benefit expense:
Service cost	0.1	0.8
Interest cost on the projected benefit obligation	0.5	3
Expected return on plan assets		-3.5
Plan curtailments	0.2
Net periodic (benefit) cost		0.3
Predecessor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Net periodic benefit expense:
Service cost	0.7		3.6	3.6
Interest cost on the projected benefit obligation	1.2		5.2	6.1
Expected return on plan assets	-1.6		-6.6	-7.3
Amortization of prior service cost			0.1	0.1
Amortization of net loss			1.6	0.6
Plan curtailments	-3
Net periodic (benefit) cost	-2.7		3.9	3.1
Predecessor [Member] \| Foreign Pension Plan [Member]
Net periodic benefit expense:
Service cost	0.1		0.6	0.7
Interest cost on the projected benefit obligation	0.5		2.5	3.1
Expected return on plan assets	-0.7		-4.1	-4.5
Amortization of net loss			0.4	0.5
Plan curtailments				0.1
Net periodic (benefit) cost	($0.10)		($0.60)	($0.10)

Note_7_Pension_PostRetirement_4

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Components of Net Periodic Benefit Cost of Postretirement Benefits (Domestic Postretirement Benefit Plan of Foreign Entity [Member], USD $)	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Successor [Member]
Net periodic benefit expense:
Service cost		$0.10
Interest cost on the projected benefit obligation	0.1	0.3
Net periodic cost (benefit)		0.4
Predecessor [Member]
Net periodic benefit expense:
Service cost			0.1	0.1
Interest cost on the projected benefit obligation	0.1		0.2	0.3
Amortization of prior service cost			-0.1	-0.1
Net periodic cost (benefit)	$0.10		$0.20	$0.20

Note_7_Pension_PostRetirement_5

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Net Periodic Benefit Expense	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Successor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	5.10%	5.20%
Rate of compensation increase	4.00%	4.00%
Long-term rate of return on assets	7.80%	7.80%
Successor [Member] \| Foreign Pension Plan [Member]
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	4.10%	4.20%
Rate of compensation increase	3.30%	3.40%
Long-term rate of return on assets	4.90%	4.20%
Predecessor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate			4.40%	5.20%
Rate of compensation increase			4.00%	4.00%
Long-term rate of return on assets			7.80%	7.80%
Predecessor [Member] \| Foreign Pension Plan [Member]
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate			4.20%	4.60%
Rate of compensation increase			3.40%	3.40%
Long-term rate of return on assets			6.50%	6.50%

Note_7_Pension_PostRetirement_6

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Net Periodic Benefit Expense	9 Months Ended	10 Months Ended	12 Months Ended
	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2014	Dec. 31, 2012
Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	5.00%	4.40%	5.10%	5.20%
Long-term rate of return on assets
Foreign Postretirement Benefit Plan [Member]
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate	11.70%	10.80%	12.40%	10.80%
Long-term rate of return on assets

Note_7_Pension_PostRetirement_7

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Changes in Funded Status of Companybs Pension and SERP Plans (USD $)	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Change in Fair Value of Plan Assets:
Balance	$215.20	$228.50
Successor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Change in Projected Benefit Obligation:
Balance		137.4
Acquisitions	142
Service cost	0.7
Interest cost	1.2	6.9
Plan curtailment	-3
Actuarial (gain)/ loss due to assumption change	-2.8	18.1
Actuarial (gain)/ loss due to plan experience		-0.6
Benefits and expenses paid	-0.7	-4.2
Balance	137.4	157.6
Change in Fair Value of Plan Assets:
Balance		127
Funded status of plan	-10.4	-23.6
Acquisitions	123.3
Actual return on plan assets, net of expenses	4.4	11.2
Benefits paid	-0.7	-4.2
Balance	127	134
Successor [Member] \| Foreign Pension Plan [Member]
Change in Projected Benefit Obligation:
Balance		73.1
Acquisitions	72.9
Service cost	0.1	0.8
Interest cost	0.5	3
Plan curtailment	0.2
Actuarial (gain)/ loss due to assumption change	-1	20.2
Actuarial (gain)/ loss due to plan experience	-0.2	1.6
Benefits and expenses paid	-0.9	-4.3
Settlement	-0.5	-0.5
Translation adjustment	2	-5.6
Balance	73.1	88.3
Change in Fair Value of Plan Assets:
Balance		88.1
Funded status of plan	15	6.2
Acquisitions	86.8
Actual return on plan assets, net of expenses	-2.5	16
Employer contributions	2.5	0.2
Benefits paid	-0.7	-3.5
Settlement	-0.6	-0.5
Translation adjustment	2.6	-5.8
Balance	88.1	94.5
Predecessor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Change in Projected Benefit Obligation:
Balance			144.3	121.5
Service cost	0.7		3.6	3.6
Interest cost	1.2		5.2	6.1
Plan curtailment	-3
Actuarial (gain)/ loss due to assumption change			-7.1	15.4
Actuarial (gain)/ loss due to plan experience			-0.6	1.5
Benefits and expenses paid			-3.4	-3.8
Balance			142	144.3
Change in Fair Value of Plan Assets:
Balance			102.6	91
Funded status of plan			-18.8	-41.7
Actual return on plan assets, net of expenses			21.7	9.4
Employer contributions			2.3	6
Benefits paid			-3.3	-3.8
Balance			123.3	102.6
Predecessor [Member] \| Foreign Pension Plan [Member]
Change in Projected Benefit Obligation:
Balance			75	67.6
Service cost	0.1		0.6	0.7
Interest cost	0.5		2.5	3.1
Plan curtailment				0.1
Actuarial (gain)/ loss due to assumption change			1.6	3.9
Actuarial (gain)/ loss due to plan experience			-3.2	0.5
Benefits and expenses paid			-2.7	-3.6
Settlement				-0.3
Translation adjustment			-0.9	3.1
Balance			72.9	75
Change in Fair Value of Plan Assets:
Balance			79.6	68.1
Funded status of plan			13.9	4.6
Actual return on plan assets, net of expenses			7.4	6.6
Employer contributions			2.7	5.1
Benefits paid			-2.2	-3.2
Settlement				-0.3
Translation adjustment			-0.7	3.3
Balance			$86.80	$79.60

Note_7_Pension_PostRetirement_8

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Changes in Company's Post-retirement Medical Benefit Obligations (USD $)	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Successor [Member] \| Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Change in Accumulated Postretirement Benefit:
Balance		$6.80
Acquisitions	6.7
Service cost		0.1
Interest cost	0.1	0.3
Actuarial loss/(gain) due to assumption change	0.1	0.5
Benefits and expenses paid	-0.1	-0.3
Balance	6.8	7.4
Successor [Member] \| Foreign Postretirement Benefit Plan [Member]
Change in Accumulated Postretirement Benefit:
Acquisitions	0.3
Balance	0.3	0.3
Predecessor [Member] \| Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Change in Accumulated Postretirement Benefit:
Balance			6.9	6
Service cost			0.1	0.1
Interest cost	0.1		0.2	0.3
Employee contributions			0.2	0.3
Actuarial loss/(gain) due to assumption change			-0.1	0.6
Actuarial loss/(gain) due to plan experience			-0.1	0.2
Benefits and expenses paid			-0.5	-0.6
Balance			6.6	6.9
Predecessor [Member] \| Foreign Postretirement Benefit Plan [Member]
Change in Accumulated Postretirement Benefit:
Balance			0.4
Actuarial loss/(gain) due to assumption change			-0.1
Other				0.4
Balance			$0.30	$0.40

Note_7_Pension_PostRetirement_9

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Change in Fair Value of Plan Assets (USD $)	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Successor [Member] \| Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Change in Fair Value of Plan Assets:
Employer contributions	$0.10	$0.30
Benefits paid	-0.1	-0.3
Funded status of plan	-6.8	-7.4
Successor [Member] \| Foreign Postretirement Benefit Plan [Member]
Change in Fair Value of Plan Assets:
Funded status of plan	-0.3	-0.3
Predecessor [Member] \| Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Change in Fair Value of Plan Assets:
Employer contributions			0.3	0.3
Employee contributions			0.2	0.3
Benefits paid			-0.5	-0.6
Funded status of plan			-6.6	-6.9
Predecessor [Member] \| Foreign Postretirement Benefit Plan [Member]
Change in Fair Value of Plan Assets:
Funded status of plan			($0.30)	($0.40)

Recovered_Sheet1

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Included in Consolidated Balance Sheets (Successor [Member], USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Prepaid pension assets
Long-term assets	$10.20	$19.10
Other current liabilities
Current liabilities	0.4
Retirement benefits, less current portion
Non-current liabilities	34.9	21.4
Foreign Pension Plan [Member]
Prepaid pension assets
Long-term assets	10.2	19.1
Retirement benefits, less current portion
Non-current liabilities	4	4
Domestic Pension Plan of Foreign Entity [Member]
Other current liabilities
Current liabilities	0.4
Retirement benefits, less current portion
Non-current liabilities	23.2	10.4
Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Retirement benefits, less current portion
Non-current liabilities	7.4	6.8
Foreign Postretirement Benefit Plan [Member]
Retirement benefits, less current portion
Non-current liabilities	$0.30	$0.20

Recovered_Sheet2

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Benefit Obligations	Dec. 31, 2014	Dec. 31, 2013
Domestic Pension Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Benefit Obligations [Line Items]
Discount rate	4.20%	5.20%
Rate of compensation increase	3.50%	4.00%
Foreign Pension Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Benefit Obligations [Line Items]
Discount rate	2.50%	4.20%
Rate of compensation increase	2.90%	3.30%
Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Benefit Obligations [Line Items]
Discount rate	4.20%	5.10%
Foreign Postretirement Benefit Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Key Assumptions Used to Determine Benefit Obligations [Line Items]
Discount rate	12.50%	12.40%

Recovered_Sheet3

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) (USD $)	Dec. 31, 2014	Dec. 31, 2012	Dec. 31, 2013	Oct. 31, 2013
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)	($21,100,000)	($17,300,000)
Successor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)	-10,400		5,700
	-10,400		5,700
Successor [Member] \| Foreign Pension Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)	-10,100		-2,100
	-10,100		-2,100
Successor [Member] \| Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)			-100
			-100
Predecessor [Member] \| Domestic Pension Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)		-35,000		10,500
Prior service credits (costs)		-700		600
		-35,700		11,100
Predecessor [Member] \| Foreign Pension Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)		-16,900		10,800
		-16,900		10,800
Predecessor [Member] \| Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)		300		100
Prior service credits (costs)		-600		-500
		-300		-400
Predecessor [Member] \| Foreign Postretirement Benefit Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)				-100
Prior service credits (costs)		400		300
		400		200
Domestic Postretirement Benefit Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Amounts Recognized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial gain (loss)	-600
	($600)

Recovered_Sheet4

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Major Categories of Assets in Companybs Defined Benefit Pension Plans (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Asset Category
Major categories of assets	$228.50		$215.20
Private Equity Funds, Domestic [Member] \| Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets	28.9		23.2
Private Equity Funds, Domestic [Member]
Asset Category
Major categories of assets	28.9		23.2
Fixed Income Securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Asset Category
Major categories of assets	9.2
Fixed Income Securities [Member]
Asset Category
Major categories of assets	9.2
US Treasury Securities [Member] \| Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets	11.8		11.8
US Treasury Securities [Member]
Asset Category
Major categories of assets	11.8		11.8
Mutual Funds Holding Domestic Securities [Member] \| Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets	4.8		4.2
Mutual Funds Holding Domestic Securities [Member]
Asset Category
Major categories of assets	4.8		4.2
Limited Partnership Interests [Member] \| Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets		[1]		[1]
Limited Partnership Interests [Member] \| Fair Value, Inputs, Level 2 [Member]
Asset Category
Major categories of assets	77.1	[1]	82.4	[1]
Limited Partnership Interests [Member] \| Fair Value, Inputs, Level 3 [Member]
Asset Category
Major categories of assets		[1]		[1]
Limited Partnership Interests [Member]
Asset Category
Major categories of assets	77.1	[1]	82.4	[1]
Designated Benefit Fund [Member] \| Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets		[2]		[2]
Designated Benefit Fund [Member] \| Fair Value, Inputs, Level 2 [Member]
Asset Category
Major categories of assets	1.1	[2]	1.5	[2]
Designated Benefit Fund [Member] \| Fair Value, Inputs, Level 3 [Member]
Asset Category
Major categories of assets		[2]		[2]
Designated Benefit Fund [Member]
Asset Category
Major categories of assets	1.1	[2]	1.5	[2]
Insurance Buy In Policy [Member] \| Fair Value, Inputs, Level 3 [Member]
Asset Category
Major categories of assets	83.2
Insurance Buy In Policy [Member]
Asset Category
Major categories of assets	83.2
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets	12.4		8.4
Cash and Cash Equivalents [Member]
Asset Category
Major categories of assets	12.4		8.4
Equity Securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Asset Category
Major categories of assets			10.9
Equity Securities [Member]
Asset Category
Major categories of assets			10.9
Real Estate [Member] \| Fair Value, Inputs, Level 2 [Member]
Asset Category
Major categories of assets			72.8
Real Estate [Member]
Asset Category
Major categories of assets			72.8
Fair Value, Inputs, Level 1 [Member]
Asset Category
Major categories of assets	57.9		47.6
Fair Value, Inputs, Level 2 [Member]
Asset Category
Major categories of assets	87.4		167.6
Fair Value, Inputs, Level 3 [Member]
Asset Category
Major categories of assets	$83.20

[1]	This category represents limited partner investments with general partners that invest in equity securities.
[2]	This category includes assets held in a fund with the Bank of Taiwan as prescribed by the Taiwan government in accordance with local statutory rules.

Recovered_Sheet5

Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Expected Future Benefit Payments (USD $)	Dec. 31, 2014
In Millions, unless otherwise specified	Dec. 31, 2014
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Expected Future Benefit Payments [Line Items]
2015	$12.20
2016	8
2017	7.4
2018	7.4
2019	7.8
Subsequent five years	44.4
Total	87.2
Domestic Pension Plan of Foreign Entity [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Expected Future Benefit Payments [Line Items]
2015	8.5
2016	7.3
2017	6.7
2018	6.6
2019	7
Subsequent five years	40.2
Total	76.3
Foreign Pension Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Expected Future Benefit Payments [Line Items]
2015	3.3
2016	0.3
2017	0.3
2018	0.4
2019	0.4
Subsequent five years	2
Total	6.7
Other Postretirement Benefit Plan [Member]
Note 7 - Pension, Post-Retirement and Post-Employment Plans (Details) - Expected Future Benefit Payments [Line Items]
2015	0.4
2016	0.4
2017	0.4
2018	0.4
2019	0.4
Subsequent five years	2.2
Total	$4.20

Note_8_Income_Taxes_Details

Note 8 - Income Taxes (Details) (USD $)	12 Months Ended	3 Months Ended
Note 8 - Income Taxes (Details) (USD $)	Dec. 31, 2014	Mar. 31, 2015	Dec. 31, 2013
Note 8 - Income Taxes (Details) [Line Items]
Deferred Tax Liabilities, Undistributed Foreign Earnings Reduction	$0
Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries	264,000,000
Deferred Tax Liabilities, Undistributed Foreign Earnings	43,500,000
Deferred Tax Assets, Valuation Allowance	19,700,000		15,800,000
Deferred Tax Assets, Operating Loss Carryforwards, Domestic	314,000,000
Deferred Tax Assets, Tax Credit Carryforwards, Foreign	27,200,000
Deferred Tax Assets, Tax Credit Carryforwards, Research	7,700,000
Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax	2,100,000
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	2,300,000
Tax Credit Carry Forward Period	10 years
Unrecognized Tax Benefits	27,700,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	17,600,000
Tax Adjustments, Settlements, and Unusual Provisions	300,000
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	3,500,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	4,700,000		4,200,000
Earliest Tax Year [Member] \| Internal Revenue Service (IRS) [Member]
Note 8 - Income Taxes (Details) [Line Items]
Open Tax Year	2011
Earliest Tax Year [Member] \| Her Majesty's Revenue and Customs (HMRC) [Member]
Note 8 - Income Taxes (Details) [Line Items]
Open Tax Year	2008
Latest Tax Year [Member] \| Internal Revenue Service (IRS) [Member]
Note 8 - Income Taxes (Details) [Line Items]
Open Tax Year	2014
Tax Year 2009 [Member] \| Her Majesty's Revenue and Customs (HMRC) [Member]
Note 8 - Income Taxes (Details) [Line Items]
Income Tax Examination, Year under Examination	2009
Tax Year 2011 [Member] \| Her Majesty's Revenue and Customs (HMRC) [Member]
Note 8 - Income Taxes (Details) [Line Items]
Income Tax Examination, Year under Examination	2011
Tax Year 2008 [Member] \| Subsidiaries [Member]
Note 8 - Income Taxes (Details) [Line Items]
Open Tax Year	2008
State Income Taxes [Member]
Note 8 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Valuation Allowance	14,600,000
Foreign Net Operating Loss Carry Forwards [Member]
Note 8 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Valuation Allowance	1,600,000
State and Local Jurisdiction [Member]
Note 8 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Valuation Allowance	1,200,000
Deferred Tax Assets, Operating Loss Carryforwards, Foreign	13,000,000
Deferred Tax Assets, Gross	14,600,000
Foreign Tax Authority [Member]
Note 8 - Income Taxes (Details) [Line Items]
Deferred Tax Assets, Gross	3,000,000
Tax Credit Carryforward, Valuation Allowance	2,300,000
Scenario, Forecast [Member]
Note 8 - Income Taxes (Details) [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$27,200,000

Note_8_Income_Taxes_Details_Lo

Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares (USD $)	9 Months Ended	12 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013	Dec. 31, 2012
Domestic Tax Authority [Member] \| Successor [Member]
Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares [Line Items]
(Loss) Income before income taxes	($7.90)	($103.90)
Domestic Tax Authority [Member] \| Predecessor [Member]
Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares [Line Items]
(Loss) Income before income taxes			-74.2	-36.8
Foreign Tax Authority [Member] \| Successor [Member]
Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares [Line Items]
(Loss) Income before income taxes	-193.5	73
Foreign Tax Authority [Member] \| Predecessor [Member]
Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares [Line Items]
(Loss) Income before income taxes			100.7	107.8
Successor [Member]
Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares [Line Items]
(Loss) Income before income taxes	-201.4	-30.9
Predecessor [Member]
Note 8 - Income Taxes (Details) - (Loss) Income Before Income Taxes, Non-controlling Interests and Accrued Payment-in-kind Dividends On Cumulative Preferred Shares [Line Items]
(Loss) Income before income taxes			$26.50	$71

Note_8_Income_Taxes_Details_In

Note 8 - Income Taxes (Details) - Income Tax (Benefit) Expense (USD $)	9 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2014	Dec. 31, 2012
Income Tax (Benefit) Expense [Abstract]
Federal	$0.30	($5.30)	($0.60)	$1.80
State and local	0.1	0.3	0.4	0.5
Foreign	1.3	22.8	36.7	30.7
Total current	1.7	17.8	36.5	33
Federal	-2.1	-3.1	-18.3	-4.9
State and local	-0.3	0.1	0.4	0.1
Foreign	-5.1	-1.8	-25.3	-3.5
Total deferred	-7.5	-4.8	-43.2	-8.3
(Benefit) Provision for income taxes	($5.80)	$13	($6.70)	$24.70

Note_8_Income_Taxes_Details_In1

Note 8 - Income Taxes (Details) - Income Tax (Benefit) Expense Differed from the Amounts Computed By Applying The U.S. Federal Statutory Tax Rates to Pretax Income (USD $)	9 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2014	Dec. 31, 2012
Note 8 - Income Taxes (Details) - Income Tax (Benefit) Expense Differed from the Amounts Computed By Applying The U.S. Federal Statutory Tax Rates to Pretax Income [Line Items]
Income tax (benefit) expense	($5.80)	$13	($6.70)	$24.70
Successor [Member]
Note 8 - Income Taxes (Details) - Income Tax (Benefit) Expense Differed from the Amounts Computed By Applying The U.S. Federal Statutory Tax Rates to Pretax Income [Line Items]
U.S. Federal Statutory tax rate	35.00%		35.00%
Taxes computed at U.S. statutory rate	-70.5		-10.8
State income taxes, net of Federal benefit	0.4		0.8
Preferred dividend valuation	60.2
Tax on foreign operations	0.4		-7.7
Net change in reserve	-0.7		1.5
Change in valuation allowances	-0.9		0.2
Provision for tax on undistributed foreign earnings	0.8		-3.7
Change of tax rate			-0.5
Non-deductible Transaction Costs	4.2		6.5
Purchase Price Contigency			6.6
Other, net	0.3		0.4
Income tax (benefit) expense	-5.8		-6.7
Effective tax rate	2.89%		21.65%
Predecessor [Member]
Note 8 - Income Taxes (Details) - Income Tax (Benefit) Expense Differed from the Amounts Computed By Applying The U.S. Federal Statutory Tax Rates to Pretax Income [Line Items]
U.S. Federal Statutory tax rate		35.00%		35.00%
Taxes computed at U.S. statutory rate		9.3		24.8
State income taxes, net of Federal benefit		-2.2		-0.4
Tax on foreign operations		0.8		-11.6
Net change in reserve		-0.1		5.7
Change in valuation allowances		3.6		6.9
Provision for tax on undistributed foreign earnings		-0.7		0.2
Change of tax rate		-0.5		-1
Non-deductible Transaction Costs		1.9
Foreign exchange impact on provision		0.1		0.1
Other, net		0.8
Income tax (benefit) expense		$13		$24.70
Effective tax rate		48.95%		34.78%

Note_8_Income_Taxes_Details_Co

Note 8 - Income Taxes (Details) - Components of Deferred Income Taxes (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets:
Valuation allowance	($19,700,000)	($15,800,000)
Deferred tax liabilities:
Undistributed foreign earnings	43,500,000
Successor [Member]
Deferred tax assets:
Accounts receivable	5,900	1,700
Inventory		3,300
Accrued liabilities	9,700	3,700
Employee benefits	20,200	12,300
Research and development costs	11,200	14,100
Tax credits	39,300	34,000
Net operating losses	17,500	21,400
Goodwill	31,800
Other	12,500	8,200
Total deferred tax assets	148,100	98,700
Valuation allowance	-19,700	-15,800
Total gross deferred tax assets	128,400	82,900
Deferred tax liabilities:
Plant and equipment	19,700	17,500
Intangibles	280,700	210,400
Undistributed foreign earnings	2,600	6,300
Other	2,500	8,000
Total gross deferred tax liabilities	305,500	242,200
Net deferred tax liability	$177,100	$159,300

Note_8_Income_Taxes_Details_Ne

Note 8 - Income Taxes (Details) - Net Current and Net Long-Term Deferred Tax Assets and Liabilities (USD $)	Dec. 31, 2014	Dec. 31, 2013
Condensed Balance Sheet Statements, Captions [Line Items]
Net noncurrent deferred tax liability	$202,300,000	$169,800,000
Successor [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Net current deferred tax asset	18,700	11,000
Net noncurrent deferred tax asset	6,500	-500
	25,200	10,500
Net noncurrent deferred tax liability	202,300	169,800
Total net deferred tax liability	$177,100	$159,300

Note_8_Income_Taxes_Details_Un

Note 8 - Income Taxes (Details) - Unrecognized Tax Benefits (USD $)	12 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2012
Note 8 - Income Taxes (Details) - Unrecognized Tax Benefits [Line Items]
Reductions due to closed statutes	($3,500,000)
Unrecognized tax benefits	27,700,000
Successor [Member]
Note 8 - Income Taxes (Details) - Unrecognized Tax Benefits [Line Items]
Unrecognized tax benefits	25,600
Additions based on current year tax positions	1,700	300
Additions based upon prior year tax positions (including acquired uncertain tax positions)	7,400	26,300
Reductions due to closed statutes	-6,700	-1,000
Reductions for settlements and payments	-300
Unrecognized tax benefits	27,700	25,600
Predecessor [Member]
Note 8 - Income Taxes (Details) - Unrecognized Tax Benefits [Line Items]
Unrecognized tax benefits			22,700	18,800
Additions based on current year tax positions			800	2,300
Additions based upon prior year tax positions (including acquired uncertain tax positions)			300	1,700
Reductions due to closed statutes			-300	-100
Unrecognized tax benefits			$23,500	$22,700

Note_8_Income_Taxes_Details_Ta

Note 8 - Income Taxes (Details) - Tax Years Subject To Examination By The Major Tax Jurisdiction Indicated (Earliest Tax Year [Member])	12 Months Ended
	Dec. 31, 2014
Belgium [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2011
Secretariat of the Federal Revenue Bureau of Brazil [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2009
State Administration of Taxation, China [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2011
Ministry of the Economy, Finance and Industry, France [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2011
Federal Ministry of Finance, Germany [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2010
Ministry of Economic Affairs and Finance, Italy [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2010
National Tax Agency, Japan [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2009
Tax and Customs Administration, Netherlands [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2009
Inland Revenue, Singapore (IRAS) [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2010
Her Majesty's Revenue and Customs (HMRC) [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2008
Internal Revenue Service (IRS) [Member]
Income Tax Examination [Line Items]
Income tax jurisdiction	2011

Note_9_Longterm_Debt_Details

Note 9 - Long-term Debt (Details)

0 Months Ended

12 Months Ended

10 Months Ended

0 Months Ended

10 Months Ended

12 Months Ended

10 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

10 Months Ended

12 Months Ended

10 Months Ended

12 Months Ended

0 Months Ended

10 Months Ended

12 Months Ended

Nov. 03, 2014

Jun. 07, 2013

Dec. 31, 2014

Dec. 31, 2013

Nov. 03, 2014

Oct. 31, 2013

Jun. 07, 2013

Nov. 03, 2014

Jun. 07, 2013

Oct. 31, 2013

Dec. 31, 2012

Apr. 12, 2007

Oct. 31, 2013

Dec. 31, 2012

Oct. 31, 2009

Sep. 30, 2007

31-May-07

Feb. 28, 2007

Jun. 07, 2013

Oct. 31, 2013

Dec. 31, 2012

Apr. 12, 2007

Jun. 07, 2013

Dec. 31, 2014

Dec. 31, 2013

Oct. 31, 2013

Jun. 07, 2013

Oct. 31, 2013

Oct. 01, 2014

Nov. 03, 2014

Dec. 31, 2014

Nov. 03, 2014

Oct. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Apr. 12, 2007

Oct. 31, 2013

Dec. 31, 2012

Apr. 12, 2007

Dec. 31, 2014

Nov. 03, 2014

Oct. 31, 2013

Dec. 31, 2012

Nov. 03, 2014

Apr. 12, 2007

USD ($)

Quarterly Payment [Member]

Multi-currency [Member]

Senior Subordinated Notes [Member]

Secured Debt [Member]

First Lien Term Loan [Member]

Second Lien Term Loan [Member]

Incremental Amendment to the Second Amended and Restated Credit Agreement [Member]

New Tranche B Term Loan [Member]

Euro Tranche Term Loans [Member]

Tranche B Term Loan [Member]

Tranche C Term Loan [Member]

Overdraft Facility [Member]

Revolving Credit Facility [Member]

Tranche B Term Loan [Member]

Tranche C Term Loan [Member]

First Lien Term Loan [Member]

Revolving Credit Facility [Member]

Predecessor Senior Subordinated Notes [Member]

Japanese Senior Secured Bank Debt [Member]

Revolving Credit Facility [Member]

London Interbank Offered Rate (LIBOR) [Member]

USD ($)

London Interbank Offered Rate (LIBOR) [Member]

USD ($)

EUR (€)

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

Revolving Credit Facility [Member]

EUR (€)

USD ($)

Subordinated Debt [Member]

Redemption Premium [Member]

USD ($)

Redemption Premium [Member]

USD ($)

Note 9 - Long-term Debt (Details) [Line Items]

Long-term Debt

$1,415,900,000

$751,300,000

$805,000,000

$743,700,000

$751,300,000

$246,200,000

$129,000,000

Debt Instrument, Face Amount

5,600,000

2,500,000

7,600,000

15,000,000

755,000,000

360,000,000

300,000,000

130,000,000

256,000,000

205,000,000

360,000,000

250,000,000

Line of Credit Facility, Maximum Borrowing Capacity

25,000,000

87,500,000

25,000,000

50,000,000

87,500,000

50,000,000

Debt Instrument, Interest Rate, Stated Percentage

9.50%

4.00%

7.75%

1.00%

6.25%

Debt Instrument, Basis Spread on Variable Rate

3.00%

6.75%

Debt Instrument, Periodic Payment, Principal

4,200,000

4,600,000

1,900,000

218,000,000

3,600,000

146,000,000

2,600,000

Debt Instrument, Maturity Date

7-Jun-18

7-Jun-20

7-Dec-20

7-Jun-20

Debt Instrument, Unamortized Discount

1,900,000

1,800,000

3,600,000

Guaranteed Credit Facilities, Stock of the Company's First Tier Foreign Subsidiaries, Percentage

65.00%

Repayments of Long-term Debt

900,000

600,000

373,000,000

10,300,000

6,800,000

Line of Credit Facility, Additional Borrowing Capacity

62,500,000

Proceeds from Lines of Credit

55,000,000

60,000,000

Percentage of Borrowings in Excess of Commitments Under Revolving Credit Facilities

25.00%

Debt to EBITDA Ratio

6.5

Letters of Credit Outstanding, Amount

1,000,000

4,600,000

3,900,000

Debt Instrument, Periodic Payment, Interest

20,000,000

33,300,000

100,000

2,100,000

5,100,000

1,500,000

3,900,000

Early Repayment of Senior Debt

101,000,000

250,000,000

206,000,000

139,000,000

Revenues and Gains, Reporting Currency Denominated, Value

1,100,000

Expenses and Losses, Reporting Currency Denominated, Value

2,700,000

Line of Credit Facility, Commitment Fee Amount

100,000

300,000

Senior Notes

350,000,000

Repayments of Senior Debt

3,200,000

9,400,000

Proceeds from Issuance of Senior Long-term Debt

106,000,000

Interest Expense, Debt

2,200,000

Short-term Debt

Overdraft Facility, Maximum Capacity

$20,900,000

$22,100,000

Note_9_Longterm_Debt_Details_D

Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (USD $)	Dec. 31, 2014	Dec. 31, 2013	Jun. 07, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Jun. 07, 2013
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	$1,415.90	$751.30
Successor [Member] \| First Lien Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	743.7
Successor [Member] \| USD Incremental Loans [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	294.9
Successor [Member] \| Tranche B Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	129
Successor [Member] \| Euro Tranche Term Loans [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	246.2
Successor [Member] \| Other Debt [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	2.1
Total debt	1,415.90
Successor [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Less: current portion debt	-15.1
Total long-term debt	1,400.80
Predecessor [Member] \| First Lien Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt		751.3
Predecessor [Member] \| Other Debt [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt		1
Total debt		752.3
Predecessor [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Less: current portion debt		-8
Total long-term debt		744.3
First Lien Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	743.7	751.3	805
USD Incremental Loans [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	294.9
Tranche B Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	129
Euro Tranche Term Loans [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	246.2
Other Debt [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations [Line Items]
Secured debt	$2.10

Note_9_Longterm_Debt_Details_D1

Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Jun. 07, 2013
Successor [Member] \| First Lien Term Loan [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Variable interest rate, basis spread	3.00%
Successor [Member] \| First Lien Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Interest rate	4.00%
Weighted average interest rate	4.00%
Successor [Member] \| USD Incremental Loans [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Variable interest rate, basis spread	3.00%
Successor [Member] \| USD Incremental Loans [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Interest rate	4.00%
Weighted average interest rate	4.00%
Successor [Member] \| Tranche B Term Loan [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Variable interest rate, basis spread	3.00%
Successor [Member] \| Tranche B Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Interest rate	4.00%
Weighted average interest rate	4.00%
Successor [Member] \| Euro Tranche Term Loans [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Variable interest rate, basis spread	3.25%
Successor [Member] \| Euro Tranche Term Loans [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Interest rate	4.25%
Weighted average interest rate	4.25%
First Lien Term Loan [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Variable interest rate, basis spread		3.00%
First Lien Term Loan [Member]
Note 9 - Long-term Debt (Details) - Debt and Capital Lease Obligations (Parentheticals) [Line Items]
Interest rate		4.00%

Note_9_Longterm_Debt_Details_M

Note 9 - Long-term Debt (Details) - Minimum Future Principal Payments on Short-Term Debt, Long-Term Debt and Capital Leases (Capital Lease Obligations [Member], USD $)	Dec. 31, 2014
In Millions, unless otherwise specified	Dec. 31, 2014
Capital Lease Obligations [Member]
Note 9 - Long-term Debt (Details) - Minimum Future Principal Payments on Short-Term Debt, Long-Term Debt and Capital Leases [Line Items]
2015	$15.10
2016	15
2017	14.7
2018	14.6
2019	14.5
Thereafter	1,342
Total	$1,415.90

Note_10_Derivative_Instruments1

Note 10 - Derivative Instruments (Details)

Dec. 31, 2014

Nov. 03, 2014

Oct. 01, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Oct. 31, 2013

Dec. 31, 2012

Oct. 01, 2014

Dec. 31, 2012

Dec. 31, 2014

Sep. 23, 2014

Dec. 31, 2012

Jun. 30, 2012

In Millions, unless otherwise specified

Other Operating Income (Expense) [Member]

Not Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Successor [Member]

Predecessor [Member]

Foreign Exchange Contract [Member]

Interest Rate Contract [Member]

Foreign Exchange Contract [Member]

Successor [Member]

Predecessor [Member]

Foreign Exchange Contract [Member]

USD ($)

Foreign Exchange Contract [Member]

USD ($)

Agriphar And CAS [Member]

USD ($)

Agriphar And CAS [Member]

USD ($)

Foreign Exchange Contract [Member]

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

Note 10 - Derivative Instruments (Details) [Line Items]

Revenues Denominated in U.S. Dollars, Percentage

35.00%

Derivative Asset, Notional Amount

$14

Derivative Liability, Current

0.1

Number of Foreign Currency Derivatives Held

Derivative, Notional Amount

204

277

100

Derivative, Forward Exchange Rate

1.284

1.287845

Derivative, Loss on Derivative

Derivative, Gain on Derivative

7.3

Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax

0.2

-0.4

0.2

-0.2

-0.3

0.5

1.5

Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax

0.1

-0.1

-0.4

0.1

-0.2

1.9

Derivative, Floor Interest Rate

5.20%

Derivative, Cap Interest Rate

6.25%

Interest Expense, Trading Liabilities

$2.40

Derivative, Fixed Interest Rate

5.20%

Note_11_Fair_Value_Measurement2

Note 11 - Fair Value Measurements (Details) (USD $)	12 Months Ended
Note 11 - Fair Value Measurements (Details) (USD $)	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Assumptions Used Money Market Net Asset Value	$1

Note_11_Fair_Value_Measurement3

Note 11 - Fair Value Measurements (Details) - Financial Instruments, Assets and Liabilities Measured at Fair Value on Recurring Basis (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Asset Category
Money market accounts	$15.40	$78.60
Available for sale equity securities	2.3	2.3
Derivatives	0.1	0.2
Total	17.8	81.1
Liability Category
Long term contingent consideration	63.9	34.8
Fair Value, Inputs, Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Asset Category
Money market accounts	15.4	78.6
Available for sale equity securities	1.5	1.5
Total	16.9	80.1
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Measurements, Recurring [Member]
Asset Category
Available for sale equity securities	0.8	0.8
Derivatives	0.1	0.2
Total	0.9	1
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Liability Category
Long term contingent consideration	$63.90	$34.80

Note_11_Fair_Value_Measurement4

Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt (USD $)	Dec. 31, 2014	Dec. 31, 2013	Jun. 07, 2013
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Jun. 07, 2013
Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt [Line Items]
Debt Carrying Value	$1,415.90	$751.30
Debt Fair Value	1,387.60	752.6
First Lien Term Loan [Member]
Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt [Line Items]
Debt Carrying Value	743.7	751.3	805
Debt Fair Value	728.8	752.6
USD Incremental Loans [Member]
Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt [Line Items]
Debt Carrying Value	294.9
Debt Fair Value	289
Tranche B Term Loan [Member]
Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt [Line Items]
Debt Carrying Value	129
Debt Fair Value	126.5
Euro Tranche Term Loans [Member]
Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt [Line Items]
Debt Carrying Value	246.2
Debt Fair Value	241.3
Other Debt [Member]
Note 11 - Fair Value Measurements (Details) - Carrying Value and Estimated Fair Value of Debt [Line Items]
Debt Carrying Value	2.1
Debt Fair Value	$2

Note_12_Stockholders_Equity_De

Note 12 - Stockholders' Equity (Details)

Dec. 31, 2014

Jan. 23, 2014

Dec. 31, 2013

Apr. 25, 2013

Nov. 06, 2014

Oct. 08, 2014

20-May-14

Nov. 06, 2014

Oct. 08, 2014

Dec. 31, 2014

Oct. 25, 2013

Dec. 31, 2014

Nov. 17, 2014

Dec. 31, 2014

Nov. 17, 2014

Dec. 31, 2014

Nov. 17, 2014

22-May-13

Dec. 31, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

22-May-13

Dec. 31, 2014

22-May-13

Dec. 31, 2014

Oct. 01, 2014

Dec. 31, 2014

Nov. 03, 2013

Dec. 31, 2014

Oct. 25, 2013

Dec. 31, 2013

Oct. 25, 2013

22-May-13

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

22-May-13

Apr. 25, 2013

Nov. 17, 2014

Apr. 03, 2014

22-May-13

Nov. 06, 2014

22-May-13

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Oct. 25, 2013

Dec. 31, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Oct. 01, 2014

Dec. 31, 2014

Mar. 04, 2014

Oct. 31, 2013

Dec. 31, 2014

USD ($)

Berggruen Acquisition Holdings, IV, Ltd [Member]

Private Placement [Member]

Shares Issued In Connection With 401(k) Exchange Agreement [Member]

Common Stock [Member]

Warrant [Member]

Preferred Stock [Member]

Successor [Member]

Predecessor [Member]

Series A Preferred Stock [Member]

United States of America, Dollars

Euro Member Countries, Euro

Agriphar [Member]

MacDermid [Member]

PDH [Member]

Successor [Member]

Common Stock [Member]

Successor [Member]

Predecessor [Member]

Minimum [Member]

Maximum [Member]

Series A Preferred Stock [Member]

Stock Dividends to Series A Preferred Stock Shareholders [Member]

United States of America, Dollars

Euro Member Countries, Euro

Warrant Exchange Offer [Member]

Agriphar [Member]

Chemtura [Member]

MacDermid [Member]

Non-founder Directors [Member]

Founders [Member]

Two Independent Directors [Member]

PDH [Member]

Founder Entities [Member]

Mariposa Acquisition, LLC [Member]

USD ($)

Agriphar [Member]

USD ($)

EUR (€)

USD ($)

Series A Preferred Stock [Member]

USD ($)

Successor [Member]

MacDermid [Member]

USD ($)

Weighted Average [Member]

Underwriter Options [Member]

Agriphar [Member]

Chemtura [Member]

USD ($)

Warrants and Rights Subject to Mandatory Redemption [Member]

USD ($)

PDH [Member]

Preferred Stock Conversion [Member]

Common Stock Conversion [Member]

Founder Entities [Member]

USD ($)

Agriphar [Member]

USD ($)

EUR (€)

USD ($)

Stock Dividends to Series A Preferred Stock Shareholders [Member]

USD ($)

Note 12 - Stockholders' Equity (Details) [Line Items]

Stock Issued During Period, Shares, New Issues

9,404,064

16,060,960

15,800,000

1,670,386

16,445,000

13,462,280

29,500

380,952

190,476

1,999,998

88,500,000

134,044

Preferred Stock, Value, Issued (in Dollars)

$20

Stock Issued During Period, Value, New Issues (in Dollars)

300,000,000

18,400,000

20,000,000

Preferred Stock, Shares Outstanding

2,000,000

315,144

2,000,000

Common Stock Dividends, Shares

10,050,290

Preferred Stock, Ordinary Share Market Price Appreciation, Dividend, Percentage

20.00%

Share Price (in Dollars per share)

$0.01

$25.59

$11

$23.16

$24.50

$10

$10.50

$18

Common Stock, Dividends, Per Share, Declared (in Dollars per share)

$22.85

Convertible Preferred Stock, Shares Issued upon Conversion

Other Preferred Stock Dividends and Adjustments (in Dollars)

172,000,000

Stock Issued During Period, Value, Stock Options Exercised (in Dollars)

2,145,000

Proceeds from Issuance of Common Stock (in Dollars)

141,000,000

403,000,000

1,019,500,000

1,512,600,000

Payments of Stock Issuance Costs (in Dollars)

13,800,000

300,000

14,100,000

Stock Issued During Period, Shares, Acquisitions

1,670,386

711,551

2,000,000

711,551

2,000,000

Stock Issued During Period, Value, Acquisitions

18,200,000

16,600,000

15,000,000

52,000,000

Foreign Currency Exchange Rate, Translation

1.21

Proceeds from Issuance of Private Placement (in Dollars)

652,000,000

16,244,694

Class of Warrant or Right, Exercised During Period

48,734,082

Proceeds from Warrant Exercises (in Dollars)

187,000,000

Warrants Redeemed

8,580

Warrants Redeemed Price (in Dollars per share)

$0.01

Business Acquisition, Percentage of Ownership

3.00%

97.00%

Business Combination, Consideration Transferred (in Dollars)

2,600,000

370,000,000

300,000,000

370,300,000

1,800,000,000

1,821,600,000

Common Stock, Shares Issued Upon Conversion

134,044

Common Stock, Par or Stated Value Per Share (in Dollars per share)

$0.01

Proceeds from Issuance Initial Public Offering (in Dollars)

885,000,000

Class of Warrant or Right, Outstanding

90,529,500

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$11.50

Class of Warrant or Right, Exercisable Time Period

3 years

Class of Warrant or Right, Warrant Redemption Price (in Dollars)

0.01

Class of Warrant or Right, Threshold Consecutive Trading Days

10 days

Sale of Stock, Price Per Share (in Dollars per share)

$1,000

$10.50

Warrants Exchanged Per Common Share

Warrants Exchanged for Common Stock

40,386,840

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned (in Dollars)

97,500,000

16,600,000

115,400,000

Annual Amount of Equity of Wholly Owned Subsidiary Eligible to be Exchanged for Common shares of the Company, Percentage

25.00%

Annual Amount of Equity of Wholly Owned Subsidiary Eligible To Be Exchanged For Common Shares Of The Company Period

4 years

Common Stock Originally Issuable Upon Exchange, Shares

8,800,000

Income (Loss) Attributable to Noncontrolling Interest (in Dollars)

-1,400,000

-6,400,000

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

6.66%

6.76%

Common Stock, Shares, Issued

182,066,980

103,571,941

50,000,000

Common Stock, Shares, Outstanding

182,066,980

103,571,941

49,582,936

Preferred Stock, Shares Issued

316,000

2,000,000

Preferred Stock, Dividend Rate, Percentage

9.00%

Dividends, Paid-in-kind (in Dollars)

$209,000,000

Note_13_Earnings_Per_Share_Det

Note 13 - Earnings Per Share (Details)	12 Months Ended
Note 13 - Earnings Per Share (Details)	Dec. 31, 2014	Dec. 31, 2013
Note 13 - Earnings Per Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	23,026,000	16,248,000
Share Adjustments [Member]
Note 13 - Earnings Per Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0

Note_13_Earnings_Per_Share_Det1

Note 13 - Earnings Per Share (Details) - Weighted Average Shares Outstanding	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Weighted average shares outstanding:
Basic	135,300		92,600
Convertible securities (1)		[1]		[1]
Diluted	135,300		92,600

[1]	No share adjustments are included in the dilutive weighted average shares outstanding computation as the year ended December 31, 2014 and the Successor 2013 Period resulted in net losses.

Note_13_Earnings_Per_Share_Det2

Note 13 - Earnings Per Share (Details) - Weighted-Average Stock Options and Warrants Not Included in the Computation of Diluted Shares Outstanding	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	23,026,000	16,248,000
Contingently Issuable Shares for the Founder Preferred Share Dividend Right [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	10,453,000
Shares Issuable Upon Conversion Of Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities		16,248,000
Shares Issuable Upon Conversion of PDH Non-controlling Interest [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	8,641,000
Shares Issuable Upon Conversion of Founder Preferred Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	2,000,000
Shares Contingently Issuable For The Contingent Consideration [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	1,503,000
Shares Issuable Upon Conversion of 401k Exchange Rights [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	270,000
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	89,000
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive securities	70,000

Note_14_Operating_Lease_Commit2

Note 14 - Operating Lease Commitments (Details) (USD $)	12 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2012
Note 14 - Operating Lease Commitments (Details) [Line Items]
Operating Leases, Rent Expense	$11.30
Successor [Member]
Note 14 - Operating Lease Commitments (Details) [Line Items]
Operating Leases, Rent Expense		1.5
Predecessor [Member]
Note 14 - Operating Lease Commitments (Details) [Line Items]
Operating Leases, Rent Expense			$9.10	$9.70

Note_14_Operating_Lease_Commit3

Note 14 - Operating Lease Commitments (Details) - Minimum Future Non-cancelable Operating Lease Commitments (USD $)	Dec. 31, 2014
Minimum Future Non-cancelable Operating Lease Commitments [Abstract]
2015	$9,300
2016	6,300
2017	4,400
2018	3,500
2019	3,400
Thereafter	15,500
	$42,400

Note_15_Other_Expense_Income_N1

Note 15 - Other (Expense) Income, Net (Details) (USD $)	12 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2012
Note 15 - Other (Expense) Income, Net (Details) [Line Items]
Other Nonoperating Income (Expense)	($2.50)
Foreign Currency Transaction Gain (Loss), before Tax	-3
Successor [Member]
Note 15 - Other (Expense) Income, Net (Details) [Line Items]
Other Nonoperating Income (Expense)	-2.5	-0.4
Foreign Currency Transaction Gain (Loss), before Tax		-0.6
Predecessor [Member]
Note 15 - Other (Expense) Income, Net (Details) [Line Items]
Other Nonoperating Income (Expense)		-0.5	-0.5	5
Foreign Currency Transaction Gain (Loss), before Tax				4.7
Derivative, Gain (Loss) on Derivative, Net			($0.40)

Note_16_Contingencies_Environm2

Note 16 - Contingencies, Environmental And Legal Matters (Details) (USD $)	0 Months Ended
	Feb. 19, 2015	Jul. 08, 2014	Dec. 31, 2014	Dec. 31, 2013
Note 16 - Contingencies, Environmental And Legal Matters (Details) [Line Items]
Asset Retirement Obligation			$18,500,000	$4,800,000
Reserves for Environmental Contingencies			4,500,000	2,900,000
Loss Contingency, Estimate of Possible Loss			4,400,000	2,900,000
Subsequent Event [Member] \| Settled Litigation [Member] \| MacDermid [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) [Line Items]
Litigation Settlement, Amount	25,000,000
Awarded for Anti-Trust Damages [Member] \| MacDermid [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) [Line Items]
Litigation Settlement, Amount		3,900,000
Awarded for Breach of Contract Damages [Member] \| MacDermid [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) [Line Items]
Litigation Settlement, Amount		7,900,000
Awarded for Additional Punitive Damages for Misappropriation of Trade Secrets [Member] \| MacDermid [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) [Line Items]
Litigation Settlement, Amount		3,800,000
Awarded for Additional Punitive Damages for Unfair Trade Practices [Member] \| MacDermid [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) [Line Items]
Litigation Settlement, Amount		$11,900,000

Note_16_Contingencies_Environm3

Note 16 - Contingencies, Environmental And Legal Matters (Details) - Changes in the Companybs AROs for the Successor and Predecessor 2013 Periods (USD $)	9 Months Ended	12 Months Ended	10 Months Ended
	Dec. 31, 2013	Dec. 31, 2014	Oct. 31, 2013
Note 16 - Contingencies, Environmental And Legal Matters (Details) - Changes in the Companybs AROs for the Successor and Predecessor 2013 Periods [Line Items]
Balance,	$4,800,000	$18,500,000
Successor [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) - Changes in the Companybs AROs for the Successor and Predecessor 2013 Periods [Line Items]
Balance, April 23, 2013 (inception)	0	4,800
Balance,	4,800	18,500
Acquisitions	4,800	13,200
Additional obligations incurred		500
Accretion expense		700
Payments		-200
Foreign currency adjustments		-500
Predecessor [Member]
Note 16 - Contingencies, Environmental And Legal Matters (Details) - Changes in the Companybs AROs for the Successor and Predecessor 2013 Periods [Line Items]
Balance, April 23, 2013 (inception)			2,300
Balance,			2,200
Settlements			-100
Accretion expense			100
Foreign currency adjustments			($100)

Note_17_Related_Party_Transact1

Note 17 - Related Party Transactions (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

2 Months Ended

10 Months Ended

12 Months Ended

0 Months Ended

Oct. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Feb. 12, 2015

20-May-14

Nov. 30, 2014

Oct. 31, 2013

Dec. 31, 2012

Aug. 26, 2013

Jan. 23, 2014

Nov. 06, 2014

Oct. 03, 2014

Note 17 - Related Party Transactions (Details) [Line Items]

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

6.66%

Share Price (in Dollars per share)

$0.01

Mariposa Capital [Member] | Annual Fee [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Related Party Transaction, Amounts of Transaction

$2,000,000

Mariposa Capital [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Related Party, Notice of Non-Renewal to Agreement

90 days

Related Party, Effective Termination Date After Expiration of Agreement Term

6 months

Related Party Transaction, Expenses from Transactions with Related Party

2,000,000

400,000

Blue Ridge Limited Partnership [Member] | Subsequent Event [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Related Party, Ownership Percentage

5.00%

Blue Ridge Limited Partnership [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares)

1,000,000

1,953,888

Share Price (in Dollars per share)

$19

$25.59

Pershing Square [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Share Price (in Dollars per share)

$25.59

Certain Stockholders [Member] | Support Agreement [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Common Stock Outstanding, Percentage

28.50%

Court Square [Member] | Predecessor [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Management Fee Expense

7,500,000

300,000

Weston Presidio [Member] | Predecessor [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Management Fee Expense

1,700,000

100,000

Officer [Member] | Loan in Exchange for Promissory Note [Member] | Predecessor [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Related Party Transaction, Amounts of Transaction

300,000

Related Party Transaction, Rate

1.00%

Interest on Credit Facilities of MacDermid [Member] | MacDermid [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Other Payments to Acquire Businesses

5,000,000

Seven-Year Period [Member] | MacDermid [Member] | Maximum [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

100,000,000

MacDermid [Member] | Equity Held By MacDermid Employee Shares [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Payments to Acquire Businesses, Gross

33,300,000

MacDermid [Member]

Note 17 - Related Party Transactions (Details) [Line Items]

Business Acquisition, Shares Price Exchange Rate

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

100,000,000

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners

6.76%

Payments to Acquire Businesses, Gross

$916,500,000

Note_18_Restructuring_Activiti1

Note 18 - Restructuring Activities (Details) (USD $)	12 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2012
Note 18 - Restructuring Activities (Details) [Line Items]
Restructuring Charges	$3
Restructuring Reserve, Current	1.6
Successor [Member]
Note 18 - Restructuring Activities (Details) [Line Items]
Restructuring Charges	3	0.8
Predecessor [Member]
Note 18 - Restructuring Activities (Details) [Line Items]
Restructuring Charges			$3.60	$0.30

Note_19_Segment_Information_De

Note 19 - Segment Information (Details)	12 Months Ended
Note 19 - Segment Information (Details)	Dec. 31, 2014
Segment Reporting [Abstract]
Number of Reportable Segments	3

Note_19_Segment_Information_De1

Note 19 - Segment Information (Details) - Financial Information Regarding Each Reportable Segment (USD $)	9 Months Ended		10 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Oct. 31, 2013		Dec. 31, 2014		Dec. 31, 2012
Net Sales:
Performance Materials	$118.20	[1]	$627.70	[1]	$843.20	[1]	$731.20	[1]
Depreciation and amortization:
Performance Materials	12.8		32.8		88		42.2
Adjusted EBITDA
Performance Materials	27.4		152.7		212.2		162.2
Performance Materials [Member]
Net Sales:
Performance Materials	92.6		481.8		589.3		559.5
Depreciation and amortization:
Performance Materials	9.7		26.5		55		34
Adjusted EBITDA
Performance Materials	21.6		115		148.7		118.6
Graphic Solutions [Member]
Net Sales:
Performance Materials	25.6		145.9		165.9		171.7
Depreciation and amortization:
Performance Materials	3.1		6.3		21.3		8.2
Adjusted EBITDA
Performance Materials	5.8		37.7		47.5		43.6
ArgoSolutions [Member]
Net Sales:
Performance Materials					88
Depreciation and amortization:
Performance Materials					11.7
Adjusted EBITDA
Performance Materials					$16

[1]	Net sales are attributed to countries based on the country which generates the sale.

Note_19_Segment_Information_De2

Note 19 - Segment Information (Details) - Reconciliation of Net (Loss) Income Attributable to Common Shareholders to Adjusted EBITDA (USD $)	9 Months Ended	10 Months Ended	12 Months Ended		3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Oct. 31, 2013	Dec. 31, 2014	Dec. 31, 2012	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013		Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012
Note 19 - Segment Information (Details) - Reconciliation of Net (Loss) Income Attributable to Common Shareholders to Adjusted EBITDA [Line Items]
Income tax benefit (provision)	$5.80	($13)	$6.70	($24.70)
Depreciation and amortization expense	-12.8	-32.8	-88	-42.2
Successor [Member]
Note 19 - Segment Information (Details) - Reconciliation of Net (Loss) Income Attributable to Common Shareholders to Adjusted EBITDA [Line Items]
Adjusted EBITDA	27.4		212.2
Income tax benefit (provision)	5.8		6.7
Interest expense	-5.5		-38.7
Depreciation and amortization expense	-12.8		-88
Non-cash charges related to preferred dividend rights	-172
Equity based compensation	-0.5		-1.3
Restructuring and related expenses	-3.5		-3
Manufacturer's profit in inventory adjustment	-23.9		-35.5
Non-cash fair value adjustment to contingent consideration	0.7		-29.1
Acquisition transaction costs	-15.2		-47.8
Other (expense) income	5.3		-5.4
Net (loss) income attributable to common shareholders	-194.2		-29.9		-34	11.9	-0.4	-7.4	-189.4		-4.7
Predecessor [Member]
Note 19 - Segment Information (Details) - Reconciliation of Net (Loss) Income Attributable to Common Shareholders to Adjusted EBITDA [Line Items]
Adjusted EBITDA		152.7		162.2
Income tax benefit (provision)		-13		-24.7
Interest expense		-46.3		-49.7
Depreciation and amortization expense		-32.8		-42.2
Equity based compensation		-9.3		-0.2
Restructuring and related expenses		-4.5		-1.2
Acquisition transaction costs		-16.9
Debt extinguishment		-18.8
Other (expense) income		2.1		1.8
Net (loss) income attributable to common shareholders		$13.20		$46					($10.70)	[1]	$14.50	($5.90)	$15.20	$5.50	$10	$25.50	$4.90

[1]	MacDermid's fourth quarter includes results from October 1, 2013 through October 31, 2013.

Note_19_Segment_Information_De3

Note 19 - Segment Information (Details) - Countries Representing 10% or More in Net Sales and Long-Lived Assets (USD $)	9 Months Ended		10 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Oct. 31, 2013		Dec. 31, 2014		Dec. 31, 2012
Revenue, Major Customer [Line Items]
Net sales revenues	$118.20	[1]	$627.70	[1]	$843.20	[1]	$731.20	[1]
Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member] \| UNITED STATES
Revenue, Major Customer [Line Items]
Net sales revenues	31.5		176.4		217.4		205.6
Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member] \| UNITED KINGDOM
Revenue, Major Customer [Line Items]
Net sales revenues	17.8		93.4		119.1		115.2
Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member] \| CHINA
Revenue, Major Customer [Line Items]
Net sales revenues	13.5		64.2		87.8		66.3
Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member] \| Other Countries [Member]
Revenue, Major Customer [Line Items]
Net sales revenues	55.4		293.7		418.9		344.1
Sales Revenue, Net [Member] \| Geographic Concentration Risk [Member] \| Foreign Sales [Member]
Revenue, Major Customer [Line Items]
Net sales revenues	$86.70		$451.30		$625.80		$525.60

[1]	Net sales are attributed to countries based on the country which generates the sale.

Note_19_Segment_Information_De4

Note 19 - Segment Information (Details) - Long-lived Assets by Country (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Long lived assets, net (1)
Long-lived assets	$175	[1]	$136.20	[1]
UNITED STATES
Long lived assets, net (1)
Long-lived assets	64.8	[1]	56.5	[1]
UNITED KINGDOM
Long lived assets, net (1)
Long-lived assets	28.9	[1]	30	[1]
ITALY
Long lived assets, net (1)
Long-lived assets	28	[1]	13.8	[1]
Other Countries [Member]
Long lived assets, net (1)
Long-lived assets	53.3	[1]	18.5	[1]
Foreign [Member]
Long lived assets, net (1)
Long-lived assets	110.2	[1]	79.7	[1]
CHINA
Long lived assets, net (1)
Long-lived assets			$17.40	[1]

[1]	Long-lived assets represent property, plant and equipment, net.

Note_19_Segment_Information_De5

Note 19 - Segment Information (Details) - External Party Sales by Product (USD $)

9 Months Ended

10 Months Ended

12 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Oct. 31, 2013

Dec. 31, 2014

Dec. 31, 2012

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

$118.20

[1]

$627.70

[1]

$843.20

[1]

$731.20

[1]

Industrial Group [Member] | Successor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

67.7

429.4

Industrial Group [Member] | Predecessor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

353.4

411.1

Electronic Group [Member] | Successor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

24.9

159.9

Electronic Group [Member] | Predecessor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

128.4

148.4

Performance Materials [Member] | Successor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

92.6

589.3

Performance Materials [Member] | Predecessor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

481.8

559.5

Performance Materials [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

92.6

481.8

589.3

559.5

Graphic Solutions [Member] | Successor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

25.6

165.9

Graphic Solutions [Member] | Predecessor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

145.9

171.7

Graphic Solutions [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

25.6

145.9

165.9

171.7

Agro Solutions [Member] | Successor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

Successor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

118.2

843.2

273.6

196.8

189.1

183.7

118.2

Predecessor [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

External party sales

$627.70

$731.20

$67.20

[2]

$188.40

$190

$182.10

$182.40

$180.40

$186.20

$182.20

[1]

Net sales are attributed to countries based on the country which generates the sale.

[2]

MacDermid's fourth quarter includes results from October 1, 2013 through October 31, 2013.

Note_20_Subsequent_Events_Deta

Note 20 - Subsequent Events (Details)

0 Months Ended

Apr. 23, 2013

Mar. 17, 2015

Feb. 02, 2015

Feb. 13, 2015

Feb. 02, 2015

Feb. 13, 2015

Feb. 19, 2015

Feb. 13, 2015

Nov. 03, 2014

Apr. 12, 2007

Nov. 03, 2014

Apr. 12, 2007

Apr. 23, 2013

Employee Stock Option [Member]

Restricted Stock Units (RSUs) [Member]

Stock Dividends to Series A Preferred Stock Shareholders [Member]

Subsequent Event [Member]

Multi-currency [Member]

Euro Tranche Term Loans [Member]

Tranche B Term Loan [Member]

Revolving Credit Facility [Member]

Former Non-founder Directory [Member]

Subsequent Event [Member]

Multi-currency [Member]

USD Notes Due 2022 [Member]

EUR Notes Due 2023 [Member]

Tranche B-2 Term Loan [Member]

Euro Tranche Term Loans [Member]

Tranche B Term Loan [Member]

Revolving Credit Facility [Member]

Arysta [Member]

Settled Litigation [Member]

Former Non-founder Directory [Member]

Revolving Credit Facility [Member]

USD ($)

EUR (€)

USD ($)

Director [Member]

USD ($)

Revolving Credit Facility [Member]

Arysta [Member]

Eurodollar [Member]

Base Rate [Member]

USD ($)

EUR (€)

Eurodollar [Member]

Base Rate [Member]

Eurodollar [Member]

Base Rate [Member]

USD ($)

MacDermid [Member]

USD ($)

EUR (€)

USD ($)

Note 20 - Subsequent Events (Details) [Line Items]

Common Stock Dividends, Per Share (in Dollars per share)

$10,050,290

Business Combination, Consideration Transferred

$3,570,000,000

Payments to Acquire Businesses, Gross

2,930,000,000

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable

600,000,000

Convertible Preferred Stock, Shares Issued upon Conversion, Shares (in Shares)

22,107,590

Convertible Preferred Stock, Value Converted, Maximum

600,000,000

Debt Instrument, Face Amount

1,100,000,000

350,000,000

500,000,000

287,000,000

256,000,000

205,000,000

360,000,000

Debt Instrument, Interest Rate, Stated Percentage

6.50%

6.00%

Debt Instrument, Maturity Date

1-Feb-22

1-Feb-23

7-Jun-20

7-Jun-18

7-Jun-20

Term Loan, Additional Borrowing Capacity (in Euro)

83,000,000

Line of Credit Facility, Additional Borrowing Capacity

75,000,000

62,500,000

Line of Credit Facility, Maximum Borrowing Capacity

163,000,000

87,500,000

50,000,000

DebtInstrumentDiscountPercentage

1.00%

2.00%

Long-term Line of Credit

160,000,000

Debt Instrument, Basis Spread on Variable Rate

3.75%

2.75%

3.50%

2.50%

3.00%

2.00%

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

5 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)

75,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)

75,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)

3,821

Litigation Settlement, Amount

$25,000,000

Note_21_Supplementary_Data_Det

Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) (USD $)	9 Months Ended		10 Months Ended		12 Months Ended				2 Months Ended	3 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013		Oct. 31, 2013		Dec. 31, 2014		Dec. 31, 2012		Jun. 30, 2013	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013
Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) [Line Items]
Net sales	$118.20	[1]	$627.70	[1]	$843.20	[1]	$731.20	[1]
Successor [Member] \| From Inception [Member]
Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) [Line Items]
Net (loss) income attributable to shareholders									-0.1
Net (loss) income attributable to common shareholders									-0.1
Successor [Member]
Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) [Line Items]
Net sales	118.2				843.2					273.6	196.8	189.1	183.7	118.2
Gross profit	35.7				396.6					112.4	103.2	96.7	84.2	35.7
Net (loss) income attributable to shareholders	-194.2				-29.9					-34	11.9	-0.4	-7.4	-189.4	-4.7
Net (loss) income attributable to common shareholders	($194.20)				($262.60)					($266.70)	$11.90	($0.40)	($7.40)	($189.40)	($4.70)
Basic earnings (loss) per share (a) (in Dollars per share)	($2.10)				($1.94)					($1.59)	$0.09	$0	($0.07)	($2.05)	($0.05)
Diluted earnings (loss) per share (a) (in Dollars per share)	($2.10)				($1.94)					($1.59)	$0.08	$0	($0.07)	($2.05)	($0.05)

[1]	Net sales are attributed to countries based on the country which generates the sale.

Note_21_Supplementary_Data_Det1

Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) (USD $)

9 Months Ended

10 Months Ended

12 Months Ended

3 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 31, 2013

Oct. 31, 2013

Dec. 31, 2014

Dec. 31, 2012

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) [Line Items]

Net sales

$118.20

[1]

$627.70

[1]

$843.20

[1]

$731.20

[1]

Predecessor [Member]

Note 21 - Supplementary Data (Details) - Selected Quarterly Financial Data (Unaudited) [Line Items]

Net sales

627.7

731.2

67.2

[2]

188.4

190

182.1

182.4

180.4

186.2

182.2

Gross profit

322.8

355.1

[2]

96.5

93.3

88.8

89.7

90.3

86.3

Net income (loss) attributable to MacDermid, Inc.

$13.20

$46

($10.70)

[2]

$14.50

($5.90)

$15.20

$5.50

$10

$25.50

$4.90

Basic earnings (loss) per share (a) (in Dollars per share)

[2],[3]

[3]

Diluted earnings (loss) per share (a) (in Dollars per share)

[2],[3]

[3]

[1]

Net sales are attributed to countries based on the country which generates the sale.

[2]

MacDermid's fourth quarter includes results from October 1, 2013 through October 31, 2013.

[3]

Earnings per share calculations for each quarter are based on the weighted average number of shares outstanding for each period. As MacDermid was not a Registrant prior to the Successor 2013 Period, no earnings per share data is presented;

Note_22_Valuation_and_Qualifyi1

Note 22 - Valuation and Qualifying Accounts and Reserves (Details) - Valuation and Qualifying Accounts and Reserves (USD $)	9 Months Ended		12 Months Ended		10 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2014		Oct. 31, 2013		Dec. 31, 2012
Successor [Member] \| Allowance for Doubtful Accounts [Member]
Note 22 - Valuation and Qualifying Accounts and Reserves (Details) - Valuation and Qualifying Accounts and Reserves [Line Items]
Balance at beginning of period		[1]	($10.10)	[1]
Charges to costs and expense	-0.3	[1]	-1.2	[1]
Deductions from reserves	0.6	[1]	0.9	[1]
Other	-10.4	[1],[2]	0.8	[1],[2]
Balance at end of period	-10.1	[1]	-9.6	[1]
Successor [Member] \| Valuation Allowance of Deferred Tax Assets [Member]
Note 22 - Valuation and Qualifying Accounts and Reserves (Details) - Valuation and Qualifying Accounts and Reserves [Line Items]
Balance at beginning of period			-15.8
Charges to costs and expense	0.9		-2
Other	-16.7	[2],[3]	-1.9	[2]
Balance at end of period	-15.8		-19.7
Predecessor [Member] \| Allowance for Doubtful Accounts [Member]
Note 22 - Valuation and Qualifying Accounts and Reserves (Details) - Valuation and Qualifying Accounts and Reserves [Line Items]
Balance at beginning of period					-8.8	[1]	-8.7	[1]
Charges to costs and expense					-2.1	[1]	-1.7	[1]
Deductions from reserves					0.6	[1]	1.7	[1]
Other					-0.1	[1],[2]	-0.1	[1],[2]
Balance at end of period					-10.4	[1]	-8.8	[1]
Predecessor [Member] \| Valuation Allowance of Deferred Tax Assets [Member]
Note 22 - Valuation and Qualifying Accounts and Reserves (Details) - Valuation and Qualifying Accounts and Reserves [Line Items]
Balance at beginning of period					-41.4		-34.5
Charges to costs and expense					-3.6		-6.9
Other						[2]		[2]
Balance at end of period					($45)		($41.40)

[1]	Principally consisting of reserves for uncollectable accounts and sales returns and allowances.
[2]	Principally consisting of the opening balance sheet as a result of the MacDermid Acquisition.
[3]	Revised to reflect final purchase price allocation as presented in updates to our annual report on Form 10-K for fiscal year ended December 31, 2013, as reported in our current report on Form 8-K filed with the SEC on September 26, 2014.